CN1348446A - Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group - Google Patents
Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group Download PDFInfo
- Publication number
- CN1348446A CN1348446A CN99815997A CN99815997A CN1348446A CN 1348446 A CN1348446 A CN 1348446A CN 99815997 A CN99815997 A CN 99815997A CN 99815997 A CN99815997 A CN 99815997A CN 1348446 A CN1348446 A CN 1348446A
- Authority
- CN
- China
- Prior art keywords
- phenyl
- carboxylic acid
- thioureido
- acid amides
- thiadiazoles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compounds having formula (I) wherein R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, CN, NO2, CO2R6, COR6, OR6, SR6, SOR6, SO2R6, CONR7R8, NR6N(R7R8), N(R7R8) or W-Y-(CH2)n-Z provided that at least one of R1-R5 is not hydrogen; or R2 and R3 or R3 and R4, taken together form a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 and R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; W is O, NR6, or is absent; Y is (CO)- or (CO2)-, or is absent; Z is alkyl of 1 to 4 carbon atoms, CN, CO2R6, COR6, CONR7R8, OCOR6, NR6COR7, OCONR6, OR6, SR6, SOR6, SO2R6, SR6N(R7R8), N(R7R8) or phenyl; G is monocyclic heteroaryl; X is a bond, NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, or thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6, useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses -6 and -7, and Kaposi herpesvirus.
Description
Background of invention
Identified the viral member (Roizman of 8 kinds of herpetoviridaes, B.1996, Herpesviridae, p.2221-2230, B.N.Fields, D.M.Knipe, and P.M.Howley (volume), Fields Virology, the third edition, Lippincott-Raven Publishers, Philadelphia summarizes among the PA).Each member's of this section feature is the envelope virus that contains outer quilt of protein and nucleocapsid, carries the relatively large double-stranded DNA genome (promptly about 80-250 kilobase) of virus in the nucleocapsid.The member of people's Alphaherpesviridae is neurotropic, comprises herpes simplex types 1 virus (HSV-1) and 2 types (HSV-2) and varicella zoster virus (VZV).People β-simplexvirus is cytomegalovirus (HCMV), herpes virus hominis 6 (HHV-6) and herpes virus hominis 7 (HHV-7).Gamma herpes viruses is that the parent is lymphatic, comprises Epstein-Barr virus (EBV) and Kaposi herpesvirus (HHV-8).Each all has cause-effect relationship with human diseases these simplexviruss, comprise herpes labialis and genital herpes (HSV-1 and HSV-2[Whitley, R.J.1996.Herpes Simplex Viruses, p.2297-2342, in B.N.Fields, D.M.Knipe, and P.M.Howley (volume) Fields Virology, the third edition, Lippincott-Raven Publishers, Philadelphia, PA]); Chicken pox and zoster (VZV[Arvin.A.1996.Varicella-Zoster Virus, p.2547-2585, in B.N.Fields, D.M.Knipe, and P.M.Howley (volume), Fields Virology, the third edition, Lippincott-RavenPublishers, Philadelphia, PA]); Infectious monocytosis (EBV[Rickinson, A.B. and Kieff, Virus E.1996.Epstein-Barr, p.2397-2446, in B.N.Fields, D.M.Knipe, and P.M.Howley (volume), Fields Virology, the third edition, Lippincott-Raven Publishers, Philadelphia, PA]); Pneumonia and the retinitis (HCMV[(Britt, W.J. and Alford, C.A.1996.Cytomegalovims, p.2493-2523, in B.N.Fields, D.M.Knipe, and P.M.Howley (volume), Fields Virology, the third edition, Lippincott-Raven Publishers, Philadelphia, PA)]); Roseola infantum (HHV-6[(Pellet, P.E. and Black, J.B.1996.Human Herpesvirus 6, p.2587-2608, in B.N.Fields, D.M.Knipe, and P.M.Howley (volume), Fields Virology, the third edition, Lippincott-Raven Publishers, Philadelphia, PA)] and HHV-7[Frenkel, N., and Roffman, E.1996.Human Herpesvirus 7, p.2609-2622, in B.N.Fields, D.M.Knipe, and P.M.Howley (volume), Fields Virology, the third edition, Lippincott-Raven Publishers, Philadelphia, PA]); And Kaposi (HHV-8[Neipel, F., Albrecht, J.C., and Fleckenstein, B.1997, the cell homologous genes of the rhadinovirus human herpes virus 8 that Kaposi is relevant: its pathogenicity bo determinant? J.Virol.71:4187-92,1997]).Considered HCMV hereinafter in more detail.After the primary infection, simplexvirus is set up in infected individuality and hides, and will have the remaining time in all one's life in his body.Regularly reactivating of latent virus is clinical relevant.With regard to HSV, the virus that reactivates can pass to fetus at birth, causes skin or ocular infection, central nervous system infection, or disseminated infections (being a plurality of organs or whole body).Zoster is the clinical manifestation that VZV reactivates.Antiviral is used in the treatment of HSV and VZV usually, and as acyclovir (Glaxo Wellcome), ganciclovir (Roche) and phosphine formic acid (foscamet) (Astra), their target is the archaeal dna polymerase of encoding viral.
HCMV is a kind of ubiquitous opportunistic pathogen, infects the crowd's of growing up 50-90% (Britt, W.J. and Alford, C.A.1 996. cytomegaloviruses, p.2493-2523, in B.N.Fields, D.M.Knipe, and P.M.Howley (volume), open-air virusology, the third edition, Lippincott-Raven Publishers, Philadelphia, PA).The primary infection of HCMV usually is asymptomatic, though observe the monocytosis of heterophil feminine gender.Pass through sexual intercourse, breast milk and saliva that virus is horizontal are transmitted.The intrauterine HCMV of existence from pregnant woman to the fetus transmits, and it usually is the reason of serious clinical consequences.HCMV is in infected human body, and its residue is all kept latent state throughout one's life eventually.Cell-mediated immunity is hidden in control and played central role in being brought back to life.The impaired HCMV that causes the seropositivity philtrum to be hidden of cellular immunity brings back to life.
The HCMV disease is relevant with defective or jejune cellular immunization.The people who suffers from the HCMV disease mainly contains three classes (Britt and Alford summary, 1996).(1) at immunocompromised host (AIDS) philtrum, HCMV is one of two kinds of modal pathogenic agent that cause clinical disease (another kind is the lung sac worm).HCMV modal performance in patient AIDS is the retinitis, though other organ comprises that the infection of suprarenal gland, lung, gi tract and central nervous system also often is in the news.90% patient AIDS suffers from active HCMV and infects; 25-40% (about~85,000 patient of the U.S.) suffers from the HCMV disease of threat to life or vision.HCMV is patient's 10%AIDS the cause of death.(2) owing to for the danger that suppresses transplant rejection suppresses immunity system, HCMV bring back to life or again subinfection be common among the patient of kidney, liver, heart and simplified marrow transplanting.Pneumonia is a modal HCMV disease among these patients, reaches 70% in these transplant patients.(3) because the congenital infection that causes of HCMV takes place approximately annual 40,000 in neonatal 1% at all.Reach 25% among these babies and have the symptom of HCMV disease between year at 0-3.The HCMV disease is progressive, causes children's backwardness and dysautonomia.Recent research prompting can reduce these children's sickness rate with anti-HCMV pharmacological agent.
That sells at present has several antiviral (Bron, D., R.Snoeck and L.Lagneaux, 1996, the new viewpoint of cytomegalovirus pathogeny and treatment, an Exp.Opin.Invest.Drugs 5:337-344; Crumpacker, C.1996. treating herpes: summary, Exp.Opin.Invest.Drugs 5:169-183).These comprise: ganciclovir (Roche), the toxic nucleosides congener of a kind of tool hematopoietic cell; Phosphine formic acid (Asta), a kind of tetra-sodium congener of tool Toxicity of Kidney; And Xi Duofuwei (cidofovir) (Gilead), the toxic nucleoside phosphonate of a kind of tool acute renal.Each target of these medicines all is the archaeal dna polymerase of encoding viral, because their low biological effectiveness, usually intravenously is used, and as mentioned above, is the source of serious toxicity.The ganciclovir resistant mutants of clinical generation usually has crossed resistance to Xi Duofuwei.Therefore, need safer (being that toxicity is less), oral biology effectively at the antiviral of new virus target.
Disclose and be used for the phenylthiourea that various pharmacology are used.Armistead etc., WO97/40028 have explained phenylurea or the thiocarbamide as the inhibitor of xanthoglobulin monophosphate dehydrogenase (IMPDH) enzyme (it is in the virus replication disease, as working in the bleb).
Widdowson etc., WO96/25157 have explained the phenylurea and the thiourea compound of following formula, are used for the treatment of the disease of chemokine interleukin 8 mediation.
Morin, Jr. etc., U.S. Patent number 5,593,993 have explained some phenylthiourea compound, are used for the treatment of AIDS and suppress duplicating of HIV and correlated virus.
Therefore, an object of the present invention is to provide acceptable salt on compound and the pharmacology thereof, suppress and/or treatment and simplexvirus, as human cytomegalic inclusion disease virus, hsv, Epstein-Barr virus, varicella zoster virus, herpes virus hominis-6 and-7, the disease relevant with Kaposi herpesvirus.
Invention is described
R
1-R
5Be selected from respectively cycloalkyl, a 3-10 carbon atom of perhaloalkyl radical, a 3-10 carbon atom of alkynyl, a 1-6 carbon atom of alkenyl, a 2-6 carbon atom of alkyl, a 2-6 carbon atom of hydrogen, a 1-6 carbon atom Heterocyclylalkyl, aryl, heteroaryl, halogen ,-CN ,-NO
2,-CO
2R
6,-COR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6,-CONR
7R
8,-NR
6N (R
7R
8) ,-N (R
7R
8) or W-Y-(CH
2)
n-Z, condition is R
1-R
5At least one be not hydrogen; Or R
2And R
3, or R
3And R
4Form 3-7 unit's Heterocyclylalkyl or 3-7 unit heteroaryl altogether;
R
6And R
7Be respectively the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, or aryl;
R
8Be the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, cycloalkyl, 3-10 unit Heterocyclylalkyl, aryl or the heteroaryl of a 3-10 carbon atom, or
R
7And R
8Can form 3-7 unit Heterocyclylalkyl altogether;
W is O, NR
6, or do not exist;
Y is-(CO)-or-(CO
2)-, or do not exist;
Z be 1-4 carbon atom alkyl ,-CN ,-CO
2R
6, COR
6,-CONR
7R
8,-OCOR
6,-NR
6COR
7,-OCONR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6, SR
6N (R
7R
8) ,-N (R
7R
8) or phenyl;
G is a bicyclic heteroaryl;
X be a key ,-alkylamino of the alkoxyl group of the alkyl of NH, a 1-6 carbon atom, the alkenyl of a 1-6 carbon atom, a 1-6 carbon atom, the alkylthio of a 1-6 carbon atom, a 1-6 carbon atom or (CH) J;
J is the alkyl of 1-6 carbon atom, cycloalkyl, phenyl or the benzyl of a 3-7 carbon atom; With
N is the integer of 1-6;
Or the salt on its pharmacology.
In preferences more of the present invention, R
1-R
5Be respectively alkyl, the halogen of hydrogen, a 1-6 carbon atom, perhaloalkyl radical, the OR of a 1-6 carbon atom
6Or N (R
7R
8).Preferred R
1-R
5In 1-3 be not hydrogen.Most preferred, R
1-R
5In 2 be not hydrogen.In preferred compound of the present invention, R
3And R
5, or R
6And R
5Difference is halogen or CF preferably
3
In some embodiments of the invention, G is a bicyclic heteroaryl, preferred thiazolyl, Sai Er Zuo Ji oxazolyl or furyl.G preferably is not substituted.
In some embodiments of the invention, X is key, CH (J) or C
1-C
4Alkyl.Preferably working as X is C
1-C
4During alkyl, described alkyl is a straight chained alkyl.When X was CH (J), J is methyl preferably.
Preferred compounds of the invention are following compounds, comprise the salt on its pharmacology.
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-piperidines-1-base-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-dimethylamino-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-dimethylamino-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-fluoro-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
The thiazole-4-carboxylic acid 4-[3-(the 4-tertiary butyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-fluoro-5-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
The thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-benzyls)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(the 4-tertiary butyl-benzyl)-thioureido]-phenyl }-acid amides
The thiazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-5-trifluoromethyl-thiophenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2,4-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-fluoro-3-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,5-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-iodo-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-thiophenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2,4-two chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-5-trifluoromethyl-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides
The thiazole-4-carboxylic acid 4-[3-(2-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-iodo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
Furans-2-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(2-methyl-butyl)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-isobutyl--5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-dimethylamino-5-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(5-bromo-2-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,5-two chloro-phenoxy groups)-ethyl]-thioureido }-phenyl)-acid amides
The thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides
The thiazole-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two chloro-thiophenyls)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-3-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-5-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-iodo-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid [4-(3-benzo [1,3] dioxole-5-ylmethyl-thioureido)-phenyl]-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,3-phenylbenzene-propyl group)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-fluoro-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two chloro-phenoxy groups)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-bromo-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-tetramethyleneimine-1-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(butyl-methyl-amino)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-dimethyl-phenmethyl)-thioureido]-phenyl }-acid amides
The thiazole-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-bromo-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-chloro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-ethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two fluoro-benzyls)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(3,5-two chloro-benzyls)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-p-methylphenyl-ethyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-phenyl-butyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-thiophenyl (phenylsulfanyl)-ethyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-iodo-benzyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid (4-{3-[2-(3-bromo-thiophenyl)-ethyl]-thioureido }-phenyl)-acid amides
Oxazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,5-two fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-iodo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-amino-5-chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-bromo-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(isobutyl--methyl-amino)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-phenyl-propyl group)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-fluoro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4,5-three chloro-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-morpholine-4-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-fluoro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-fluoro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-iodo-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-bromo-4-trifluoromethoxy-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-dimethylamino-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[4-(4-methyl-piperazine-1-yl)-3-trifluoromethyl-benzyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-bromo-3-chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-phenoxy group-ethyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-methoxyl group-phenyl)-ethyl]-thioureido }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(3-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-nitro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-piperidines-1-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
Oxazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(3,4,5-three chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid [4-(3-benzo [1,3] dioxole-5-base-methyl-thioureido)-phenyl]-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid [4-(3-styroyl-thioureido)-phenyl]-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-chloro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-chloro-4-(1H-pyrazole-3-yl)-phenyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-chloro-4-(2-piperidines-1-base-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-acid amides
Furans-2-carboxylic acid [4-(3-benzyl-thioureido)-phenyl]-acid amides
Furans-2-carboxylic acid (4-{3-[2-(3,5-two chloro-phenoxy groups)-ethyl]-thioureido }-phenyl)-acid amides
Furans-2-carboxylic acid 4-[3-(2-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-4-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
Oxazole-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid (4-{3-[2-(3,4-two chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-chloro-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-bromo-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-fluoro-benzyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(4-bromo-3-chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[(1S)-1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[(1R)-1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[1-(3,5-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[(1S)-1-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[(1R)-1-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
N-[4-[[[[1-(4-cyano-phenyl) ethyl] amino] sulphomethyl] amino] phenyl]-1,2,3-thiadiazoles-4-carboxylic acid amides
The thiazole-4-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[(1S)-1-(3,5-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
N-(4-{[({1-[4-fluoro-3-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl]-amino }-phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides
N-(4-{[({1-[4-chloro-3-thiadiazoles (hiadiazole)-4-carboxylic acid amides
N-(4-{[({ (1 S)-1-[3,5-thiazole-4-carboxylic acid amides
N-(4-{[({1-[3-fluoro-5-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[2-fluoro-4-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl]-amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[2-fluoro-5-trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl]-amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[2,4-two (trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl]-amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(2, the 4-3,5-dimethylphenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(2,4 dichloro benzene base) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(3-aminomethyl phenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[4-fluoro-3-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl]-amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(2-chloro-4-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(3, the 4-difluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(4-bromo-2-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(3-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(2-bromophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(3-bromophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[2-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(2,4 difluorobenzene base) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({ (1R)-1-[3,5-two (trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(3, the 4-dichlorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[3-fluoro-4-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[4-chloro-3-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(4-chloro-2-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[4-fluoro-2-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(4-chloro-3-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(2-bromo-4-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(3, the 4-dibromo phenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(3-chloro-4-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[3,5-two (trifluoromethyl) phenyl] propyl group } amino) thiocarbonyl] amino }-phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides
N-(4-{[({1-[3,5-two (trifluoromethyl) phenyl] butyl } amino) thiocarbonyl] amino }-phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides
N-(4-{[({1-[3,5-two (trifluoromethyl) phenyl] amyl group } amino) thiocarbonyl] amino }-phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides
N-{4-[({[[3,5-two (trifluoromethyl) phenyl] (phenyl) methyl] amino } thiocarbonyl) amino] phenyl }-1,2,3-thiadiazoles-4-carboxylic acid amides
N-(4-{[({1-[3,5-two (trifluoromethyl) phenyl]-the 1-methylethyl } amino) thiocarbonyl] amino }-phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides
N-{4-[({[3,5-two (trifluoromethyl) benzyl] amino } thiocarbonyl) amino] phenyl }-1H-imidazoles-4-carboxylic acid amides
N-{4-[({[1-(4-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1H-imidazoles-4-carboxylic acid amides
N-{4-[({[3,5-two (trifluoromethyl) benzyl] amino } thiocarbonyl) amino] phenyl }-1-methyl isophthalic acid H-imidazoles-4-carboxylic acid amides
N-(4-{[({1-[3,5-two (trifluoromethyl) phenyl] propyl group } amino) thiocarbonyl] amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides; And the salt on the medicine.
Unless otherwise defined, term used herein has to give a definition:
Alkyl used herein refers to the straight or branched low alkyl group of 1-6 carbon atom.Exemplary alkyl comprises methyl, ethyl, propyl group, sec.-propyl, butyl, isobutyl-, the tertiary butyl, amyl group and hexyl.
Alkenyl used herein refers to the straight or branched of 2-6 carbon atom, contains the low alkyl group of at least one carbon-carbon double bond.Alkenyl comprises vinyl.
Alkynyl used herein refers to 2-6 carbon atom, contains at least one carbon carbon triple-linked straight or branched low alkyl group.
Alkyl of the present invention, alkenyl and alkynyl can be that replace or unsubstituted.
Cycloalkyl refers to the saturated monocycle or the bicyclic system of 3-10 carbon atom.Exemplary cycloalkyl comprises cyclopentyl, cyclohexyl and suberyl.Cycloalkyl of the present invention can be that replace or unsubstituted.
Heterocyclylalkyl refers to 3-10 unit, have 1-3 heteroatomic saturated monocycle or bicyclic system that is selected from N, S and O, include but not limited to: '-aziridino, azetidinyl, imidazolidyl, morpholinyl, thio-morpholinyl, piperazinyl, pyrazolidyl, piperidyl and pyrrolidyl.Heterocyclylalkyl of the present invention can be that replace or unsubstituted.
Aryl used herein refers to the aromatic monocyclic or the dicyclo of 6-10 carbon atom.Exemplary aryl comprises phenyl, naphthyl and xenyl.Aryl of the present invention can be that replace or unsubstituted.
Heteroaryl used herein refers to 5-10 unit, has 1-3 heteroatomic aromatic monocyclic or dicyclo that is selected from N, S or O, includes but not limited to: thiazolyl, thiadiazolyl group, oxazolyl, furyl, indyl, benzothiazolyl, benzotriazole base, benzo dioxolyl (benzodioxyl), indazolyl and benzofuryl.Preferred heteroaryl comprises quinolyl, isoquinolyl, naphthyl (napthalenyl), benzofuryl, benzothienyl, indyl, pyridyl, pyrazinyl, thienyl, furyl, pyrryl, isoxazolyl, oxazolyl, isothiazolyl, thiazolyl, pyrazolyl, triazolyl, thiadiazolyl group and imidazolyl.Heteroaryl of the present invention can be that replace or unsubstituted.
Perhaloalkyl radical refers to the alkyl of 1-6 carbon atom, and wherein three or more hydrogen is replaced by halogen.
Phenyl used herein refers to 6 yuan of aromatic rings.
Halogen used herein refers to chlorine, bromine, iodine and fluorine.
Unless otherwise defined, substituting group is unsubstituted, and can comprise cycloalkyl, the 1-6 unit Heterocyclylalkyl of alkyl, a 1-6 carbon atom of 1-6 carbon atom, perhaloalkyl radical, amino, azido-, hydroxyl, alkylamino, dialkyl amido, aryl or the heteroaryl of a 1-6 carbon atom.
Carbon number refers to the carbonatoms in the carbon skeleton, does not comprise being present in substituting group, as the carbon atom in alkyl or the alkoxy substituent.
When uniting the use term, the definition of this combination each several part is all worked, unless otherwise defined.For example, alkyl-cycloalkyl is an alkyl-group of naphthene base, and wherein alkyl and cycloalkyl are all as previously mentioned.
Acceptable salt is acid salt on the pharmacology, it can form as acid such as phosphoric acid, sulfuric acid, hydrochloric acid, Hydrogen bromide, citric acid, toxilic acid, succsinic acid, fumaric acid, acetate, lactic acid, nitric acid, sulfonic acid, tosic acid, methylsulfonic acids from acceptable acid on the compound of above-mentioned general formula and a kind of pharmacology.
Compound of the present invention contains chiral centre, and the various stereoisomeric forms in any ratio of compound are provided, as racemic mixture and each other optical isomer.In preferences more of the present invention, compound of the present invention is pure optical isomer on substantially.Substantially the pure composition that means contains desired isomer more than 75%, and can comprise and be lower than 25% unwanted isomer.In preferred embodiment, pure optical isomer is a desired isomer more than 90%.Can be directly with asymmetric or stereospecificity synthetic, or from racemic mixture conventional separating optical isomeric body, prepare various isomer.
Unless describe in addition, can use following method by the technician in organic synthesis field, utilize the reagent and the parent material that obtain easily, prepare compound of the present invention.Therefore, according to following flow preparation compound of the present invention.
Prepared compounds of the present invention according to following reaction process.
According to method 31 and 34, make suitable replacement amine 2 (substituent R wherein
1-R
5With X as mentioned above) and the lsothiocyanates 3 (wherein substituting group G as mentioned above) of suitable replacement under solvent-free condition or at suitable solvent (as tetrahydrofuran (THF), acetonitrile, ethyl acetate, methylene dichloride or N, dinethylformamide) reaction obtains desired thiocarbamide 1 in.Similarly, as mentioned above, make the lsothiocyanates 4 (substituent R wherein of suitable replacement
1-R
5With X as mentioned above) and the aniline 5 (wherein substituting group G as mentioned above) of suitable replacement in solvent (as above listing) reaction easily, obtain desired thiocarbamide 1.Method 31 and 34
In addition, can be as the thiocarbamide 1 of the suitable replacement of preparation as described in method 32 and 33, by making aniline 2 and 5 (R wherein
1-R
5With G as mentioned above) 1,1 of 1 molar equivalent '-thio-carbonyldiimidazole or 1,1 '-existence of carbonyl dimidazoles under, in suitable solvent, in methylene dichloride and tetrahydrofuran (THF) or its mixture, or at 1 of 1 molar equivalent, 1 '-thiocarbonyl-two-(1,2,4)-triazole or 1,1 '-carbonyl-two-(1,2,4)-existence of triazole under, in suitable solvent (as methylene dichloride and tetrahydrofuran (THF) or its mixture) solution, reaction at room temperature.Method 32,33
In some example, need subsequently final thiocarbamide 1 to be carried out chemically modified.These methods have hereinafter been summed up, method 35-39.
Can be from corresponding alkyl ester, by with sodium hydroxide or potassium hydroxide aqueous solution in suitable solvent (as methyl alcohol, tetrahydrofuran (THF) or its mixture), according to method 35 and 36 basic hydrolysis at room temperature, preparation thiocarbamide 1 (at least one R wherein
1-R
5Substituting group is that 1-hydroxyl-oxethyl or carboxyl-methoxyl group, G as above define, and X is a key).
Can be from corresponding 1-'-hydroxyethoxy radical derivative; by with suitable acylating agent (as Benzoyl chloride or methylsulfonyl chloride) in the presence of suitable tertiary amine base (as triethylamine or diisopropyl ethyl amine); in suitable solvent (as methylene dichloride etc.); according to method 37 and 38 acidylate at room temperature, preparation thiocarbamide 1 (at least one R wherein
1-R
5Substituting group is 1-acyloxy oxyethyl group or mesyloxy oxyethyl group, and G as above defines, and X is a key).
Can be from corresponding 1-mesyloxy oxyethyl group derivative, by with suitable secondary amine (as dimethyl amine) at suitable solvent mixture (as tetrahydrofuran (THF) and water etc.), at room temperature react preparation thiocarbamide 1 (R wherein according to method 39
1-R
5In at least one substituting group be the 1-amino ethoxy, G as above defines, X is a key).
Can be from corresponding 1-alkyl azide derivative, by with tin protochloride in suitable solvent (as methyl alcohol, ethanol etc.), at room temperature react preparation thiocarbamide 1 (R wherein according to method 40
1-R
5In at least one substituting group be the 1-aminoalkyl group, G as above defines, X is a key).
According to method 41 (hereinafter),, H.A. and Walther, G.Justus Liebigs Ann.Chem.657,104 (1962) mainly according to Staab) program, (the R wherein of the amine 5 or 2 by making suitable replacement respectively
1-R
5With G as mentioned above, X as above defines) and 1 molar equivalent 1,1 '-thio-carbonyldiimidazole reacts in suitable solvent (as methylene dichloride and tetrahydrofuran (THF) or its mixture etc.), prepared the intermediate lsothiocyanates 3 and 4 shown in the method 31 and 34.
Can prepare intermediate 2 and 5 according to following scheme:
According to method 1A-1G, can be by the program that oneself knows according to various those skilled in the art, and R.J.Lindsay, Comprehensive Organic Chemistry (Suthefland volume), volume 2,6.3.1 chapter, aromatic amine, 1979 is described, and the oil of mirbane of suitable replacement of reducing prepares amine 2 (R wherein
1-R
5As above definition, X as above defines) and amine 5.These programs comprise reduction oil of mirbane, behind the following material of contact, form aniline:
A) in room temperature arrives the temperature range of solvent refluxing temperature, solvent-free or iron powder in alcoholic solvent (as methyl alcohol or ethanol) and strong acid (example hydrochloric acid) (method 1A), or;
B) in room temperature arrives the temperature range of solvent refluxing temperature, solvent-free or iron powder in alcoholic solvent (as methyl alcohol or ethanol) and Glacial acetic acid (method 1B), or;
C) in room temperature arrives the temperature range of solvent refluxing temperature, solvent-free or iron powder in alcoholic solvent (as methyl alcohol or ethanol) and aqueous ammonium chloride solution (method 1C), or;
D) in room temperature arrives the temperature range of solvent refluxing temperature, solvent-free or tin in alcoholic solvent (as methyl alcohol or ethanol) and strong mineral acid (example hydrochloric acid) (method 1D), or;
E) work as R
1-R
5Be selected from C1, Br, I ,-(OSO
2)-CF
3, or-(OSO
2During)-1-(4-aminomethyl phenyl),, in the atmosphere of one or more barometric points, use hydrogen and palladium carbon catalytic reduction (method 1E) by in suitable solvent (as methyl alcohol, ethanol or ethyl acetate), or;
F) work as R
1-R
5And R
9-R
12Be selected from Cl, Br, I ,-(OSO
2)-CF
3, or-(OSO
2During)-1-(4-aminomethyl phenyl),, in the scope of solvent refluxing temperature, use tetrahydrobenzene and palladium carbon catalytic reduction (method 1F) in room temperature by in suitable solvent (as methyl alcohol or ethanol), or;
G) in room temperature arrives the scope of solvent refluxing temperature, the aqueous solution of sodium bisulfite in alcoholic solvent (method 1G).
In addition, according to method 3A-3C, can pass through according to various programs well known by persons skilled in the art, and Greene, Protective Gromps in Organic Synthesis, volume 2, chapter 7,1991 described and reference wherein, cut the acid amides of these aniline and the aniline nitrogen-carbon bond of carbamate derivatives, prepare amine 2 (R wherein
1-R
5As above definition, X as above defines) and aniline 5.These programs comprise:
A) solvent-free or in suitable solvent (as methylene dichloride), between 0 ℃ and room temperature, make suitable substituted aryl amino-t-butyl carbamate contact (method 3A) with strong acid (as trifluoroacetic acid), or;
B) in acetonitrile solution or tetrahydrofuran (THF) or its mixture, in the temperature range of room temperature between the solvent refluxing temperature, make arylamino-(2-trimethyl silyl ethyl) carbamate of suitable replacement contact (method 3B) with fluoride sources (as tetrabutyl ammonium fluoride or Potassium monofluoride), or;
C) in alcoholic solvent (as methyl alcohol or ethanol), in the temperature range of room temperature between the solvent refluxing temperature, make the arylamino-trifluoroacetamide of suitable replacement and highly basic (as sodium hydroxide or potassium hydroxide, or yellow soda ash or salt of wormwood) contact (method 3C).
In addition, according to method 11, can be mainly according to V.Farina and G.P.Roth in Advances in Metal-Organic Chemistry, volume 5,1-53,1996 and reference wherein, by using palladium catalyst (as three (dibenzalacetone)-two palladiums) and part (as triphenylarsine), in suitable solvent (as tetrahydrofuran (THF) or N-Methyl pyrrolidone), in room temperature arrives the scope of solvent refluxing temperature, make the bromo-or the iodo-aniline (as 3-chloro-4-iodo-aniline) of a kind of vinyl trialkyltin reagent (as tributylvinyl tin) and a kind of suitable replacement carry out the palladium catalytic coupling, prepare amine 2 (R wherein
1-R
5As above definition, X is a key, R
1-R
5In at least one substituting group be vinyl).
In addition, according to method 42, can be mainly according to J.F.Hartwig and J.Louie Tetrahedron Letters36 (21), 3609 (1995) program, by in the temperature range of room temperature to 100 ℃, in suitable solvent (as tetrahydrofuran (THF) or toluene), using palladium catalyst (as two (dibenzalacetone) palladium) and part (as three-o-tolylphosphine), under the condition of the highly basic of at least 2 molar equivalents (as two (trimethyl silyl lithamides) in tube sealing), with 3-bromine or 5-bromo-or the iodo-aniline (as 3-amino-5-5 bromine benzotrifluoride) of secondary amine, prepare amine 2 (R wherein by the suitable replacement of palladium catalytic ammoniation
1-R
5As above definition, X as above defines, R
2Or R
4In at least one substituting group be defined as dialkyl amido).
In addition, according to method 43, can be by in room temperature arrives the temperature range of solvent refluxing temperature, in suitable solvent (as tetrahydrofuran (THF) etc.), using palladium catalyst (as 1,1 '-two (diphenylphosphino) ferrocene] Palladous chloride (II)-methylene dichloride mixture, under the condition that exists at assorted two ring [3.3.1] nonanes of 9-boron and suitable alkali (as aqueous sodium hydroxide solution), pass through palladium catalysis with alkene, the 3-of the replacement that alkylation is suitable or 5-bromo-or iodo-aniline (as 3-amino-5-5 bromine benzotrifluoride) prepare amine 2 (R wherein
1-R
5As above definition, X equals key, R
2Or R
4In at least one substituting group be defined as alkyl).
2A-2G is described as method; according to various well known by persons skilled in the art and at Greene; Protective Groups in Organic Synthesis; volume 2; chapter 7; 1991 and the described program of reference, by the derivatize of corresponding amine, preparation is used as the acyl group and the carbamyl sulfonamide derivatives of parent material in method 3A-3C.These programs comprise:
A) one or the tertiary amine of several molar equivalents (as triethylamine or N, the N-diisopropylethylamine) under existence or the non-existent condition, in suitable solvent (as acetone, tetrahydrofuran (THF), dimethyl formamide, methylene dichloride etc.), in room temperature arrives the scope of solvent refluxing temperature, make the amine and the Di-tert butyl pyrocarbonate reaction (method 2A) of suitable replacement, produce corresponding arylamino-t-butyl carbamate, or;
B) in the presence of tertiary amine (as triethylamine or diisopropylethylamine), in suitable solvent (as dimethyl formamide), at room temperature make the aniline and 1-[2-(trimethyl silyl) ethoxy carbonyl-oxygen base of suitable replacement] benzotriazole reaction (method 2B), produce corresponding arylamino-(2-trimethyl silyl ethyl) carbamate, or;
C) solvent-free or in suitable solvent (as tetrahydrofuran (THF), dimethyl formamide, methylene dichloride, pyridine etc.), one or the tertiary amine base of several molar equivalents (as triethylamine or N, the N-diisopropylethylamine) exists down, make aniline and the carboxylic acid chloride or the anhydride reaction (method 2C) of suitable replacement, produce corresponding arylamino acid amides, or;
D) one or the tertiary amine base of several molar equivalents (as triethylamine or N, the N-diisopropylethylamine) do not exist down, solvent-free or at suitable solvent (as tetrahydrofuran (THF), 1,4-diox etc.) in, in room temperature arrives the scope of solvent refluxing temperature, make the N-methyl-p-nitroaniline and the carboxylic acid chloride reaction (method 2D) of suitable replacement, produce corresponding nitro arylamino acid amides, or;
E) at coupling agent (as benzotriazole-1-base oxygen base-three-(dimethylamino)-phosphorus phosphofluoric acid, 2-(1H-benzotriazole-1-base oxygen base)-1,1,3,3-tetramethyl- phosphofluoric acid, dicyclohexylcarbodiimide etc.) existence under and in the presence of tertiary amine (as triethylamine or diisopropylethylamine), in suitable solvent (as methylene dichloride, dimethyl formamide etc.), at room temperature make the aniline and the carboxylic acid reaction (method 2E) of suitable replacement, produce corresponding arylamino acid amides, or;
F) in the presence of suitable alkali (as pyridine), in suitable solvent (as methylene dichloride, dimethyl formamide etc.), 0 ℃ in the temperature range of room temperature, make suitable protection aniline (as arylamino-tertiary butyl-carbamate etc., R wherein
1-R
12In at least one substituting group be defined as-W-Y-(CH
2)
n-Z, wherein W, X and Z as above define) and carboxylic acid anhydride reaction (method 2F), produce the corresponding carboxylic acid ester, or;
G) one or the tertiary amine of several molar equivalents (as triethylamine or N, the N-diisopropylethylamine) under the non-existent condition, in suitable solvent (as acetone, tetrahydrofuran (THF), dimethyl formamide, methylene dichloride etc.), in the scope of solvent refluxing temperature, make the aniline (R wherein of suitable replacement in room temperature
1-R
5In at least one substituting group be defined as hydroxyl) and Di-tert butyl pyrocarbonate reaction (method 2G), produce corresponding arylamino-tertiary butyl one carbamate.
Can be according to method 4A, 4C, 4E-4F, preparation finally is converted into the oil of mirbane intermediate of amine 2 and 5 by the method that shows among the method 1A-1G.
According to method 4A, 4C and 4E-4H; available following method; 2-, 4-by making suitable replacement and/or 6-fluoro-, chloro-, bromo-, iodo-, trifluoromethyl sulfonyl-or the oil of mirbane generation nucleophilic substitution of (4-aminomethyl phenyl) alkylsulfonyl-replacement, prepare the oil of mirbane intermediate (R that finally changes into amine 2
2And R
4As above definition, R
1, R
3And/or R
5Be defined as alkoxyl group, thio alkoxy, alkyl sulphinyl, alkyl sulfinyl and dialkyl amido):
A) solvent-free or at suitable solvent (as tetrahydrofuran (THF), diox, acetonitrile, N, dinethylformamide or dimethyl sulfoxide (DMSO)) in, one the alkali (as yellow soda ash, salt of wormwood, sodium hydroxide, potassium hydroxide, sodium hydride, potassium hydride KH etc.) of several molar equivalents exists or not in the presence of, in the scope of solvent refluxing temperature, make the oil of mirbane of pure and mild suitable replacement or 2-or the 4-halides or the sulphonate reaction (method 4A) of benzonitrile in room temperature;
B) solvent-free or at suitable solvent (as tetrahydrofuran (THF), diox, acetonitrile, N, dinethylformamide or dimethyl sulfoxide (DMSO)) in, in room temperature arrives the scope of solvent refluxing temperature, make 2-or the 4-halides or the sulphonate reaction (method 4H) of the oil of mirbane or the benzonitrile of ready-formed phenoxy group sodium, lithium or potassium and suitable replacement, or;
C) solvent-free or at suitable solvent (as tetrahydrofuran (THF), diox, acetonitrile, N, dinethylformamide or dimethyl sulfoxide (DMSO)) in, in the scope of solvent refluxing temperature, make the oil of mirbane of ammonia, primary amine or secondary amine and suitable replacement or 2-or the 4-halides or the sulphonate reaction (method 4C, F) of benzonitrile in room temperature;
D) in suitable solvent (as tetrahydrofuran (THF)), 0 ℃ in the scope of solvent refluxing temperature, make sodium, lithium or sylvite and the oil of mirbane of suitable replacement or 2-or the 4-halides or sulphonate reaction (method 4G) reaction of benzonitrile of ready-formed amine, or;
E) solvent-free or at suitable solvent (as tetrahydrofuran (THF), diox, acetonitrile, N, dinethylformamide or dimethyl sulfoxide (DMSO)) in, in room temperature arrives the scope of solvent refluxing temperature, make 2-or the 4-halides or the sulphonate reaction of the oil of mirbane or the benzonitrile of sodium sulphite and suitable replacement, then direct adding alkyl halide (method 4E) in reaction mixture.
In addition, according to method 5C and 6, available following method finally changes into amine 2 (R wherein from the hydroxyl of corresponding replacement-oil of mirbane preparation
1-R
5In at least one substituting group be defined as alkoxyl group) the oil of mirbane intermediate:
A) at suitable solvent (as acetone, N, dinethylformamide, tetrahydrofuran (THF) or dimethyl sulfoxide (DMSO)) in, in the presence of alkali (as salt of wormwood, yellow soda ash, potassium hydroxide, sodium hydroxide, potassium hydride KH or sodium hydride etc.), in room temperature arrives the scope of solvent refluxing temperature, make hydroxyl-oil of mirbane and alkyl halide or sulfonic acid dialkyl reaction (method 5C), or;
B) in anhydrous aprotonic solvent (as ether or tetrahydrofuran (THF)), arrive in the scope of solvent refluxing temperature at 0 ℃, mainly according to Mitsunobu, O, Synthesis 1981,1 and reference, make hydroxyl-oil of mirbane and alkyl alcohol, triphenyl phosphine and azo-2-carboxylic acid's dialkyl reagent (as the diethylazodicarboxylate) reaction (method 6).
In addition, according to method 5A and 5E, can be at suitable solvent (acetone, toluene or N, dinethylformamide) in, in room temperature arrives the scope of solvent refluxing temperature, in the presence of suitable alkali (as salt of wormwood), reaction such as hydroxyaryl amino-tertiary butyl-carbamate by making corresponding replacement and halogenated alkyl thing, trifluoromethane-sulphonate, 4-toluene sulfonic acide ester, sulfonic acid dialkyl, ethylene carbonate prepares and finally changes into amine 2 (R wherein
1-R
5Be defined as alkoxyl group) the carbamyl sulfonamide derivatives as the parent material of method 3A-3C.
In addition, according to method 7A-G, can finally change into amine 2, R by the standard halogenating reaction preparation that comprises following reaction
1And/or R
3Be alkoxyl group, R
2And/or R
4Be halogen, X equals the oil of mirbane intermediate of key:
A) at room temperature make 2-or 4-hydroxyl oil of mirbane and aqueous sodium hypochlorite solution reaction (method 7A and 7B), or;
B) in suitable solvent (as chloroform, methylene dichloride, Glacial acetic acid etc.),, at room temperature make 2-hydroxyl-4-methoxyl group or 2 in the existence of trifluoroacetic acid silver or not, 4-dimethoxy oil of mirbane and bromine reaction (method 7C and 7D), or;
C) in the presence of Zinc Chloride Anhydrous, in suitable solvent (as Glacial acetic acid), at room temperature make 2,4-dimethoxy oil of mirbane and phenmethyl trimethylammonium dichloro ammonium iodate reaction (method 7E), or;
D) in the presence of sodium bicarbonate, in suitable solvent mixture (as methylene dichloride and methyl alcohol), at room temperature make 2-hydroxyl-4-methoxy nitrobenzene and phenmethyl trimethylammonium dichloro ammonium iodate reaction (method 7F), or;
E) in suitable solvent (as tetrachloroethane), in the scope of solvent refluxing temperature, make 2 in room temperature, 4-dimethoxy oil of mirbane and 3,5-two chloro-1-fluorine pyridine fluoroform sulphonates (triflate) reactions (method 7G).
According to method 8, can be at suitable solvent (as N, dinethylformamide etc.) in, in room temperature arrives the scope of solvent refluxing temperature, in sealed reaction vessel, react in the presence of cuprous iodide and Potassium monofluoride by 4-iodo-oil of mirbane and trimethylammonium (trifluoromethyl) silane that makes corresponding replacement, prepare and finally change into amine 2 (R wherein
4=-CF
3, R
1-R
3And R
5-R
8As above the definition, X equals key) the oil of mirbane intermediate.
According to method 19A and 19B; 4-(N-the chloracetyl)-N-methyl-p-nitroaniline that can make corresponding replacement is in suitable solvent (as tetrahydrofuran (THF) and/or water mixture); in room temperature arrives the scope of solvent refluxing temperature; with suitable secondary amine (as dimethyl amine, morpholine etc.) reaction; or at suitable solvent (as tetrahydrofuran (THF), 1; 4-diox etc.) in; in the presence of suitable alkali (as yellow soda ash or salt of wormwood etc.); in room temperature arrives the scope of solvent refluxing temperature; with suitable thiol reactant, prepare and finally change into amine 2 (R wherein
4=-HNCOCH
2NR
7R
8Or-HNCOCH
2SR
6, R
1-R
3And R
5As above the definition, X equals key) the oil of mirbane intermediate.
According to method 25, can in suitable solvent (as methylene dichloride), arrive in the temperature range of room temperature, in the presence of tertiary amine (triethylamine or diisopropyl ethyl amine etc.) at 0 ℃, finally change into amine 2 (R wherein by making the reaction of corresponding phenol and trifluoromethane-sulphonic acid anhydride, preparing
1-R
5In at least one substituting group be defined as the trifluoromethanesulfonic acid base, X equals key) the oil of mirbane intermediate.
According to method 9; 9B and 10; can be in suitable solvent mixture (as acetone and methylene dichloride or water); at room temperature; make the reaction of suitable 4-alkylthio acyl group-arylamino or formamyl arylamino derivative and suitable oxygenant (as dimethyl ethylene oxide (dimethyloxirane) or sodium periodate), prepare and finally change into amine 2 (R wherein
1-R
5At least one substituting group is defined as alkyl sulphinyl or alkyl sulfinyl) the carbamyl sulfonamide derivatives as the parent material of method 3A-3C.
According to method 12, can be in suitable solvent (as tetrahydrofuran (THF), diox etc. and water), at room temperature, in the presence of mercuric acetate, finally change into amine 2 (R wherein by making the reaction of corresponding 4-vinyl formamyl aniline and sodium borohydride, preparing
4Be defined by the 1-hydroxyethyl, and R
1-R
3And R
5As above the definition, X equals key) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 13, can be in suitable solvent (as tetrahydrofuran (THF), l, 4-diox etc.), 0 ℃ under room temperature, in the presence of Glacial acetic acid, finally change into amine 2 (R wherein by making the reaction of corresponding 4-vinyl formamyl aniline and sodium borohydride, preparing
4Be defined by the 2-hydroxyethyl, and R
1-R
3And R
5As above the definition, X equals key) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 14; can be in suitable solvent mixture (as tetrahydrofuran (THF) and methylene dichloride); at 0 ℃ under room temperature; in the presence of azo-2-carboxylic acid's dialkyl (as the diethylazodicarboxylate) and triphenyl phosphine; finally change into amine 2 (R wherein by making the reaction of corresponding 4-(1-hydroxyethyl) formamyl aniline and hydrazoic acid, preparing
4Be defined by the 1-azidoethyl, and R
1-R
3And R
5As above the definition, X as above defines) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 15; can be in suitable tertiary amine solvent (as triethylamine or diisopropyl ethyl amine); in temperature range from room temperature to the solvent refluxing temperature; in the presence of two (triphenylphosphine) Palladous chloride (II) and cuprous iodide; finally change into amine 2 (R wherein by making the reaction of corresponding 4-iodo formamyl aniline and 1-dimethylamino-2-propine, preparing
4Be defined by 3-dimethylamino third-1-alkynyl, and R
1-R
3And R
5As above the definition, X as above defines) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 16; can be in suitable solvent mixture (as methylene dichloride and methyl alcohol); at 0 ℃ under the temperature between the room temperature; make the reaction of corresponding 4-(3-dimethylamino third-1-alkynyl) formamyl aniline and suitable peracid (as the 3-chloroperoxybenzoic acid), prepare and finally change into amine 2 (R wherein
4Be defined by 3-dimethylamino acryl, and R
1-R
3And R
5As above the definition, X equals key) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 17 and 18; can be in suitable solvent (as 1,4-diox or ethanol etc.), at room temperature; make the reaction of corresponding 4-(3-dimethylamino-acryl) formamyl aniline and hydroxylamine hydrochloride or hydrazine hydrate, prepare and finally change into amine 2 (R wherein
4Be defined by 4-isoxazole-5-base or 4-(1H-pyrazole-3-yl), and R
1-R
3And R
5As above the definition, X equals key) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 20; can be in suitable solvent mixture (as tetrahydrofuran (THF) and methylene dichloride etc.); under the temperature in room temperature arrives the solvent refluxing temperature range; make the amino formamyl aniline and 1 of corresponding 4-; 1-carbonyl-two-(1; 2,4)-and the alcohol reaction of triazole and suitable replacement, prepare and finally change into amine 2 (R wherein
4Be defined by-HNCO
2Z, and R
1-R
3, R
5As above define with Z, X equals key) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 26 and 30, can be in suitable solvent (as water, methyl alcohol, tetrahydrofuran compound or toluene etc.), at room temperature, in the presence of sodium cyanoborohydride or hydrogen and 10% palladium carbon, by making the aldehyde reaction of suitable replacement, prepare and finally change into amine 2 (R wherein
1-R
5At least one substituting group is defined as dialkyl amido, and X as above defines) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 27 and 28, can be in suitable solvent mixture (as methanol-water mixtures), under the temperature of room temperature between the solvent refluxing temperature, corresponding ester (as acetic ester) and suitable alkali (as sodium bicarbonate or sodium hydroxide) are reacted, prepare amine 2 (R wherein
1-R
5At least one substituting group be defined as hydroxyl, X as above defines).
According to method 29, can be in suitable solvent (as tetrahydrofuran (THF), ether etc.), at room temperature, make the reaction of corresponding N-(4-aminophenyl) phthalic imidine and lithium borohydride, prepare amine 2 (R wherein
1-R
5In at least one substituting group be defined as the 2-(2-hydroxybenzoyl) amino, X as above defines).
Can prepare intermediate amine 2 (R wherein according to following process
1-R
5As above definition, X equals-CH
2Or-(CH
2)
2):
A) with borine-dimethyl thioether mixture in suitable solvent (as glycol dimethyl ether, tetrahydrofuran (THF) etc.), under the temperature of room temperature in the solvent refluxing temperature, reduce the benzonitrile or the phenylacetonitrile of suitable replacement.(method 44);
B) in suitable solvent (as methyl glycol, ethyl acetate, ethanol etc.), at room temperature, appropriate catalyst (palladium carbon) as 5% or 10% and acid (4-methyl-Phenylsulfonic acid, hydrochloric acid etc.)) in the presence of, under one or more normal atmosphere hydrogen atmosphere, reduce.(method 50);
C) in suitable solvent (as tetrahydrofuran (THF) or ether), under 0 ℃ of temperature in the room temperature, use lithium aluminium hydride reduction.(method 51);
Can be in suitable solvent (as acetate), under the temperature of room temperature in the solvent refluxing temperature, in the presence of ammonium acetate, react by phenyl aldehyde and the Nitromethane 99Min. that makes suitable replacement, prepare and finally change into amine 2 (R wherein
1-R
5As above definition, X equals-(CH
2)
2-) the unsaturated nitro precursor as method 51 parent materials.(method 53); Can reduce the benzonitrile of suitable replacement by diisobutyl aluminium hydride, come the phenyl aldehyde of preparation method's 53 parent materials.(method 52); Can be in suitable solvent (as N, dinethylformamide), under the temperature in room temperature arrives the solvent refluxing temperature, from corresponding aryl bromide and cupric cyanide reaction, preparation is as the benzonitrile of the replacement of method 52 parent materials.(method 59).
According to method 49, for amine 2 (R wherein
1-R
5As above definition, X equals-O (CH
2)
2NH
2Or-S (CH
2)
2NH
2), can be in suitable solvent (as acetone), at room temperature, in the presence of suitable alkali (as salt of wormwood), phenol or thiophenol and bromination acetonitrile reaction by making suitable replacement prepare essential nitrile precursor.
In addition, according to Wilk, B.Synthetic Comm., 23,2481 (1993), for amine 2 (R wherein
1-R
5As above definition, X equals-(CH
2)
3-), can be in suitable solvent (as ether or tetrahydrofuran (THF) etc.), at 0 ℃ under the temperature between the room temperature, in the presence of suitable azodicarboxylate (as azodicarboxylate's diethyl ester), phenylethyl alcohol and acetone cyanohydrin and triphenyl phosphine reaction by making suitable replacement prepare the nitrile precursor.(method 54)
In addition, can be in suitable solvent mixture (as water and methyl alcohol or water and ethanol), under the temperature of room temperature between the solvent refluxing temperature, with suitable acid catalyst (as 6N hydrochloric acid) or suitable alkaline catalysts (as 5N sodium hydroxide or potassium hydroxide) acid or the corresponding methane amide of alkali catalyzed hydrolysis, prepare intermediate amine 2 (R wherein
1-R
5As above definition, X equals-(CH (CH
3))-).(method 46)
According to method 45, can be under the temperature between the solvent refluxing temperature in room temperature, the phenyl methyl ketone with the suitable replacement of ammonium formiate, formic acid and methane amide processing prepares the parent material as method 46, and finally changes into the methane amide precursor of amine 2.
In addition, method 48 is basically according to Itsuno, S., Sakurai, Y., Ito, K., Synthesis, 1988,995 program, can be in suitable solvent (as tetrahydrofuran (THF) or ether), at room temperature, in the presence of sodium borohydride and zirconium tetrachloride, by reducing the O-methyloxime of suitable replacement, prepare amine 2 (R wherein
1-R
5As above definition, X equals-(CH (CH
3))-).Can in suitable solvent (as ethanol or methyl alcohol), under the temperature between the solvent refluxing temperature, make the reaction of corresponding phenyl methyl ketone and methoxy amine hydrochlorate and pyridine, prepare essential O-methyloxime in room temperature.(method 47)
Available aforesaid method (method 45,47 and 48) prepares amine 2 (R wherein by reducing the ketone of suitable replacement
1-R
5As above definition, X equals-CH (J)-, wherein J as above defines).When can not commodity buying, phenyl aldehyde that can be by making suitable replacement and suitable organometallic reagent (as phenyl lithium, sec.-propyl bromination magnesium or ethylmagnesium bromide etc.) are in suitable solvent (as ether or tetrahydrofuran (THF) etc.), under the temperature between-78 ℃-0 ℃, react, prepare these ketone.(method 57).Available suitable oxygenant (as chromium trioxide in aqueous sulfuric acid and acetone or pyridinium chlorochromate or dichromic acid pyridine in suitable solvents such as methylene dichloride), the alcohol that oxidation at room temperature obtains makes corresponding ketone.(method 58).
Available preceding method 3A prepares intermediate aniline 5.Use pure trifluoroacetic acid, at room temperature handle the phenylcarbamic acid tert-butyl ester 6 (wherein G as mentioned above), with the aqueous sodium hydroxide solution neutralization, obtain desired aniline 5 then.Shown in method 2C, isoxazolecarboxylic acid 8 (wherein G as mentioned above) by making replacement and 4-aminophenyl t-butyl carbamate 7 have prepared required carbamate 6 (wherein G as mentioned above) in suitable solvent (as methylene dichloride, dimethyl sulfoxide (DMSO) or dimethyl formamide or its mixture) in the presence of triethylamine.Carboxyl acyl chloride 8 can be used as commodity and buys, or passes through suitable solvent (as methylene dichloride) from corresponding carboxylic acid, and at room temperature reaction makes with oxalyl chloride.Method 2C, 3A
In addition, shown in method 2E, can be at suitable solvent (as methylene dichloride, dimethyl formamide etc.) in, at room temperature, in suitable coupling agents (as benzotriazole-1-base oxygen base-three-(dimethylamino) Phosphonium phosphofluoric acid, 2-(1H-benzotriazole-1-base oxygen base)-1,1,3,3-tetramethyl- phosphofluoric acid, dicyclohexylcarbodiimide etc.) under the existence, and tertiary amine base (as triethylamine or diisopropyl ethyl amine etc.) exists down, 4-aminophenyl t-butyl carbamate 7 reactions of carboxylic acid 8a (wherein G as mentioned above) by making replacement and suitable replacement, prepare carbamate 6 (wherein G as mentioned above), produce corresponding arylamino acid amides.
Commodity are buied or are prepared carboxylic acid 8a according to literature method.For example, when G is the thiadiazoles that replaces, can at room temperature make corresponding carboxylic acid ester and suitable alkali (as sodium hydroxide or potassium hydroxide) reaction, preparation acid by in suitable solvent mixture (as methyl alcohol or second alcohol and water).
Similarly, when G replaces or unsubstituted thiazole, replacement or do not replace De oxazole, replacement or during for the isothiazole that replaces or replacement or unsubstituted isoxazole, when can not commodity buying, can be from corresponding ethyl ester or methyl esters by at room temperature reacting preparation corresponding carboxylic acid 8a at suitable solvent mixture (as methyl alcohol or second alcohol and water) with suitable alkali (as sodium hydroxide or potassium hydroxide).These esters can be that commodity are buied or prepare according to literature method.
When can not commodity buying the carboxylicesters precursor that finally changes into acid 8, they can be according to known method preparation in the document.For example, can be basically according to Caron, M.J.Org.Chem., 51,4075 (1986) and Taber, D.F., Ruckle, R.E.J.Amer.Chem., 108,7686 (1986) program prepares 5-and replaces 1,2,3-thiadiazoles-4 carboxylicesters.Therefore,, in the presence of tertiary amine base (as triethylamine or diisopropyl ethyl amine), in suitable solvent (as acetonitrile), handle β-esters of keto-carboxylic acid, obtain corresponding two azos-β-esters of keto-carboxylic acid with 4-Methyl benzenesulfonyl nitrine or methylsulfonyl nitrine according to method 21.In suitable solvent (as benzene or toluene etc.), under the temperature in room temperature arrives the scope of solvent refluxing temperature, with 2,4-two (4-p-methoxy-phenyl)-1,3-two thiophenes-2,4-two phospha butane-2, the 4-disulfide is handled this compound, obtain desired 5-and replace-1,2,3-thiadiazoles-4-carboxylicesters.
In addition, can be substantially according to Shafiee, A., Lalezari, I., Yazdami, S., Shahbazian, F.M., Patovi, the program of T.J.Pharmaceutical Sci.65.304 (1976), preparation 4-replaces-1,2,3-thiadiazoles-5-carboxylicesters.Therefore, according to method 22 and 23, in suitable alcoholic solvent (as methyl alcohol or ethanol), make the β-esters of keto-carboxylic acid of suitable replacement and the carbamylhydrazine hydrochloride aqueous solution in room temperature under the temperature between the solvent refluxing temperature, reaction obtains corresponding semicarbazone derivative in the presence of suitable alkali (as pyridine).Handle this compound at 0 ℃ with pure thionyl chloride, handle with the excess bicarbonate aqueous solution then, obtain corresponding 4-and replace-1,2,3-thiadiazoles-5-carboxylicesters.
Can be substantially according to Sch llkopf, U., Porsch, P., Lau, H., the program of Liebigs Ann.Chem 1444 (1979), preparation 4-carbalkoxy thiazole.Therefore,, make isocyano acid B ester in suitable alcoholic solvent (as ethanol) according to method 55 and 56, at room temperature, and N, the reaction of dinethylformamide dimethylacetal obtains corresponding 3-dimethylamino-2-isocyano--ethyl propenoate.In the presence of suitable tertiary amine base (as triethylamine or diisopropyl ethyl amine etc.), at room temperature handle the solution that this compound is dissolved in suitable solvent (as tetrahydrofuran (THF)) with hydrogen sulfide, obtain corresponding 4-carbalkoxy-thiazole.
Can be substantially according to Bredenkamp, M.W., Holzafel, C.W., van Zyl, W.J.Synthetic Comm.20,2235 (1990) program prepares the thiazole of other suitable replacement.Basically according to Henneke, K.H., Sch llkopf, U., Neudecker, the program of T.Liebigs Ann.Chem 1979 (1979) prepares suitable unsaturated De oxazole.Can be substantially according to Galeotti, N., Montagene, C., Poncet, J., Jouin, P.Tetrahedron Lett.33,2807 (1992) and Shin, C., Okumura, K., Ito, A., Nakamura, Y.Chemistry Lett.1305, (1994) preparation replaces the De oxazole.
Following specific embodiment is illustrative, and does not mean that and will limit the present invention.
Embodiment 1 (method 1A)
4-methoxyl group-3-trifluoromethyl-phenyl amine
The suspension in ethanol (35 milliliters) and water (15 milliliters) with concentrated hydrochloric acid (0.42 milliliter) solution-treated 4-methoxyl group-3-trifluoromethyl-oil of mirbane that is dissolved in ethanol (6 milliliters) and water (3 milliliters) (2.2 gram) and iron powder (1.68 restrain), then with mixture heating up to refluxing about 1 hour.Cooling mixture and filtration then, concentrating under reduced pressure.The oil that obtains is dissolved in ethyl acetate also with 5% aqueous hydrochloric acid extraction 3 times.In ice bath, cool off the acid extraction thing that merges then, and, use ethyl acetate extraction then with solid-state carbonic acid potashization.Wash these organic extracts with saturated sodium-chloride water solution, use anhydrous sodium sulfate drying, concentrating under reduced pressure by short silicagel column (using ethyl acetate as elutriant), obtains desired amber oily compound then.
Use said procedure and suitable parent material to prepare following compounds:
2,6-two chloro-benzene-1,4-diamines
3-chloro-4-methylthio group-phenyl amine
2,6-two bromo-benzene-1,4-diamines
3-chloro-4-trifluoromethyl-phenyl amine
3-chloro-4-ethylmercapto group-phenyl amine
4-methoxyl group-3-trifluoromethyl-phenyl amine
3,5-two chloro-4-methoxyl group-2-methyl-phenyl amine
5-chloro-2-oxyethyl group-4-methoxyl group-phenyl amine
5-chloro-4-oxyethyl group-2-methoxyl group-phenyl amine
5-iodo-2,4-dimethoxy-phenyl amine
3,5-two iodo-2,4-dimethoxy-phenyl amine
3,5-two bromo-2,4-dimethoxy-phenyl amine
5-chloro-2-methoxyl group-4-methyl-phenyl amine
2-chloro-N (1), N (1)-dimethyl-benzene-1,4-diamines
3-chloro-4-piperidines-1-base-phenyl amine
3-chloro-4-tetramethyleneimine-1-base-phenyl amine
N (1)-benzyl-2-chloro-benzene-1, the 4-diamines
3-chloro-4-(4-methyl-piperazine-1-yl)-phenyl amine
2-chloro-N (1)-methyl-N (1)-(1-methyl-piperidin-4-yl)-benzene-1, the 4-diamines
2-chloro-N (1)-methyl-N (1)-(1-methyl-tetramethyleneimine-3-yl)-benzene-1, the 4-diamines
2-chloro-N (1)-methyl-N (1)-phenyl-benzene-1, the 4-diamines
N (1)-(1-benzyl-tetramethyleneimine-3-yl)-2-chloro-N (1)-methyl-benzene-1, the 4-diamines
2-chloro-N (1)-cyclopentyl-N (1)-methyl-benzene-1, the 4-diamines
2-[(4-amino-2-chloro-phenyl)-(2-hydroxyethyl)-amino]-ethanol
2-chloro-N (1)-hexyl-N (1)-methyl-benzene-1, the 4-diamines
2-chloro-N (1)-isobutyl--N (1)-methyl-benzene-1, the 4-diamines
2-[(4-amino-2-chloro-phenyl)-methyl-amino]-ethanol
2-chloro-N (1)-(3-dimethylamino-propyl group)-N (1)-methyl-benzene-1, the 4-diamines
2-chloro-N (1)-(2-dimethylamino-ethyl)-N (1)-methyl-benzene-1, the 4-diamines
2-chloro-N (1)-(2-dimethylamino-ethyl)-benzene-1, the 4-diamines
N (1)-(1-benzyl-piperidin-4-yl)-2-chloro-benzene-1, the 4-diamines
2-chloro-N (1)-(2-methoxyl group-ethyl)-N (1)-methyl-benzene-1, the 4-diamines
2-chloro-N (1)-(3-dimethylamino-propyl group)-benzene-1, the 4-diamines
N (1)-(1-benzyl-tetramethyleneimine-3-yl)-2-chloro-benzene-1, the 4-diamines
3-chloro-4-(1-methyl-piperidin-4-yl oxygen base)-phenyl amine
3-chloro-4-(2-dimethylamino-oxyethyl group)-phenyl amine
3-chloro-4-(3-dimethylamino-propoxy-)-phenyl amine
3-chloro-4-(1-methyl-tetramethyleneimine-3-base oxygen base)-phenyl amine
3-chloro-4-cyclohexyloxy-phenyl amine
Embodiment 2 (method B)
4-bromo-2,4-dimethoxy one phenyl amine
With 4-bromo-2,4-dimethoxy-oil of mirbane (0.48 gram) and iron powder (0.42 restrains) suspension in acetate (10 milliliters) and ethanol (10 milliliters) be heated to 120 ℃ about 5 hours.Cooling mixture and filtration then, concentrating under reduced pressure.Add entry, cooling mixture in ice bath, and, use dichloromethane extraction then with solid-state carbonic acid potashization.Wash these organic extracts with saturated sodium-chloride water solution, use anhydrous sodium sulfate drying, concentrating under reduced pressure is used silica gel (hexane solution of 20% ethyl acetate is as elutriant) chromatography then, obtains desired amber oily compound.
Embodiment 3 (method 1C)
(4-amino-2,6-two chloro-phenoxy groups)-tert.-butyl acetate
Handle the ethanol (17 milliliters) of (4-nitro-2,6-two chloro-phenoxy groups)-tert.-butyl acetate (1 gram) and the solution of water (8.6 milliliters) with iron powder (0.861 gram) and ammonium chloride (86 milligrams).With mixture heating up to refluxing about 1 hour.Mixture filters and concentrating under reduced pressure then.Distribute the oil that obtains between water and ethyl acetate, wash organic phase with saturated sodium-chloride water solution then, use anhydrous sodium sulfate drying, concentrating under reduced pressure obtains desired faint yellow solid-state compound.
Use said procedure and suitable parent material to prepare following compounds:
4-chloro-benzene-1, the 2-diamines
N-(4-amino-2-chloro-phenyl)-ethanamide
(4-amino-2,6-two chloro-phenoxy groups)-acetonitrile
(4-amino-2,6-two chloro-phenoxy groups)-tert.-butyl acetate
(2-amino-4-chloro-5-methoxyl group-phenoxy group)-acetonitrile
(4-amino-2-chloro-5-methoxyl group-phenoxy group)-methyl acetate
(4-amino-2-chloro-5-methoxyl group-phenoxy group)-tert.-butyl acetate
(2-amino-4-chloro-5-methoxyl group-phenoxy group)-tert.-butyl acetate
N (1)-benzyl-4-chloro-5-methoxyl group-benzene-1, the 2-diamines
N-(4-amino-2-chloro-phenyl)-2-fluoro-benzamide
N-(4-amino-5-chloro-2-hydroxyl-phenyl)-ethanamide
N-(4-amino-5-chloro-2-hydroxyl-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-2-chloro-phenyl)-acid amides
(4-amino-2-chloro-phenyl) urethanum
N-(4-amino-5-chloro-2-methyl-phenyl)-ethanamide
N-(4-amino-5-chloro-2-methyl-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-5-chloro-2-methyl-phenyl)-acid amides
N-(4-amino-3-chloro-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-3-chloro-phenyl)-acid amides
N-(4-amino-2-chloro-phenyl)-2-dimethylamino-ethanamide
N-(4-amino-2-chloro-phenyl)-2-piperidines-1-base-ethanamide
N-(4-amino-2-chloro-phenyl)-2-morpholine-4-base-ethanamide
N-(4-amino-2-chloro-phenyl)-Toluidrin
N-(4-amino-2-chloro-phenyl)-benzamide
N-(4-amino-2-chloro-phenyl)-2-diethylamino-ethanamide
N-(4-amino-2-chloro-phenyl)-2-tetramethyleneimine-1-base-ethanamide
N-(4-amino-2-chloro-phenyl)-2-nitrogen heterocyclic heptan (azepanyl)-1-base-ethanamide
N-(4-amino-2-chloro-phenyl)-2-(2-methyl-piperidines-1-yl)-ethanamide
N-(4-amino-2-chloro-phenyl)-2-(3-methyl-piperidines-1-yl)-ethanamide
3-chloro-benzene-1, the 2-diamines
4-chloro-N, N-dimethyl-benzene-1,2-diamines
Embodiment 4 (method 1D)
3,5-two chloro-4-phenoxy group-phenyl amine
3, drip concentrated hydrochloric acid (60 milliliters) in the slurries of 5-two chloro-4-phenoxy group-oil of mirbane (6.1 gram) and glass putty (12 gram).Add ethanol (60 milliliters), and heated mixt is to refluxing about 1 hour.The alkalization of the solid sodium hydroxide of cooling mixture in ice bath, and adding then.With the suspension filtration over celite plate that obtains, and with ethyl acetate extraction 3 times.The organic extract that merges with the saturated sodium-chloride water solution washing is used anhydrous magnesium sulfate drying then, and concentrating under reduced pressure, obtains desired yellow solid product.Recrystallization obtains faint yellow solid-state product from ethyl acetate-hexane.
Use said procedure and suitable parent material to prepare following compounds:
1-furans-2-base-ethylamine
3-chloro-4-isopropoxy-phenyl amine
2-butoxy-5-chloro-4-methoxyl group-phenyl amine
3,5-two chloro-2-methoxyl group-4-methyl-phenyl amine
2-benzyloxy-5-chloro-2-methoxyl group-phenyl amine
4-benzyloxy-5-chloro-2-methoxyl group-phenyl amine
5-fluoro-2,4-dimethoxy-phenyl amine
(4-amino-2,6-two chloro-phenoxy groups)-ethyl acetate
3,5-two chloro-4-phenoxy group-phenyl amine
2-(4-amino-2-chloro-5-methoxyl group-phenoxy group)-ethanamide
(4-amino-2-chloro-5-methoxyl group-phenoxy group)-acetonitrile
2-(2-amino-4-chloro-5-methoxyl group-phenoxy group)-ethanol
2-(4-amino-2-chloro-5-methoxyl group-phenoxy group)-ethanol
4-(4-amino-2-chloro-5-methoxyl group-phenoxy group)-butyronitrile
4-amino-2-chloro-5-methoxyl group-phenol
2-amino-4-chloro-5-methoxyl group-phenol
5-chloro-4-methoxyl group-2-morpholine-4-base-phenyl amine
4-chloro-5-methoxyl group-N (1), N (1)-dimethyl-benzene-1,2-diamines
5-chloro-4-methoxyl group-2-piperidines-1-base-phenyl amine
5-chloro-4-methoxyl group-2-tetramethyleneimine-1-base-phenyl amine
2-chloro-N (1)-cyclohexyl-N (1)-methyl-benzene-1, the 4-diamines
N (2)-benzyl-4-methoxyl group-benzene-1, the 2-diamines
2-(4-amino-2-chloro-phenoxy group)-ethanol
2-chloro-N (1)-cyclohexyl-N (1)-ethyl-benzene-1, the 4-diamines
4-butoxy-3-chloro-phenyl amine
(4-amino-2-chloro-phenoxy group)-acetonitrile
2-chloro-N (1)-cyclohexyl-benzene-1, the 4-diamines
2-chloro-N (1), N (1)-dipropyl-benzene-1,4-diamines
3-chloro-4-(2,2,2-three fluoro-oxyethyl groups)-phenyl amine
3-chloro-4-(octahydro-quinoline-1-yl)-phenyl amine
N (1)-allyl group-2-chloro-N (1)-cyclohexyl-benzene-1, the 4-diamines
N-(4-amino-2-methoxyl group-5-methyl-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-2-methoxyl group-5-methyl-phenyl) acid amides
N-(4-amino-naphthalene-1-yl)-2-fluoro-benzamide
3-chloro-N, N-dimethyl-benzene-1,2-diamines
3-chloro-4-propoxy--phenyl amine
3-iodo-4-methoxyl group-phenyl amine
3-chloro-2,4-dimethoxy-aniline
3-bromo-4-methoxyl group-phenyl amine
3-chloro-4-oxyethyl group-phenyl amine
Embodiment 5 (method 1E)
(4-amino-phenyl)-isobutyl carbamate
In 100 milliliters of methyl glycols (100ml) solution of N-(4-nitro-phenyl)-isobutyramide (2.0 gram), add 10% palladium carbon (275 milligrams).Hydrogenated mixture is 2 hours under the hydrogen at 30psi on the Parr hydrogenation instrument.Filtration over celite is removed catalyzer then, and decompression is extremely done with 3 evaporated filtrates of heptane azeotropic.Grind residuum with heptane and obtain desired white solid product.
Prepared following compounds with said procedure and suitable parent material:
2-methyl-3H-benzoglyoxaline-5-base amine
N-(4-amino-phenyl)-methane amide
1H-benzoglyoxaline-5-base amine
(4-amino-phenyl)-isobutyl carbamate
N-(4-amino-phenyl)-isobutyramide
N-(5-amino-pyridine-2-yl)-2-methyl-benzamide
Furans-2-carboxylic acid (5-amino-pyridine-2-yl)-acid amides
N-(5-amino-pyridine-2-yl)-2-fluoro-benzamide
[6-(2,2,2-three fluoro-acetylamino)-pyridin-3-yl]-t-butyl carbamate
N-(5-amino-pyridine-2-yl)-2,2,2-three fluoro-ethanamides
(4-amino-benzyl) t-butyl carbamate
2-(3,5-di-trifluoromethyl-phenyl)-ethamine
The 1-tertiary butyl-1H-imidazoles-2-base amine
3-(3-dimethylamino-propyl group)-5-trifluoromethyl-phenyl amine
Embodiment 6 (method 1F)
N-(4-amino-2-methyl phenyl)-2-fluorobenzamide
The mixture heating up of heating 2-fluoro-N-(2-methyl-4-nitrophenyl) benzamide (4.55 gram), tetrahydrobenzene (30 milliliters), ethanol (70 milliliters), water (30 milliliters) and 10% palladium carbon (3 gram) is to refluxing 30 minutes.With the mixture filtration over celite, and concentrating under reduced pressure.The oil that obtains is dissolved in 50 milliliters of ethyl acetate, and 4 ℃ were cooled off 12 hours.Filtration obtains the tawny solid product.
Use said procedure and suitable parent material to prepare following compounds:
N-(4-amino-2-methyl-phenyl)-ethanamide
2-methyl-benzoxazoles-6-base amine
N-(4-amino-3-methoxyl group-phenyl)-ethanamide
2-acetylamino-5-amino-phenylformic acid
N-(4-amino-phenyl)-ethanamide
[4-(3-amino-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2-amino-benzoyl-amido)-phenyl]-t-butyl carbamate
N-(4-amino-2-cyano group-phenyl)-ethanamide
N-(4-amino-2,5-dimethoxy-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-2,5-dimethoxy-phenyl)-acid amides
N-(4-amino-2-cyano group-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-2-methoxyl group-phenyl)-acid amides
N-(4-amino-2-methoxyl group-phenyl)-2-fluoro-benzamide
N-(4-amino-2-methoxyl group-5-methyl-phenyl)-ethanamide
N-(4-amino-2-benzoyl-phenyl)-ethanamide
N-(4-amino-2-benzoyl-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-2-benzoyl-phenyl)-acid amides
N-(4-amino-3-methyl-phenyl)-ethanamide
N-(4-amino-3-methyl-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-3-methyl-phenyl)-acid amides
5-amino-2-[(2-fluoro benzoyl) amino]-the N-phenylbenzamaide
Furans-2-carboxylic acid (4-amino-2-phenyl amino formyl radical-phenyl) acid amides
N-(4-amino-naphthalene-1-yl)-ethanamide
Furans-2-carboxylic acid (4-amino-naphthalene-1-yl)-acid amides
N-(4-amino-2-trifluoromethyl-phenyl)-ethanamide
Furans-2-carboxylic acid (4-amino-2-cyano group-phenyl)-acid amides
Furans-2-carboxylic acid (4-amino-2-trifluoromethyl-phenyl)-acid amides
N-(4-amino-2-methyl-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-2-methyl-phenyl)-acid amides
5-amino-2-(2-fluoro-benzoyl-amido)-phenylformic acid
5-amino-2-[(furans-2-carbonyl)-amino]-phenylformic acid
N-(4-amino-2-cyano group-phenyl)-2,2,2-three fluoro-ethanamides
N-(4-amino-3-methyl-phenyl)-2,6-two fluoro-benzamide
N-(4-amino-3-trifluoromethyl-phenyl)-ethanamide
N-(4-amino-3-trifluoromethyl-phenyl)-2-fluoro-benzamide
N-(4-amino-2-trifluoromethyl-phenyl)-2,2,2-three fluoro-ethanamides
N-(4-amino-2-methoxyl group-phenyl)-2,2,2-three fluoro-ethanamides
N-(4-amino-2-trifluoromethyl-phenyl)-2-fluoro-N-(2-fluoro-benzoyl)-benzamide
N-(4-amino-2-trifluoromethyl-phenyl)-2-fluoro-benzamide
Embodiment 7 (method 1G)
N-(4-amino-2-chloro-phenyl-)-2-thiomorpholine-4-base-ethanamide
Ethanol (200 milliliters) solution of N-(2-chloro-4-nitrophenyl)-2-thiomorpholine-4-base-ethanamide (3.02 gram) is added in water (60 milliliters) solution of Sulfothiorine (12 gram).Reflux mixture 12 hours cools off and pours in the water.Use the ethyl acetate extraction mixture then.Wash ethyl acetate solution 2 times with saturated nacl aqueous solution, use the Anhydrous potassium carbonate drying, filtration over celite plate, and concentrating under reduced pressure obtain oil.Add toluene, frozen soln obtains desired greenish orange look lenticular solid product.
Use said procedure and suitable parent material to prepare following compounds:
N-(4-amino-2-chloro-phenyl)-2-thiomorpholine-4-base-ethanamide
N-(4-amino-2-chloro-phenyl)-2-dipropyl amino-ethanamide
Embodiment 8 (method 2A)
(3-chloro-4-iodo-phenyl)-t-butyl carbamate
Add Di-tert butyl pyrocarbonate (8.6 gram) in the solution of the tetrahydrofuran (THF) (40 milliliters) (containing diisopropyl ethyl amine (6.9ml)) of 3-chloro-4-iodo-aniline (10 gram), heated mixt is to refluxing.Add another part diisopropyl ethyl amine (6.9 milliliters) and Di-tert butyl pyrocarbonate (21 gram) after about 15 hours, continue about 24 hours of heating.Cooling solution then, concentrating under reduced pressure with the ethyl acetate dilution, and is used 5% salt acid elution 3 times continuously, with saturated sodium-chloride washing 1 time.Use anhydrous sodium sulfate drying solution, concentrating under reduced pressure obtains desired brown oily crude product then.Cause crystallization by adding hexane, the solid matter that recrystallization is collected from hexane obtains desired white solid state product.
Use said procedure and suitable parent material to prepare following compounds:
N '-(4-nitro-benzoyl)-hydrazine carboxylic acid's tert-butyl ester
(3-chloro-4-iodo-phenyl)-t-butyl carbamate
(4-bromo-3-chloro-phenyl)-t-butyl carbamate
(3-chloro-4-vinyl-phenyl)-t-butyl carbamate
(3-chloro-4-methylthio group-phenyl)-t-butyl carbamate
(4-amino-3-chloro-phenyl)-t-butyl carbamate
(4-chloro-2-nitro-phenyl)-t-butyl carbamate
(3-tert-butoxycarbonyl amino-5-chloro-phenyl)-t-butyl carbamate
(4-nitro-benzyl)-t-butyl carbamate
(3-bromo-5-trifluoromethyl-phenyl)-t-butyl carbamate
(2-amino-3-chloro-5-trifluoromethyl-phenyl)-t-butyl carbamate
Embodiment 9 (method 2B)
(3-chloro-4-vinyl-phenyl)-carboxylamine 2-TMS ethyl ester
N at 3-chloro-4-vinyl-phenyl amine (3.4 gram), in the solution of dinethylformamide (44 milliliters) (containing diisopropyl ethyl amine (5.8 milliliters)), add 1-[2-(TMS)-ethoxy carbonyl-oxygen base] benzotriazole (7.1 gram), under the room temperature, under argon gas, stirred the mixture 3.Dilute with water solution is used extracted with diethyl ether 3 times then.The organic extract that water, saturated sodium-chloride water solution continuous washing merge is used anhydrous magnesium sulfate drying, concentrating under reduced pressure.With silica gel (hexane solution of 10% ethyl acetate is as the elutriant) residuum that chromatography obtains, provide desired yellow oil product.
Embodiment 10 (method 2C)
[4-(2-fluoro-benzoyl-amido)-phenyl]-t-butyl carbamate
At one-N-(tert-butoxycarbonyl)-1, add o-fluoro-benzoyl chloride (1.20 gram) in 25 milliliters of dichloromethane solutions of 4-phenylenediamine (1.58 gram) and triethylamine (1.50 milliliters).Form solid immediately, filter and wash, obtain white solid 1.90 grams with fresh solvent.
Use said procedure and suitable parent material to prepare following compounds:
N-(3-methoxyl group-4-nitro-phenyl)-ethanamide
N-(4-aminophenyl)-isobutyramide
2,2,2-three fluoro-N-(2-methoxyl group-4-nitro-phenyl)-ethanamide
[4-(2-methyl-benzoyl-amido)-phenyl]-t-butyl carbamate
Acetate 2-(4-tert-butoxycarbonyl amino-phenyl amino formyl radical)-phenyl ester
[4-(4-fluoro-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(3-fluoro-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2-fluoro-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2-methoxyl group-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(3-methoxyl group-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(4-methoxyl group-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2,2-dimethyl-propionyl amino)-phenyl]-t-butyl carbamate
[4-(2-bromo-acetylamino)-phenyl]-t-butyl carbamate
[4-(2,2,2-three fluoro-acetylamino)-phenyl]-t-butyl carbamate
(4-benzoyl-amido-phenyl)-t-butyl carbamate
(4-methylsulfonyl amino-phenyl)-t-butyl carbamate
(4-phenyl acetyl amino-phenyl)-t-butyl carbamate
4-[(thiophene-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
[4-(3-nitro-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(3-acetylamino-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(3-methylsulfonyl amino-benzoyl-amido)-phenyl]-t-butyl carbamate
[3-[[[4-[[(1,1-dimethyl oxyethyl group) carbonyl] amino] phenyl] amino] carbonyl]-phenyl] urethanum
[4-(2-trifluoromethyl-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2,6-two fluoro-benzoyl-amidos)-phenyl]-t-butyl carbamate
[4-(2-chloro-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2-bromo-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2-nitro-benzoyl-amido)-phenyl]-t-butyl carbamate
4-[(benzo [b] thiophene-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(pyridine-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(naphthalene-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(naphthalene-1-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(3-bromo-thiophene-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(xenyl-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
N-(4-tert-butoxycarbonyl amino-phenyl)-phthalamic acid
[4-(2,3-two fluoro-benzoyl-amidos)-phenyl]-t-butyl carbamate
[4-(2,5-two fluoro-benzoyl-amidos)-phenyl]-t-butyl carbamate
[4-(2,4-two fluoro-benzoyl-amidos)-phenyl]-t-butyl carbamate
[4-(2-acetylamino-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2-methylsulfonyl amino-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2,3,4-three fluoro-benzoyl-amidos)-phenyl]-t-butyl carbamate
[4-(2,3,4,5,6-five fluoro-benzoyl-amidos)-phenyl]-t-butyl carbamate
N-(4-tert-butoxycarbonyl amino-phenyl)-isophthalamic acid methyl esters
2-methylthio group (methylsulfanyl)-N-[4-(2,2,2-three fluoro-acetylamino)-phenyl]-benzamide
[4-(3-benzyloxy-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(3-butoxy-benzoyl-amido)-phenyl]-t-butyl carbamate
4-[(5-difluoromethyl-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(thiophene-3-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(5-methyl-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(5-bromo-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
(4-caproyl amino-phenyl)-t-butyl carbamate
[4-(2-thiophene-2-base-acetylamino)-phenyl]-t-butyl carbamate
4-[(pyridine-3-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(4-bromo-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(furans-3-carbonyl)-amino]-phenyl }-t-butyl carbamate
(4-phenyloxycarbonyl amino-phenyl)-t-butyl carbamate
4-[(benzo [1,3] dioxole-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
[4-(3-trifluoromethoxy-benzoyl-amido)-phenyl]-t-butyl carbamate
N-(2,5-dimethoxy-4 '-nitro-phenyl)-2-fluoro-benzamide
4-[(furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
[4-(2-phenoxy group-acetylamino)-phenyl]-t-butyl carbamate
4-[(5-nitro-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(5-chloro-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(3-methyl-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
[4-(2-methoxyl group-acetylamino)-phenyl]-t-butyl carbamate
4-[(4-furans-3-base-[1,2,3] thiadiazoles-5-carbonyl)-amino]-phenyl }-t-butyl carbamate
The 4-[(5-tertiary butyl-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
N-[3-cyano group-4-(2,2,2-three fluoro-acetylamino)-phenyl]-2-fluoro-benzamide
Furans-2-carboxylic acid [3-cyano group-4-(2,2,2-three fluoro-acetylamino)-phenyl] acid amides
N-(4-acetylamino-2-cyano group-phenyl)-2,2,2-three fluoro-ethanamides
2,2,2-three fluoro-N-(4-nitro-2-trifluoromethyl-phenyl)-ethanamide
N-(4-acetylamino-2-trifluoromethyl-phenyl)-2,2,2-three fluoro-ethanamides
2-fluoro-N-[4-(2,2,2-three fluoro-acetylamino)-3-trifluoromethyl-phenyl] benzamide
Furans-2-carboxylic acid [4-(2,2,2-three fluoro-acetylamino)-3-trifluoromethyl-phenyl] acid amides
2-fluoro-N-(2-methyl-benzoxazoles-6-yl)-benzamide
4-(2-fluoro-benzoyl-amido)-2-hydroxy-benzoic acid phenyl ester
4-[(isoxazole-5-carbonyl)-amino]-phenyl }-t-butyl carbamate
N-(4-acetylamino-2-methoxyl group-phenyl)-2,2,2-three fluoro-ethanamides
2-fluoro-N-[3-methoxyl group-4-(2,2,2-three fluoro-acetylamino)-phenyl] benzamide
2-fluoro-N-(2-fluoro-benzoyl)-N-(4-nitro-2-trifluoromethyl-phenyl) benzamide
4-[(1H-pyrazoles-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(1H-imidazoles-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(5-methyl-[1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(5-furans-3-base-[1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
2,2,2-three fluoro-N-(5-nitro-pyridine-2-yl)-ethanamide
4-[(1-methyl isophthalic acid H-pyrazoles-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-(2-fluoro-benzoyl-amido)-2-hydroxy-benzoic acid methyl esters
N-(5-chloro-2,4-dimethoxy-phenyl)-oxalyl amino acid
Isoxazole-5-carboxylic acid (4-amino-phenyl)-acid amides
2-fluoro-N-(4-nitro-benzyl)-benzamide
Furans-2-carboxylic acid 4-nitrobenzyl acid amides
N-[3-chloro-5-(2,2,2-three fluoro-acetylamino)-phenyl]-2,2,2-three fluoro-ethanamides
N-(3-amino-5-chloro-phenyl)-2,2,2-three fluoro-ethanamides
[4-(2-fluoro-benzoyl-amido)-benzyl]-t-butyl carbamate
[4-(2,6-two fluoro-benzoyl-amidos)-benzyl]-t-butyl carbamate
2,6-two fluoro-N-(4-nitro-benzyl)-benzamide
4-[(furans-2-carbonyl)-amino]-benzyl }-t-butyl carbamate
N-(3-amino-5-chloro-phenyl)-ethanamide
[4-(3-chloro-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(4-chloro-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(4-dimethylamino-benzoyl-amido)-phenyl]-t-butyl carbamate
(4-benzenesulfonyl amino-phenyl)-t-butyl carbamate
[4-(3-trifluoromethyl-benzoyl-amido)-phenyl]-t-butyl carbamate
2,2,2-three fluoro-N-(5-nitro-pyrimidine-2-base)-ethanamide
Embodiment 11 (method 2D)
2-chloro-N-(2-chloro-4-nitrophenyl) ethanamide
Tetrahydrofuran (THF) (150 milliliters) solution of reflux 2-chloro-4-N-methyl-p-nitroaniline (19.0 gram) and chloroacetyl chloride (30 milliliters) 1 hour.Cooling solution and concentrating under reduced pressure obtain wet yellow solid.Add ether (250 milliliters), and collect yellow solid.
Use said procedure and suitable parent material to prepare following compounds:
N-(4-nitro-3-trifluoromethyl-phenyl)-ethanamide
(2-chloro-4-nitro-phenyl)-urethanum
2-acetylamino-5-nitro-phenylformic acid
Furans-2-carboxyl (5-chloro-2-hydroxyl-4-nitro-phenyl)-acid amides
Furans-2-carboxylic acid (2-methyl-4-nitro-phenyl)-acid amides
Furans-2-carboxylic acid (2-methoxyl group-4-nitro-phenyl)-acid amides
N-(2-chloro-4-nitro-phenyl)-benzamide
2-methoxyl group-N-(4-nitro-phenyl)-ethanamide
N-(4-nitro-phenyl)-acrylamide
N-(4-nitro-phenyl)-isobutyramide
[4-(acryl amino)-phenyl] t-butyl carbamate
(4-nitro-phenyl)-isobutyl carbamate
[1,2,3] thiadiazoles-4-carboxylic acid (5-nitro-pyridine-2-yl)-acid amides
Furans-2-carboxylic acid (5-nitro-pyridine-2-yl)-acid amides
2-fluoro-N-(5-nitro-pyridine-2-yl)-benzamide
N-(2-chloro-4-nitro-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (2,5-dimethoxy-4 '-nitro-phenyl)-acid amides
N-(2-cyano group-4-nitro-phenyl)-2-fluoro-benzamide
2-fluoro-N-(2-methoxyl group-4-nitro-phenyl)-benzamide
2-methyl-N-(5-nitro-pyridine-2-yl)-benzamide
Furans-2-carboxylic acid (2-methoxyl group-5-methyl-4-nitro-phenyl)-acid amides
2-furans-N-(2-methoxyl group-5-methyl-4-nitro-phenyl)-benzamide
N-(2-benzoyl-4-nitro-phenyl)-ethanamide
N-(2-benzoyl-4-nitro-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (2-benzoyl-4-nitro-phenyl)-acid amides
N-(3-methyl-4-nitro-phenyl)-ethanamide
2-fluoro-N-(3-methyl-4-nitro-phenyl)-benzamide
Furans-2-carboxylic acid (3-methyl-4-nitro-phenyl)-acid amides
2-acetylamino-5-nitro-N-phenyl-benzamide
The 2-[(2-fluoro benzoyl) amino]-5-nitro-N-phenylbenzamaide
Furans-2-carboxylic acid (4-nitro-2-phenyl amino formyl radical-phenyl)-acid amides
2-fluoro-N-(4-nitro-naphthalene-1-yl)-benzamide
Furans-2-carboxylic acid (4-nitro-naphthalene-1-yl)-acid amides
N-(5-chloro-2-hydroxyl-4-nitro-phenyl)-ethanamide
N-(5-chloro-2-hydroxyl-4-nitro-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (2-chloro-4-nitro-phenyl)-acid amides
N-(4-nitro-2-trifluoromethyl-phenyl)-ethanamide
Furans-2-carboxylic acid (2-cyano group-4-nitro-phenyl)-acid amides
2-fluoro-N-(4-nitro-2-trifluoromethyl-phenyl)-benzamide
Furans-2-carboxylic acid (4-nitro-2-trifluoromethyl-phenyl)-acid amides
2-fluoro-N-(2-methyl-4-nitro-phenyl)-benzamide
N-(5-chloro-2-methyl-4-nitro-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (5-chloro-2-methyl-4-nitro-phenyl)-acid amides
2-(2-fluoro-benzoyl-amido)-5-nitro-phenylformic acid
2-[(furans-2-carbonyl)-amino]-5-nitro-phenylformic acid
N-(3-chloro-4-nitro-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (3-chloro-4-nitro-phenyl)-acid amides
2,6-two fluoro-N-(3-methyl-4-nitro-phenyl)-benzamide
2-fluoro-N-(4-nitro-3-trifluoromethyl-phenyl)-benzamide
Furans-2-carboxylic acid (4-nitro-3-trifluoromethyl-phenyl)-acid amides
2-chloro-N-(2-chloro-4-nitro-phenyl)-ethanamide
N-(2-chloro-4-nitrophenyl) Toluidrin
Furans-2-carboxylic acid [3-methoxyl group-4-(2,2,2-three fluoro-acetylamino)-phenyl]-acid amides
N-(2-chloro-4-nitro-phenyl)-2,2,2-three fluoro-ethanamides
Embodiment 12
4-[(4-phenyl-[1,2,3] thiadiazoles-5-carbonyl)-amino]-phenyl }-t-butyl carbamate
Handle 1-(N-tert-butoxycarbonyl)-1 with triethylamine (1.3 milliliters) and benzotriazole-1-base oxygen base-three (dimethylamino)-phosphorus hexafluorophosphate (1.6 gram), 4-phenylenediamine (0.8 gram) and 4-phenyl-[1,2,3] methylene dichloride (10 milliliters) solution of thiadiazoles-5-carboxylic acid (0.7 gram).After at room temperature stirring, the dilute with water reactant, and use dichloromethane extraction.Organic layer is used dried over mgso then with 0.5N hydrochloric acid, saturated sodium bicarbonate and water washing, filters, and concentrating under reduced pressure, obtain desired product.
Use said procedure and suitable parent material to prepare following compounds:
4-[(1H-pyrroles-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(pyrazine-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(5-methyl-thiophene-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(1-methyl isophthalic acid H-pyrroles-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(quinoline-8-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(cumarone-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(isoquinoline 99.9-1-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(quinoline-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(pyridine-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(isoquinoline 99.9-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[([1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(1H-[1,2,3] triazole-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
[4-(2-methylthio group-benzoyl-amido)-phenyl]-t-butyl carbamate
4-[(quinoline-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(4-methyl-[1,2,3] thiadiazoles-5-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(4-phenyl-[1,2,3] thiadiazoles-5-carbonyl)-amino]-phenyl }-t-butyl carbamate
The 4-[(1H-indole-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
[1,2,3] thiadiazoles-4-carboxylic acid 4-nitrobenzyl acid amides
4-[([1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
Acetate 4-(4-tert-butoxycarbonyl amino-phenyl amino formyl radical)-phenyl ester
4-[(quinoline-6-carbonyl)-amino]-phenyl }-t-butyl carbamate
Embodiment 13 (method 2F)
Acetate 2-(4-tert-butoxycarbonyl amino-2,6-two chloro-phenoxy groups)-ethyl ester
Handle pyridine (14 milliliters) solution of [3,5-two chloro-4-(2-hydroxyl-oxyethyl group)-phenyl]-t-butyl carbamate (0.85 restrains), stirring at room mixture 15 hours with diacetyl oxide (1.24 milliliters).Removal of solvent under reduced pressure is dissolved in ethyl acetate with residuum.Solution % salt acid elution is 2 times then, with saturated sodium bicarbonate aqueous solution washing 1 time, washs with saturated sodium-chloride water solution then.Use anhydrous magnesium sulfate drying solution, removal of solvent under reduced pressure obtains desired colorless oil product.
Use said procedure and suitable parent material to prepare following compounds:
Thiophenyl-acetonitrile
Acetate 2-(4-tert-butoxycarbonyl amino-2,6-two chloro-phenoxy groups)-ethyl ester
Embodiment 14 (method 2G)
(3,5-two chloro-4-hydroxyl-phenyl)-t-butyl carbamate
2, add Di-tert butyl pyrocarbonate (11.7 gram) in tetrahydrofuran (THF) (130 milliliters) solution of 6-two chloro-4-amino-phenols (9.5 gram), and with mixture heating up to refluxing about 15 hours.Cooling mixture then, concentrating under reduced pressure with the ethyl acetate dilution, and with 5% hydrochloric acid continuous washing 3 times, washs 1 time with saturated sodium-chloride water solution.Use anhydrous sodium sulfate drying solution, concentrating under reduced pressure obtains desired crude product then.Then this material is ground with cold methylene dichloride, obtain the white solid state product.
Use said procedure and suitable parent material to prepare following compounds:
(3-amino-5-chloro-phenyl)-t-butyl carbamate
Embodiment 15 (method 3A)
3,5-two chloro-4-oxyethyl group-phenyl amine
In solid (3,5-two chloro-4-oxyethyl group-phenyl)-t-butyl carbamate (0.97 gram), add trifluoroacetic acid (5 milliliters), stirred the mixture under the room temperature about 45 minutes.Add entry then, cooling mixture in ice bath, and with solid carbonic acid potashization.With this solution of ethyl acetate extraction 3 times,, use anhydrous sodium sulfate drying then with the organic phase that the saturated sodium-chloride water solution washing merges.Concentrating under reduced pressure, recrystallization from hexane obtains desired faint yellow crystalline solid-state product.
Use said procedure and suitable parent material to prepare following compounds:
5-bromo-pyridin-3-yl amine
3-chloro-4-methylsulfonyl-phenyl amine
N-(4-amino-phenyl)-2-methyl-benzamide
Acetate 2-(4-amino-phenyl amino formyl radical)-phenyl ester
N-(4-amino-phenyl)-4-fluoro-benzamide
N-(4-amino-phenyl)-3-fluoro-benzamide
N-(4-amino-phenyl)-2-fluoro-benzamide
N-(4-amino-phenyl)-2-methoxyl group-benzamide
N-(4-amino-phenyl)-3-methoxyl group-benzamide
N-(4-amino-phenyl)-4-methoxyl group-benzamide
N-(4-amino-phenyl)-2-phenyl-ethanamide
N-(4-amino-phenyl)-2,2-dimethyl-propionic acid amide
N-(4-amino-phenyl)-2,2,2-three fluoro-ethanamides
Thiophene-2-carboxylic acid (4-amino-phenyl)-acid amides
1H-pyrroles-2-carboxylic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-3-nitro-benzamide
3-acetylamino-N-(4-amino-phenyl)-benzamide
N-(4-amino-phenyl)-3-dimethylamino-benzamide
N-(4-amino-phenyl)-3-methylsulfonyl amino-benzamide
N-(4-amino-phenyl)-2-trifluoromethyl-benzamide
N-(4-amino-phenyl)-2,6-two fluoro-benzamide
N-(4-amino-phenyl)-2-chloro-benzamide
N-(4-amino-phenyl)-2-bromo-benzamide
N-(4-amino-phenyl)-2-nitro-benzamide
Pyrazine-2-carboxylic acid (4-amino-phenyl)-acid amides
5-methyl-thiophene-2-carboxylic acid (4-amino-phenyl)-acid amides
Quinoline-8-carboxylic acid (4-amino-phenyl)-acid amides
1-methyl isophthalic acid H-pyrroles-2-carboxylic acid (4-amino-phenyl)-acid amides
Benzo [b] thiophene-2-carboxylic acid (4-amino-phenyl)-acid amides
Cumarone-2-carboxylic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-Isonicotinamide
Naphthalene-2-carboxylic acid (4-amino-phenyl)-acid amides
Naphthalene-1-carboxylic acid (4-amino-phenyl)-acid amides
Isoquinoline 99.9-1-carboxylic acid (4-amino-phenyl)-acid amides
Quinaldic acid's (4-amino-phenyl)-acid amides
3,5-two chloro-4-oxyethyl group-phenyl amine
4-butoxy-3,5-two chloro-phenyl amine
Isoquinoline 99.9-4-carboxylic acid (4-amino-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-amino-phenyl)-acid amides
1H-[1,2,3] triazole-4-carboxylic acid (4-amino-phenyl)-acid amides
3-bromo-thiophene-2-carboxylic acid (4-amino-phenyl)-acid amides
4-benzyloxy-3,5-two chloro-phenyl amine
2-(4-amino-2,6-two chloro-phenoxy groups)-ethanamide
(4-amino-2,6-two chloro-phenoxy groups)-methyl acetate
[3-(4-amino-phenyl amino formyl radical)-phenyl]-urethanum
2-amino-N-(4-amino-phenyl)-benzamide
Xenyl-2-carboxylic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-2,3-two fluoro-benzamide
N-(4-amino-phenyl)-2,5-two fluoro-benzamide
N-(4-amino-phenyl)-2,4-two fluoro-benzamide
2-acetylamino-N-(4-amino-phenyl)-benzamide
N-(4-amino-phenyl)-2-methylsulfonyl amino-benzamide
N-(4-amino-phenyl)-2,3,4-three fluoro-benzamide
N-(4-amino-phenyl)-2,3,4,5,6-five fluoro-benzamide
N-(4-amino-phenyl)-2-methylthio group-benzamide
Acetate 2-(4-amino-2,6-two chloro-phenoxy groups)-ethyl ester
N-(4-amino-phenyl)-isophthalamic acid methyl esters
N-(4-amino-phenyl)-3-benzyloxy-benzamide
N-(4-amino-phenyl)-3-butoxy-benzamide
[3-(4-amino-phenyl amino formyl radical)-phenoxy group]-ethyl acetate
Pyridine-2-carboxylic acids (4-amino-phenyl)-acid amides
Cinchonic Acid's (4-amino-phenyl)-acid amides
5-methyl-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
5-difluoromethyl-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
1H-Indoline-2-carboxylic acid (4-amino-phenyl)-acid amides
4-methyl-[1,2,3] thiadiazoles-5-carboxylic acid (4-amino-phenyl)-acid amides
Thiophene-3-carboxylic acid (4-amino-phenyl)-acid amides
5-chloro-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
5-nitro-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-2-thiophene-2-base-ethanamide
3-methyl-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
5-bromo-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
4-bromo-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-niacinamide
N-(4-amino-phenyl)-3-furans carboxylic acid amides
4-phenyl-[1,2,3] thiadiazoles-5-carboxylic acid (4-amino-phenyl)-acid amides
Acetate 3-(4-amino-phenyl amino formyl radical)-phenyl ester
Benzo [1,3] dioxole-4-carboxylic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-3-(2-dimethylamino-oxyethyl group)-benzamide
N-(4-amino-phenyl)-3-trifluoromethoxy-benzamide
N-(4-amino-phenyl)-3-(2-morpholine-4-base-oxyethyl group)-benzamide
The own ester of (4-amino-phenyl)-carboxylamine
Furans-2-carboxylic acid (4-amino-phenyl)-acid amides
(4-amino-phenyl)-phenyl carbamate
Caproic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-acrylamide
N-(4-amino-phenyl)-2-methoxyl group-ethanamide
4-furans-3-base-[1,2,3] thiadiazoles-5-carboxylic acid (4-amino-phenyl)-acid amides
The 5-tertiary butyl-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
3-chloro-4-methanesulfinyl-phenyl amine
5-methyl-[1,2,3] thiadiazoles-4-carboxylic acid (4-amino-phenyl)-acid amides
2-(4-amino-2-chloro-phenyl)-ethanol
(4-amino-2-chloro-phenyl)-carboxylamine 2-piperidines-1-base-ethyl ester
5-chloro-N, N-dimethyl-benzene-1,3-diamines
3-(2-methyl-butyl)-5-trifluoromethyl-phenyl amine
3-isobutyl--5-trifluoromethyl-phenyl amine
Furans-2-carboxylic acid (4-amino methyl-phenyl)-acid amides
N-(4-amino methyl-phenyl)-2-fluoro-benzamide
[1,2,3] thiadiazoles-4-carboxylic acid (4-amino methyl-phenyl)-acid amides
N-(4-amino methyl-phenyl)-2,6-two fluoro-benzamide
Oxazole-4-carboxylic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-3-chloro-benzamide
N-(4-amino-phenyl)-4-chloro-benzamide
Acetate 4-(4-amino-phenyl amino formyl radical)-phenyl ester
N-(4-amino-phenyl)-4-dimethylamino-benzamide
1-(4-amino-phenyl)-3-(3,5-di-trifluoromethyl-phenyl)-thiocarbamide
N-(4-amino-phenyl)-2-iodo-benzamide
N-(4-amino-phenyl)-3-trifluoromethyl-benzamide
Embodiment 16 (method 3B)
1-(4-amino-2-chloro-phenyl)-ethanol
Tetrahydrofuran (THF) (5.7 milliliters) solution of 1M tetrabutyl ammonium fluoride is added in [3-chloro-4-(1-hydroxyl-ethyl)-phenyl]-carboxylamine 2-TMS ethyl ester (0.5 gram) about 3.5 hours of stirring at room mixture.Concentrating under reduced pressure mixture then is dissolved in 1: 1 the ethyl acetate and hexanes mixtures, water continuously, and the saturated sodium-chloride water solution washing, and use anhydrous magnesium sulfate drying.Removal of solvent under reduced pressure is used silica gel (with the hexane solution of 40% ethyl acetate as elutriant) chromatography then, obtains amber oily product.
Embodiment 17 (method 3C)
N-(4-amino-3-cyano-phenyl)-2-fluoro-benzamide
Salt of wormwood (5.0 gram) is added to N-[3-cyano group-4-(2,2,2-trifluoroacetyl group-amino)-phenyl]-methyl alcohol (270 milliliters) of 2-fluoro-benzamide (2.5 gram) and the solution of water (16 milliliters) in, the backflow mixture overnight.After the removal of solvent under reduced pressure, residuum is suspended in water, use dichloromethane extraction.Merge organic extract, water with the saturated sodium-chloride water solution washing, is used anhydrous magnesium sulfate drying then, filters and concentrating under reduced pressure, obtains desired white solid state compound.
Use said procedure and suitable parent material to prepare following compounds:
N-(4-amino-phenyl)-2-methanesulfinyl-benzamide
N-(4-amino-3-cyano group-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-3-cyano group-phenyl)-acid amides
N-(4-amino-3-cyano group-phenyl)-ethanamide
Furans-2-carboxylic acid (4-amino-3-trifluoromethyl-phenyl)-acid amides
N-(4-amino-3-methoxyl group-phenyl)-ethanamide
N-(4-amino-3-methoxyl group-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-3-methoxyl group-phenyl)-acid amides
Embodiment 17 (method 4A)
2-chloro-1-cyclohexyl oxygen base-4-oil of mirbane
Under the argon gas, slowly dimethyl sulfoxide (DMSO) (20 milliliters) solution with hexalin (2.9 gram) is added in the flask that contains potassium hydride KH (0.90 gram washs 3 times in advance with hexane) stirring at room solution 1 hour.Add dimethyl sulfoxide (DMSO) (10 milliliters) solution of 3-chloro-4-fluoro-oil of mirbane (1 gram), then about 100 degree were arrived in the dark red solution heating that obtains in 3 hours.Reaction mixture with ether (300 milliliters) dilution, and with saturated aqueous ammonium chloride, water (3 times), is the saturated sodium-chloride water solution washing then then.Use the anhydrous magnesium sulfate drying organic layer then, removal of solvent under reduced pressure with silica gel (with the hexane solution of 5% ethyl acetate as the elutriant) oil that chromatography obtains, obtains desired orange solid product.
Embodiment 18 (method 4C)
(2-chloro-4-nitro-phenyl)-methyl-(1-methyl-tetramethyleneimine-3-yl)-amine
Merge 3-chloro-4-fluoronitrobenzene (1.0 gram) and N, N '-dimethyl-3-amino-pyrrolidine (1.72 gram), stir about 24 hours.Use ethyl acetate diluted mixture thing then, wash with water 2 times,, use anhydrous sodium sulfate drying with saturated sodium-chloride washing 1 time.After removal of solvent under reduced pressure,, obtain desired yellow oil product with silica gel column chromatography residuum (is that pure methyl alcohol is as elutriant then with pure ethyl acetate).
Use said procedure and suitable parent material to prepare following compounds:
(2-chloro-4-nitro-phenyl)-dipropyl-amine
1-(2-chloro-4-nitro-phenyl)-piperidines
1-(2-chloro-4-nitro-phenyl)-tetramethyleneimine
(2-chloro-4-nitro-phenyl)-cyclohexyl-methylamine
Benzyl-(2-chloro-4-nitro-phenyl)-amine
(2-chloro-4-nitro-phenyl)-methyl-(1-methyl-piperidin-4-yl)-amine
(2-chloro-4-nitro-phenyl)-cyclohexyl-ethyl-amine
(2-chloro-4-nitro-phenyl)-cyclohexyl-amine
(2-chloro-4-nitro-phenyl)-methyl-(1-methyl-tetramethyleneimine-3-yl)-amine
(1-benzyl-tetramethyleneimine-3-yl)-(2-chloro-4-nitro-phenyl)-methyl-amine
(2-chloro-4-nitro-phenyl)-cyclopentyl-methyl-amine
1-(2-chloro-4-nitro-phenyl)-decahydro-quinoline
Allyl group-(2-chloro-4-nitro-phenyl)-cyclohexyl-amine
2-[(2-chloro-4-nitro-phenyl)-(2-hydroxyl-ethyl)-amino]-ethanol
(2-chloro-4-nitro-phenyl)-isobutyl--methyl-amine
(2-chloro-4-nitro-phenyl)-hexyl-methyl-amine
2-[(2-chloro-4-nitro-phenyl)-methyl-amino]-ethanol
N-(2-chloro-4-nitro-phenyl)-N, N ', N '-trimethylammonium-ethane-1,2-diamines
N-(2-chloro-4-nitro-phenyl)-N, N ', N '-trimethylammonium-propane-1,3-diamines
(1-benzyl-piperidin-4-yl)-(2-chloro-4-nitro-phenyl)-amine
N-(2-chloro-4-nitro-phenyl)-N, N '-dimethyl-ethane-1,2-diamines
N-(2-chloro-4-nitro-phenyl)-N ', N '-dimethyl-propane-1,3-diamines
(2-chloro-4-nitro-phenyl)-(2-methoxyl group-ethyl)-methyl-amine
(1-benzyl-tetramethyleneimine-3-yl)-(2-chloro-4-nitro-phenyl)-amine
4-piperidines-1-base-3-trifluoromethyl-benzonitrile
4-dimethylamino-3-trifluoromethyl-benzonitrile
4-(4-methyl-piperazine-1-yl)-3-trifluoromethyl-benzonitrile
Embodiment 19 (method 4E)
Butyl-(2-chloro-4-nitro-phenyl) thioether
At room temperature stir the N of 3-chloro-4-fluoro-oil of mirbane (5.0 gram) and sodium sulphite (2.5 gram), dinethylformamide (30 milliliters) solution 1 hour uses 1-iodate butane (12.6 gram) to handle then.Removal of solvent under reduced pressure is handled the residuum that obtains with ethyl acetate and hexane then, precipitates inorganic salt.Solids removed by filtration, concentrating under reduced pressure filtrate.Make the residuum that obtains by hydrous magnesium silicate then, as elutriant, obtain desired yellow solid compounds with methylene dichloride.
Use said procedure and suitable parent material to prepare following compounds:
1-butylthio-2-chloro-4-oil of mirbane
2-chloro-1-hexamethylene sulfenyl-4-oil of mirbane
2-chloro-1-ethylmercapto group-4-oil of mirbane
Embodiment 20 (method 4F)
(4-chloro-5-methoxyl group-2-nitro-phenyl)-dimethyl-amine
In tetrahydrofuran (THF) (2.0 milliliters) solution of trifluoromethanesulfonic acid 4-chloro-5-methoxyl group-2-nitro-phenyl ester (1.0 gram), add dimethyl amine (40% aqueous solution, 4 milliliters), at room temperature stirred the mixture about 15 hours.Decompression concentrated solution is dissolved in ethyl acetate with residuum then, washes with water then.With ethyl acetate extraction water layer 1 time,, use anhydrous sodium sulfate drying with the organic layer that the saturated sodium-chloride water solution washing merges.Solvent removed by evaporation at reduced pressure is ground residuum and hexane altogether, obtains desired colourless solid product.
Use said procedure and suitable parent material to prepare following compounds:
(4-chloro-2-nitro-phenyl)-dimethyl-amine
4-(4-chloro-5-methoxyl group-2-nitro-phenyl)-morpholine
(4-chloro-5-methoxyl group-2-nitro-phenyl)-dimethyl-amine
1-(4-chloro-5-methoxyl group-2-nitro-phenyl)-piperidines
1-(4-chloro-5-methoxyl group-2-nitro-phenyl)-tetramethyleneimine
Benzyl-(4-chloro-5-methoxyl group-2-nitro-phenyl)-amine
(2-chloro-6-nitro-phenyl)-dimethyl-amine
Embodiment 21 (method 4G)
(2-chloro-4-nitro-phenyl)-methyl-phenyl-amine
At 0 ℃, in tetrahydrofuran (THF) (75 milliliters) solution of methylphenylamine (3.0 gram), drip n-Butyl Lithium (12.3 milliliters 2.5M hexane solutions).Make mixture be slowly to warm to room temperature, be cooled to 0C then again, and be added to intubate in tetrahydrofuran (THF) (35 milliliters) solution of the 3-chloro-4-fluoronitrobenzene (4.9 gram) that remains on-78 ℃.After adding, make mixture warm to room temperature in 1 hour, concentrating under reduced pressure by adding the saturated aqueous ammonium chloride cancellation, is used ethyl acetate extraction 3 times then.With 5% hydrochloric acid (3 times), water (1 time), usefulness saturated sodium bicarbonate aqueous solution (1 time), the organic layer of using saturated sodium-chloride water solution (1 time) washing to merge is again used anhydrous magnesium sulfate drying then.After the removal of solvent under reduced pressure,, obtain desired clear colorless oil shape product with silica gel (with the hexane solution of 5% ether as elutriant) chromatography residuum.
Embodiment 22 (method 4H)
2,6-two chloro-4-nitrophenolss
With 3,4,5-trichloronitrobenzene (14.86 gram) is added in ethylene glycol (66 milliliters) solution of phenoxy group potassium (8.66 gram), heated mixt to 160 ℃ about 15 hours.The dark brown solution that obtains is chilled to room temperature, pours in 100 milliliters of cold water, use extracted with diethyl ether 2 times.Water, 10% aqueous sodium hydroxide washes are washed the organic extract of merging, use anhydrous magnesium sulfate drying then.After the removal of solvent under reduced pressure, in the Kugelrohr device, distill, solidify when the yellow oil that obtains is placed.Recrystallization obtains desired faint yellow solid-state product from alcohol-water.
Embodiment 23 (method 5A)
(3,5-two chloro-4-oxyethyl group-phenyl)-t-butyl carbamate
In acetone (18 milliliters) solution of (3,5-two chloro-4-hydroxyl-phenyl)-t-butyl carbamate (1.0 gram) and salt of wormwood (1.0 gram), add ethyl iodide (0.36 milliliter), about 15 hours of stirring at room mixture.Filtering solution then, concentrating under reduced pressure, and between ethyl acetate and water, distribute.Then use the isolating water layer of ethyl acetate extraction 2 times again, the organic extract that merges with 10% aqueous sodium hydroxide solution, water washing is used anhydrous sodium sulfate drying then continuously.Solvent evaporated under reduced pressure obtains desired brown solid product.
Use said procedure and suitable parent material to prepare following compounds:
(3,5-two chloro-4-oxyethyl group-phenyl)-t-butyl carbamate
(4-butoxy-3,5-two chloro-phenyl)-t-butyl carbamate
(4-benzyloxy-3,5-two chloro-phenyl)-t-butyl carbamate
(4-carbamyl ylmethoxy-3,5-two chloro-phenyl)-t-butyl carbamate
[3,5-two chloro-4-(2-nitrilo oxyethyl group)-phenyl]-t-butyl carbamate
(4-tert-butoxycarbonyl amino-2,6-two chloro-phenoxy groups)-methyl acetate
3-butoxy-methyl benzoate
3-tert-butoxycarbonyl methoxyl group-methyl benzoate
3-carbamyl ylmethoxy-methyl benzoate
[4-(3-carbamyl ylmethoxy-benzoyl-amido)-phenyl]-t-butyl carbamate
4-[3-(2-chloro-oxyethyl group)-benzoyl-amido]-phenyl }-t-butyl carbamate
Embodiment 24 (method 5C)
(2,6-two chloro-4-nitro-phenoxy groups)-tert.-butyl acetate
2, in dimethyl formamide (50 milliliters) solution of 6-two chloro-4-nitrophenolss (2.5 gram) and salt of wormwood (3.3 gram), add bromo-acetic acid tert-butyl (10 milliliters), stirring at room mixture 2 days.Then solution is poured in 500 ml waters, used hexane extraction 3 times,, use anhydrous magnesium sulfate drying then with the organic extract that the saturated aqueous ammonium chloride washing merges.Solvent evaporated under reduced pressure makes the oil and the hexane that obtain grind altogether then, obtains desired white solid state product.
Use said procedure and suitable parent material to prepare following compounds:
3-dimethylamino-1-(4-nitro-phenyl)-acrylketone
2-chloro-1-isopropoxy-4-oil of mirbane
1,3-two chloro-2-methoxyl groups-4-methyl-5-nitro benzene
1-chloro-4-oxyethyl group-2-methoxyl group-5-nitro-benzene
1-butoxy-4-chloro-5-methoxyl group-2-nitro-benzene
1-chloro-2-methoxyl group-5-nitro-4-(phenyl methoxyl group) benzene (CA title)
1-chloro-4-methoxyl group-5-nitro-2-(phenyl methoxyl group) benzene (CA title)
(2,6-two chloro-4-nitro-phenoxy groups)-tert.-butyl acetate
(2,6-two chloro-4-nitro-phenoxy groups)-acetonitrile
1-chloro-4-methoxyl group-2-methyl-5-nitro-benzene
2-(4-chloro-5-methoxyl group-2-nitro-phenoxy group)-ethanamide
2-(2-chloro-5-methoxyl group-4-nitro-phenoxy group)-ethanamide
(4-chloro-5-methoxyl group-2-nitro-phenoxy group)-acetonitrile
(2-chloro-5-methoxyl group-4-nitro-phenoxy group)-acetonitrile
4-(2-chloro-5-methoxyl group-4-nitro-phenoxy group)-butyronitrile
2-(4-chloro-5-methoxyl group-2-nitro-phenoxy group)-ethanol
2-(2-chloro-5-methoxyl group-4-nitro-phenoxy group)-ethanol
(2-chloro-5-methoxyl group-4-nitro-phenoxy group)-tert.-butyl acetate
(2-chloro-5-methoxyl group-4-nitro-phenoxy group)-methyl acetate
(4-chloro-5-methoxyl group-2-nitro-phenoxy group)-methyl acetate
(4-chloro-5-methoxyl group-2-nitro-phenoxy group)-tert.-butyl acetate
(2-chloro-4-nitro-phenoxy group)-acetonitrile
1-butoxy-2-chloro-4-nitro-benzene
2-chloro-4-nitro-1-(2,2,2-three fluoro-oxyethyl groups)-benzene
2-chloro-4-nitro-1-propoxy--benzene
2-chloro-1-oxyethyl group-4-nitro-benzene
1,3-two iodo-2,4-dimethoxy-5-nitro-benzene
1,3-two bromo-2,4-dimethoxy-5-nitro-benzene
3-chloro-2,4-dimethoxy-oil of mirbane
Embodiment 25 (method 5E)
[3,5-two chloro-4-(2-hydroxyl-oxyethyl group)-phenyl]-t-butyl carbamate
In toluene (20 milliliters) solution of (3,5-two chloro-5-hydroxyl-phenyl)-t-butyl carbamate (1.0 gram) and salt of wormwood (0.55 gram), add ethylene carbonate (1.6 gram), heated mixt is to refluxing 3 hours.Add 2.5M aqueous sodium hydroxide solution (50 milliliters) in the refrigerative reaction mixture, water, the saturated isolating organic layer of sodium chloride aqueous solution continuous washing are used anhydrous sodium sulfate drying then then.Solvent removed by evaporation at reduced pressure then with silica gel (with the hexane solution of 30% ethyl acetate as the elutriant) residuum that chromatography obtains, obtains desired white foam shape product.
Embodiment 26 (method 6)
3-(2-chloro-4-nitro-phenoxy group)-1-methyl-tetramethyleneimine
In tetrahydrofuran (THF) (60 milliliters) solution of 2-chloro-4-nitrophenols (2.0 gram), add 1-methyl-3-pyrrolidinol (2.3 gram), triphenyl phosphine (6.0 gram) and diethylazodicarboxylate's (3.6 milliliters), in argon gas atmosphere, at room temperature stirred the mixture 1.5 hours.Decompression concentrated solution then with the ethyl acetate dilution, is used 10% saturated aqueous sodium hydroxide solution, water, saturated sodium chloride aqueous solution continuous washing then, uses anhydrous sodium sulfate drying.Solvent removed by evaporation at reduced pressure then, the residuum that obtains with silica gel (use ethyl acetate earlier, the dichloromethane solution of using 10% methyl alcohol again is as elutriant) chromatography.The product component that recrystallization goes out to merge from hexane obtains desired yellow solid product then.
Use said procedure and suitable parent material to prepare following compounds:
4-(2-chloro-4-nitro-phenoxy group)-1-methyl-piperidines
3-(2-chloro-4-nitro-phenoxy group)-1-methyl-tetramethyleneimine
[2-(2-chloro-4-nitro-phenoxy group)-ethyl]-dimethyl-amine
[3-(2-chloro-4-nitro-phenoxy group)-propyl group]-dimethyl-amine
Embodiment 27 (method 7A)
2-chloro-3-methoxyl group-6-nitro-phenol and 2,4-two chloro-3-methoxyl group-6-nitro-phenol
2-chloro-3-methoxyl group-6-nitro-phenol and 2,4-two chloro-3-methoxyl group-6-nitro-phenol
In the flask that contains 3-methoxyl group-6-nitro-phenol (0.5 gram), add aqueous sodium hypochlorite solution (5.25% aqueous solution, 21 milliliters), about 24 hours of stirring at room mixture.Cooling mixture in ice bath is used the concentrated hydrochloric acid acidifying then, then uses ethyl acetate extraction 2 times.Use the anhydrous magnesium sulfate drying organic extract.Solvent removed by evaporation at reduced pressure with silica gel (with the hexane solution of 15% acetone as elutriant) chromatography residuum, provides one solid-state-or two-chlorating product of yellow.
Use said procedure and suitable parent material to prepare following compounds:
3-chloro-2-hydroxyl-4-methoxyl group-oil of mirbane
3,5-two chloro-2-hydroxyl-4-methoxyl group-oil of mirbane
Embodiment 28 (method 7B)
2,4-two chloro-3-methyl-6-nitro-phenol
In water (150 milliliters) solution of 3-methyl-4-nitro-phenol (5.0 gram), add aqueous sodium hypochlorite solution (5.25% aqueous solution, 230 milliliters), about 15 hours of stirring at room mixture.Add aqueous sodium hypochlorite solution (5.25% aqueous solution, 230 milliliters) once more, stirring at room mixture 2.5 days.Cooling mixture in ice bath is used the concentrated hydrochloric acid acidifying then, then uses ethyl acetate extraction 2 times.With these organic extracts of dried over mgso, solvent removed by evaporation at reduced pressure,, obtain desired yellow solid product with silica gel (using ethyl acetate) chromatography residuum as elutriant.Recrystallization obtains analytically pure sample 1 time from chloroform.
Embodiment 29 (method 7C)
1-bromo-2,4-dimethoxy-5-nitro-benzene
2, chloroform (1 milliliter) solution of dripping bromine (0.23 gram) in chloroform (3 milliliters) solution of 4-dimethoxy-oil of mirbane (0.50 gram), about 15 hours of stirring at room mixture.Chloroform (1 milliliter) solution that adds bromine (0.15 gram) once more, restir mixture 4 hours.Mixture is poured in 5% aqueous solution of sodium bisulfite then, then used chloroform extraction.Use 5% aqueous solution of sodium bisulfite then continuously, the organic extract that merges with the saturated sodium-chloride washing is used anhydrous sodium sulfate drying then then.Removal of solvent under reduced pressure, recrystallization from toluene obtains desired yellow solid product.
Embodiment 30 (method 7D)
2,4-two bromo-3-methoxyl group-6-nitro-phenol
Glacial acetic acid (3 milliliters) solution of dripping bromine (1.42 gram) in Glacial acetic acid (3 milliliters) solution of 5-methoxyl group-2-nitro-phenol (0.25 gram) and trifluoroacetic acid silver (0.49 gram), about 24 hours of stirring at room mixture.Then solution is distributed between ethyl acetate and water, organic layer is continuously with 5% aqueous solution of sodium bisulfite washing 3 times, with saturated sodium bicarbonate aqueous solution washing 3 times, with saturated sodium-chloride water solution washing 1 time.Use the anhydrous magnesium sulfate drying organic layer then, removal of solvent under reduced pressure.With silica gel (with the hexane solution of 20% ethyl acetate as elutriant) chromatography residuum, recrystallization from chloroform obtains desired orange solid-state dibrominated product then.
Embodiment 31 (method 7E)
1-iodo-2,4-dimethoxy-5-nitro-benzene
2, add two chloriodic acid benzyltrimethylammon.um (1.90 gram) and Zinc Chloride Anhydrous (1.0 gram) in Glacial acetic acid (30 milliliters) solution of 4-dimethoxy-oil of mirbane (1.0 gram), stirring at room mixture under one deck argon gas.After 5 hours, add two chloriodic acid benzyltrimethylammon.um (0.4 gram) once more, add again 1 time after 24 hours.After 24 hours, add zinc chloride (0.5 gram) and Glacial acetic acid (15 milliliters) once more.Stirring at room mixture 3 days filters then, with the dilution of 5% aqueous solution of sodium bisulfite, uses ethyl acetate extraction 3 times.Wash the organic extract of these merging with 5% sulfurous hydracid sodium water solution, saturated sodium-chloride water solution, use anhydrous magnesium sulfate drying then.Removal of solvent under reduced pressure, residuum and hexane grind altogether, obtain desired faint yellow solid-state product.
Embodiment 32 (method 7F)
2,4-two iodo-3-methoxyl group-6-nitro-phenol
In the solution of the methylene dichloride (15 milliliters) of 5-methoxyl group-2-nitro-phenol (0.25 gram) and methyl alcohol (6 milliliters), add two chloriodic acid benzyltrimethylammon.um (1.08 gram) and sodium bicarbonate (0.85 restrains), stirring at room mixture 24 hours.Filtering solution then, concentrating under reduced pressure filtrate is dissolved in ethyl acetate with residuum, then with 5% sodium bicarbonate aqueous solution, 5% sulfurous hydracid sodium water solution and saturated sodium-chloride water solution continuous washing.Behind anhydrous magnesium sulfate drying, solvent removed by evaporation at reduced pressure, recrystallization residuum from toluene obtains the acicular product of desired yellow.
Embodiment 33 (method 7G)
1-fluoro-2,4-dimethoxy-5-nitro-benzene
2, add 3 in tetrachloroethane (10 milliliters) solution of 4-dimethoxy-oil of mirbane (1.0 gram), 5-two chloro-1-fluoro-pyridine fluoroform sulphonates (85%, 5.07 gram), heated mixt to 120 ℃ 5 hours.Add 3 again, 5-two chloro-1-fluorine pyridine fluoroform sulphonates (85%, 0.25 gram) continue to stir 1 hour.Then solution is cooled to room temperature, by silicagel column (is that the hexane solution of 30% ethyl acetate is as elutriant then with hexane).Merge the product that contains component, reduction vaporization, recrystallization from hexane obtains desired brown solid product.
Embodiment 34 (method 8)
3-chloro-4-trifluoromethyl-oil of mirbane
With the N of 3-chloro-4-iodo-oil of mirbane (2.26 gram), trimethylammonium (trifluoromethyl) silane (5.68 gram), cupric iodide (I) (2.28 gram) and Potassium monofluoride (0.56 gram), dinethylformamide (8 milliliters) solution was tube sealing internal heating to 80 ℃ 40 hours.Cooling solution dilutes with ether then, filtration over celite, and water, saturated sodium-chloride water solution wash filtrate are used anhydrous sodium sulfate drying then continuously.Removal of solvent under reduced pressure with silica gel (with the hexane solution of 1% ether, the hexane solution of using 10% ethyl acetate then is as elutriant) chromatography residuum, obtains desired colorless oil product.
Embodiment 35 (method 9)
(3-chloro-4-methanesulfinyl-phenyl)-t-butyl carbamate
In methylene dichloride (15 milliliters) solution of (3-chloro-4-methylthio group-phenyl)-t-butyl carbamate (0.89 gram), add dimethyl ethylene oxide (the dimethyldioxirane) (acetone soln of~0.11M at 0 ℃, 34 milliliters), 0 ℃ stirred the mixture 1 hour.Removal of solvent under reduced pressure is dissolved in methylene dichloride with residuum, with the saturated sodium-chloride water solution washing, uses colourless dried over mgso then.Removal of solvent under reduced pressure obtains desired orange spumescence product.
Embodiment 36 (method 9B)
[4-(2-methylsulfinyl-benzoyl-amido)-phenyl]-t-butyl carbamate
At 2-methylthio group-N-[4-(2,2,2-three fluoro-acetylamino)-phenyl]-add the saturated solution (5 milliliters) of sodium periodate in the solution of benzamide (234 milligrams), stirred the mixture 12 hours.The purple mixture is poured in the water, used ethyl acetate extraction, use the Anhydrous potassium carbonate drying, evaporation obtains 101 milligrams of red solid.
Use said procedure and suitable parent material to prepare following compounds:
[4-(2-methanesulfinyl-benzoyl-amido)-phenyl]-t-butyl carbamate
2-methanesulfinyl-N-[4-(2,2,2-three fluoro-acetylamino)-phenyl]-benzamide
Embodiment 37 (method 10)
(3-chloro-4-methylsulfonyl-phenyl)-t-butyl carbamate
In methylene dichloride (30 milliliters) solution of (3-chloro-4-methylthio group-phenyl)-t-butyl carbamate (0.90 gram), add dimethyl ethylene oxide (acetone soln of~0.11M, 80 milliliters) at 0 ℃, 0 ℃ stirred the mixture 1 hour.Removal of solvent under reduced pressure is dissolved in methylene dichloride with residuum, with the saturated sodium-chloride water solution washing, uses anhydrous magnesium sulfate drying then.Removal of solvent under reduced pressure obtains desired orange spumescence product.
Embodiment 38 (method 11)
3-chloro-4-vinyl-phenyl amine
In tetrahydrofuran (THF) (120 milliliters) solution of 3-chloro-4-iodo-aniline (6.95 gram), triphenylarsine (0.67 gram) and three (dibenzalacetone) palladium (0) (0.50 gram), add tributylvinyl tin (10 gram) at 50 ℃, 50 ℃ stirred the mixture under argon gas about 15 hours.Cool off reactant then, filtration over celite, reduction vaporization filtrate is to doing.Residuum is dissolved in hexane, then with 5% aqueous hydrochloric acid extraction 3 times.Use these acid extraction thing aqueous solution of solid-state carbonic acid potashization then, and with ethyl acetate extraction 3 times.Wash the organic extract of these merging then with saturated sodium-chloride water solution, use anhydrous magnesium sulfate drying, removal of solvent under reduced pressure.Residuum with silica gel (hexane, the hexane solution that is 10% ethyl acetate then is as elutriant) chromatography obtains obtains desired amber oily product.
Embodiment 39 (method 12)
[3-chloro-4-(1-hydroxyl-ethyl)-phenyl]-carboxylamine 2-TMS-ethyl ester
(3-chloro-4-vinyl-phenyl)-carboxylamine 2-TMS-ethyl ester (2.6 gram) is added in the water (7 milliliters) and tetrahydrofuran (THF) (5.25 milliliters) solution of mercuric acetate (3.48 gram), stirred the mixture about 15 hours.Add the solution of the 3N aqueous sodium hydroxide solution (8.7 milliliters) of 3N aqueous sodium hydroxide solution (8.7 milliliters) and 0.5M sodium borohydride then, then stirred 6 hours.Use sodium chloride saturated solution then, use ethyl acetate extraction.Wash these organic extracts with saturated sodium-chloride water solution then, and use anhydrous sodium sulfate drying.Removal of solvent under reduced pressure with silica gel (with the hexane solution of 20% ethyl acetate as elutriant) chromatography residuum, obtains desired white solid state product.
Embodiment 40 (method 13)
[3-chloro-4-(2-hydroxyl-ethyl)-phenyl]-t-butyl carbamate
In the stirring suspension of the tetrahydrofuran (THF) (13 milliliters) of sodium borohydride (0.45 gram),, stirred the mixture 1 hour at 0 ℃ at 0 ℃ of adding Glacial acetic acid (0.75 milliliter).Then with the solution temperature to room temperature, add (3-chloro-4-vinyl-phenyl)-carboxylamine 2-TMS-ethyl ester (1.0 gram).About 15 hours of stirring at room reactant is heated to then and refluxed about 20 hours.Cooling mixture then adds the solution of 5N aqueous sodium hydroxide solution (0.80 milliliter) and 30% aqueous hydrogen peroxide solution (0.56 milliliter).After stirring 15 hours once more, separating layer is used extracted with diethyl ether water layer 3 times, uses the anhydrous magnesium sulfate drying organic extract.After the removal of solvent under reduced pressure,, obtain desired amber oily product with silica gel (with the hexane of 40% ethyl acetate as elutriant) chromatography residuum.
Embodiment 41 (method 14)
[4-(1-azido--ethyl)-3-chloro-phenyl]-carboxylamine 2-TMS-ethyl ester
In tetrahydrofuran (THF) (20 milliliters) solution of [3-chloro-4-(1-hydroxyl-ethyl)-phenyl]-carboxylamine 2-TMS-ethyl ester (1.25 gram), at 0 ℃, under one deck argon gas, add triphenyl phosphine (2.6 gram), the hydrazoic acid (dichloromethane solution of about 2.5 molar equivalents, according to Fieser and Fierser, Reagents for Organic Synthesis, Vol.1, pg.446; Wiley, the method preparation of New York) and diethylazodicarboxylate's (1.72 gram).After about 10 minutes, removal of solvent under reduced pressure with silica gel (with the hexane solution of 5% ethyl acetate as elutriant) chromatography residuum, obtains desired colorless oil product.
Embodiment 42 (method 15)
[3-chloro-4-(3-dimethylamino-third-1-alkynyl)-phenyl]-t-butyl carbamate
In the deoxidation solution of the triethylamine (120 milliliters) of (3-chloro-4-iodo-phenyl)-t-butyl carbamate (10.0 gram), add 1-dimethylamino-2-propine (2.82 gram), chlorination two (triphenyl phosphine) palladium (II) (0.4 gram) and cuprous iodide (0.054 gram).Under the argon gas, about 6 hours of stirring at room mixture, short period of time heating (about 10 minutes) is to 60 ℃ then.Reaction mixture then, filtration over celite, solvent removed by evaporation at reduced pressure.Residuum is dissolved in ethyl acetate, washes with water 3 times,, use anhydrous magnesium sulfate drying with saturated sodium-chloride water solution washing 1 time.Solvent removed by evaporation at reduced pressure with silica gel (with the hexane solution of 80% ethyl acetate as elutriant) chromatography residuum, obtains the amber oily product of purifying, and it solidifies in placement.
Use said procedure and suitable parent material to prepare following compounds:
[3-chloro-4-(3-dimethylamino-third-1-alkynyl)-phenyl]-t-butyl carbamate
[3-(4-methoxyl group-phenyl)-Propargyl]-dimethyl-amine
4-(3-dimethylamino-third-1-alkynyl)-benzonitrile
Dimethyl-[3-(4-nitro-phenyl)-Propargyl]-amine
Embodiment 43 (method 16)
[3-chloro-4-(3-dimethylamino-acryl)-phenyl]-t-butyl carbamate
In the freezing solution of the methylene dichloride (30 milliliters) of [3-chloro-4-(3-dimethylamino-third-1-alkynyl)-phenyl]-t-butyl carbamate (4.0 gram), divide and add 3-chlorine peroxybenzoic acid (2.34 gram) in a small amount.0 ℃ of reaction stirred is after 20 minutes, with the alkali alumina (Brockmann Grade I, 150 orders) of mixture by 20 weight equivalents, with the dichloromethane solution wash-out N-oxide compound of 5% methyl alcohol.Merge the component that all contain desired amine n-oxide, reduction vaporization is to approaching dry.Handle 3 times with small portion methyl alcohol (about 50 milliliters) continuously, reduction vaporization is adjusted to 250 milliliter by adding methyl alcohol with liquor capacity near dry then.Methanol solution with the N-oxide compound is heated to about 15 hours of backflow then, cooling then, and solvent evaporated under reduced pressure is to doing.With silica gel (with the hexane solution of 80% ethyl acetate as elutriant) chromatography residuum, obtain desired faint yellow solid-state product.
Embodiment 44 (method 17)
(3-chloro-4-isoxazole-5-base-phenyl)-t-butyl carbamate
Handle [3-chloro-4-(3-dimethylamino-acryl-phenyl]-t-butyl carbamate (270 milligrams of) De dioxs (3 milliliters) solution, stirring at room mixture 10 days with oxammonium hydrochloride (122 milligrams).With ethyl acetate diluted mixture thing, water, 5% sodium bicarbonate aqueous solution, saturated sodium-chloride water solution continuous washing are used anhydrous magnesium sulfate drying.Solvent removed by evaporation at reduced pressure with silica gel (with the hexane solution of 33% ethyl acetate as the elutriant) residuum that chromatography obtains, obtains desired colourless solid product.
Embodiment 45 (method 18)
[3-chloro-4-(1H-pyrazole-3-yl)-phenyl]-t-butyl carbamate
With ethanol (1.25 milliliters) solution of hydrazine hydrate (0.25 milliliter) processing [3-chloro-4-(3-dimethylamino-acryl)-phenyl]-t-butyl carbamate (250 milligrams), stirring at room mixture 3 hours.Use 30 milliliters of ether diluted mixture things then, wash with water 3 times,, use anhydrous magnesium sulfate drying with saturated sodium-chloride water solution washing 1 time.Solvent removed by evaporation at reduced pressure with silica gel (with the hexane solution of 67% ethyl acetate as the elutriant) residuum that chromatography obtains, obtains desired oily product.
Embodiment 46 (method 19A)
N-(2-chloro-4-nitrophenyl)-2-thiomorpholine-4-base-ethanamide
In tetrahydrofuran (THF) (50 milliliters) solution of N-(chloracetyl)-2-chloro-4-N-methyl-p-nitroaniline (3.80 gram), add thiomorpholine (10 milliliters), placed solution 1 hour.Reaction mixture is poured in the water, collected faint yellow solid, recrystallization from the 2-propyl alcohol of heat obtains faint yellow crystalline solid then.
Use said procedure and suitable parent material to prepare following compounds:
(4-{2-[two-(2-hydroxyl-ethyl)-amino]-acetylamino }-phenyl)-t-butyl carbamate
[4-(2-dimethylamino-acetylamino)-phenyl]-t-butyl carbamate
4-[3-(2-dimethylamino-oxyethyl group)-benzoyl-amido]-phenyl }-t-butyl carbamate
4-[3-(2-morpholine-4-base-oxyethyl group)-benzoyl-amido]-phenyl }-t-butyl carbamate
N-(2-chloro-4-nitro-phenyl)-2-dimethylamino-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-piperidines-1-base-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-morpholine-4-base-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-dipropyl amino-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-thiomorpholine-4-base-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-diethylamino-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-tetramethyleneimine-1-base-ethanamide
2-nitrogen heterocyclic heptan-1-base-N-(2-chloro-4-nitro-phenyl)-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-(2-methyl-piperidines-1-yl)-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-(3-methyl-piperidines-1-yl)-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-(4-methyl-piperidines-1-yl)-ethanamide
Embodiment 47 (method 19B)
N-(2-chloro-4-nitrophenyl)-2-(2-dimethylamino ethylmercapto group) ethanamide
At the N of N-(chloracetyl)-2-chloro-4-N-methyl-p-nitroaniline (3.01 gram), add powdered sodium carbonate (6.0 gram) and 2-dimethylaminoethyl thiolate hydrochlorate (6.0 gram) in the solution of dinethylformamide (100 milliliters).25 ℃ stirred the mixture 1 hour, poured in the water, used ethyl acetate extraction.With the dry ethyl acetate solution of Anhydrous potassium carbonate, concentrating under reduced pressure obtains oil.From toluene-hexane (3: 1) recrystallization, obtain faint yellow solid-state crystalline solid.
Embodiment 48 (method 20)
(4-tert-butoxycarbonyl amino-2-chloro-phenyl)-carboxylamine 2-piperidines-1-base-ethyl ester
1, in methylene dichloride (40 milliliters) suspension of 1-carbonyl-two-(1,2,4)-triazole (4.0 gram) with methylene dichloride (45 milliliters) solution that was added dropwise to (4-amino-3-chloro-phenyl) t-butyl carbamate (5.0 restrain) in 20 minutes.Stirring at room mixture 30 minutes forms precipitation at this time point.In this mixture, add piperidines ethanol (6.6 milliliters) and tetrahydrofuran (THF) (20 milliliters), to keep homogeneous phase.After reflux was spent the night, the cooling reactant was poured in the water then, separates organic layer, washs with saturated sodium-chloride water solution then.Use anhydrous sodium sulfate drying solution, filter and concentrating under reduced pressure, obtain thick oil,, obtain desired white foam shape product with silica gel (with the dichloromethane solution of 5% methyl alcohol as elutriant) chromatography purification.
Embodiment 49 (method 21)
5-phenyl-[1,2,3] thiadiazoles-4-carboxylate methyl ester
Handle acetonitrile (10 milliliters) solution of ethyl benzoylacetate (1.1 gram) with 4-Methyl benzenesulfonyl nitrine (1.3 gram) and triethylamine (1.6 gram).After the stirred overnight at room temperature, the concentrating under reduced pressure reactant, the crude product that obtains with acetic acid ethyl dissolution, and wash with 1N sodium hydroxide.Use the anhydrous magnesium sulfate drying organic layer then, filter and concentrating under reduced pressure, obtain yellow oil.Dissolve this oil with methylene dichloride, filter hydrated magnesium silicate, use the methylene dichloride wash-out, obtain partially purified colorless oil diazo-ketones.To be dissolved in toluene (25 milliliters) from the diazo-ketones sample (1.2 gram) that obtains, with 2,4-two (4-p-methoxy-phenyl)-1,3-dithia-2,4-two phosphorus heterocycle butane-2,4-disulphide (2.8 gram) is handled, and the reacting by heating thing is to refluxing.After 3 hours, reactant is cooled to room temperature, is added on the silicagel pad, use the methylene dichloride wash-out.After the removal of solvent under reduced pressure, with silica gel (with the petroleum ether solution of 30% ether as elutriant) chromatography, the oil that purifying obtains, recrystallization from hexane obtains desired faint yellow needle-like product then.
Use said procedure and suitable parent material to prepare following compounds:
5-phenyl-[1,2,3] thiadiazoles-4-carboxylic acid, ethyl ester
5-methyl-[1,2,3] thiadiazoles-4-carboxylate methyl ester
Embodiment 50
The ethyl benzoylacetate Urea,amino-
Ethyl benzoylacetate (5.0 gram) is dissolved in methyl alcohol (10 milliliters), is added to rapidly in water (13 milliliters) solution of hot carbamylhydrazine hydrochloride (29 gram).In this solution, add pyridine (4.1 gram), be heated to then and refluxed 5 minutes, reaction mixture is cooled to-20 ℃ and spends the night.Filter and collect the solid semicarbazone that obtains, wash with water, with the ether washing, obtain desired white crystalline product then.
Use said procedure and suitable parent material to prepare following compounds:
(Z)-and the 3-[(aminocarboxyl) hydrazone group]-4,4,4-trifluoroacetic acid ethyl ester
3-[(Z)-2-(aminocarboxyl) hydrazone group]-3-phenylpropionic acid ethyl ester
3-[(E)-2-(aminocarboxyl) hydrazone group]-3-(3-furyl) ethyl propionate
Embodiment 51
5-phenyl-[1,2,3] thiadiazoles-5-carboxylic acid, ethyl ester
0 ℃ of pure thionyl chloride (5 milliliters) solution that stirs ethyl benzoylacetate semicarbazone (2.5 gram) 1 hour.Add methylene dichloride (25 milliliters) then, slowly destroy excessive thionyl chloride with saturated sodium bicarbonate aqueous solution.The precipitation that forms when removing by filter cancellation is used dichloromethane extraction filtrate.Organic extract with anhydrous magnesium sulfate drying merges filters and concentrating under reduced pressure.With silica gel (with the dichloromethane solution of 50% hexane as elutriant) chromatography, obtain desired colorless oil product.
Use said procedure and suitable parent material to prepare following compounds:
4-methyl-[1,2,3] thiadiazoles-5-carboxylate methyl ester
4-phenyl-[1,2,3] thiadiazoles-5-carboxylic acid, ethyl ester
4-furans-3-base-[1,2,3] thiadiazoles-5-carboxylic acid, ethyl ester
Embodiment 52
4-methyl-[1,2,3] thiadiazoles-5-carboxylic acid
4-methyl-[1,2,3] thiadiazoles-5-carboxylate methyl ester (1.7 gram) is dissolved in methyl alcohol (15 milliliters), and handles with 1N sodium hydroxide (16 milliliters).After the stirring at room 1 hour, with concentrated hydrochloric acid (1.5 milliliters) processing reaction thing, and concentrating under reduced pressure.The muddy water layer that obtains with extracted with diethyl ether 2 times, the organic layer with anhydrous magnesium sulfate drying merges filters, and concentrating under reduced pressure, obtains desired white powder compound.
Use said procedure and suitable parent material to prepare following compounds:
3-ethoxycarbonyl methoxy-phenylformic acid
5-furans-3-base-[1,2,3] thiadiazoles-4-carboxylic acid
The thiazole-4-carboxylic acid
4-methyl-[1,2,3] thiadiazoles-5-carboxylic acid
5-methyl-[1,2,3] thiadiazoles-4-carboxylic acid
Embodiment 53 (method 25)
Three fluoro-methylsulfonic acid 4-chloro-5-methoxyl group-2-nitro phenyl esters
In the solution of the methylene dichloride (150 milliliters) of 4-chloro-5-methoxyl group-2-nitrophenols (6.5 gram), at 0 ℃, under argon gas, add triethylamine (10 gram), add methylene dichloride (30 milliliters) solution of trifluoromethanesulfanhydride anhydride (13.5 gram) then.0 ℃ of stirred solution 10 minutes is then with the methylene dichloride dilution, with saturated sodium bicarbonate aqueous solution and saturated sodium-chloride water solution washing.Behind anhydrous sodium sulfate drying, solvent removed by evaporation at reduced pressure is dissolved in the hexane solution of 20% methylene dichloride with residuum, and by magnesium silicate hydrate short column (with the hexane solution of 20% methylene dichloride as elutriant).Merge the product that contains component, solvent removed by evaporation at reduced pressure obtains desired yellow oil product.
Use said procedure and suitable parent material to prepare following compounds:
Three fluoro-methylsulfonic acid 4-chloro-5-methoxyl group-2-nitro-phenyl esters
Three fluoro-methylsulfonic acid 4-chloro-2-nitro-phenyl esters
Three fluoro-methylsulfonic acid 2-chloro-6-nitro-phenyl esters
Embodiment 54 (method 26)
[4-(3-dimethylamino-benzoyl-amido)-phenyl]-t-butyl carbamate
1: 2 tetrahydrofuran (THF)-methyl alcohol (15 milliliters) solution of stirring [4-(3-amino-benzoyl-amido)-phenyl]-t-butyl carbamate (505 milligrams), sodium cyanoborohydride (250 milligrams), acetate (3) and 40% formalin (4 milliliters) 15 minutes; pour into then in the saturated sodium bicarbonate aqueous solution, be extracted into ethyl acetate.With the dry ethyl acetate solution of Anhydrous potassium carbonate, concentrating under reduced pressure obtains solid, uses the acetonitrile recrystallization, obtains rose pink crystalline solid.
Use said procedure and suitable parent material to prepare following compounds:
[4-(3-dimethylamino-benzoyl-amido)-phenyl]-t-butyl carbamate
(3-bromo-5-trifluoromethyl-phenyl)-dimethyl-amine
N-(3-chloro-5-dimethylamino-phenyl)-ethanamide
Embodiment 55 (method 27)
N-(4-aminophenyl)-2-hydroxybenzamide
In methyl alcohol (10 milliliters) solution of acetate 2-(4-aminophenyl formamyl) phenyl ester (580 milligrams), add saturated sodium bicarbonate (2 milliliters) and water (3 milliliters).Mixture 80 ℃ of heating 30 minutes, is poured in the half saturated sodium chloride aqueous solution then, used ethyl acetate extraction.Use the anhydrous sodium sulfate drying ethyl acetate solution, concentrating under reduced pressure obtains oil, then should oil and ether grind altogether, obtain desired white solid state product.
Embodiment 56 (method 28)
[4-(3-(hydroxy benzoyl amino) phenyl) } t-butyl carbamate
In methyl alcohol (75 milliliters) solution of acetate 3-(4-aminophenyl formamyl) phenyl ester (4.34 gram), add 0.1N aqueous sodium hydroxide solution (25 milliliters) and tetrahydrofuran (THF) (25 milliliters).40 ℃ were heated this solution 30 minutes, and cooling is poured in the 1M hydrochloric acid, and used ethyl acetate extraction then.Use the anhydrous sodium sulfate drying ethyl acetate solution, concentrating under reduced pressure obtains white solid, and it is further by grinding purifying altogether with ether.
Embodiment 57 (method 29)
N-(4-aminophenyl)-2-hydroxymethyl benzamide
Add lithium borohydride (1.0 gram) in tetrahydrofuran (THF) (4 milliliters) solution of N-(4-aminophenyl) phthalic imidine (332 milligrams), 25 ℃ were stirred this mixture 1 hour.Mixture is poured in the water, used ethyl acetate extraction.Use the anhydrous sodium sulfate drying ethyl acetate solution, concentrating under reduced pressure obtains white foam, when it and ether grind altogether, obtains desired white powder product.
Embodiment 58 (method 30)
(3-chloro-5-dimethylamino-phenyl)-t-butyl carbamate
In toluene (10 milliliters) solution of (3-amino-5-chloro-phenyl)-t-butyl carbamate (0.32 gram), add formalin (37%, 1.5 milliliter), add 10% palladium carbon (0.50 gram) then, under hydrogen, stirred the mixture about 15 hours.Then with the solution filtration over celite, concentrating under reduced pressure filtrate.With silica gel (with the hexane solution of 50% methylene dichloride as elutriant) chromatography residuum, obtain desired white solid state product.
Embodiment 59 (method 35)
N-(4-{3-[3,5-two chloro-4-(2-hydroxyl-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide
At acetate 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2; 6-two chloro-phenoxy groups }-add 1N aqueous sodium hydroxide solution (1 milliliter), about 2 hours of stirring at room mixture in 1: 1 tetrahydrofuran (THF) of ethyl ester (0.16 gram) and the mixture solution of methyl alcohol (2.5 milliliters).Then solution is poured in the 2M aqueous hydrochloric acid (3 milliliters), be extracted into ethyl acetate, use anhydrous sodium sulfate drying.Solvent removed by evaporation at reduced pressure is ground residuum and ether altogether, obtains desired white solid state product.
Embodiment 60 (method 36)
4-[3-(4-acetylamino-phenyl)-thioureido] and-2,6-two chloro-phenoxy groups }-acetate
In the mixture solution of 1: 1 tetrahydrofuran (THF) of { 4-[3-(4-acetylamino-phenyl)-thioureido]-2,6-two chloro-phenoxy groups }-ethyl acetate (0.29 gram) and methyl alcohol (4 milliliters), add 1N sodium hydroxide (2 milliliters), about 2 hours of stirring at room mixture.Then solution is poured in the 2M aqueous hydrochloric acid (5 milliliters), be extracted into ethyl acetate, use the anhydrous sodium sulfate drying extract.Solvent removed by evaporation at reduced pressure is ground residuum and ether altogether, obtains desired white solid state product.
Use said procedure and suitable parent material to prepare following compounds:
4-[3-(4-acetylamino-phenyl) thioureido] and-2,6-two chloro-phenoxy groups }-acetate
2-[3-(4-acetylamino-phenyl) thioureido]-4-chloro-5-methoxyl group-phenoxy group }-acetate
4-[3-(4-acetylamino-phenyl) thioureido]-2-chloro-5-methoxyl group-phenoxy group }-acetate
Embodiment 61 (method 37)
Phenylformic acid 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2, the 6-dichlorophenoxy }-ethyl ester
At N-(4-{3-[3,5-two chloro-4-(2-hydroxyl-oxyethyl group)-phenyl]-thioureido }-phenyl)-add Benzoyl chloride (0.08 restrains) in the pyridine (2 milliliters) of ethanamide (0.20 gram) and the ice-cold solution of tetrahydrofuran (THF) (0.5 milliliter), 0 ℃ stirred the mixture 1.5 hours.Use ethyl acetate diluted mixture thing then,,, use anhydrous sodium sulfate drying then with saturated sodium-chloride water solution washing 1 time with 2% salt acid elution 2 times.After the removal of solvent under reduced pressure, with silica gel (with the dichloromethane solution of 5% methyl alcohol as elutriant) chromatography residuum, merging contains the branch that washes out of product, reduction vaporization, and recrystallization residuum from acetone-hexane obtains desired white powder product.
Embodiment 62 (method 38)
Methylsulfonic acid 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2,6-two chloro-phenoxy groups }-ethyl ester
At N-(4-{3-[3,5-two chloro-4-(2-hydroxyl-oxyethyl group)-phenyl]-thioureido }-phenyl)-add methylsulfonyl chloride (0.11 restrains) in the pyridine (2 milliliters) of ethanamide (0.20 gram) and the ice-cold solution of tetrahydrofuran (THF) (0.5 milliliter), 0 ℃ stirred the mixture 45 minutes.Use ethyl acetate diluted mixture thing then,,, use anhydrous magnesium sulfate drying then with saturated sodium-chloride water solution washing 1 time with 2% salt acid elution 2 times.After the solvent removed by evaporation at reduced pressure, recrystallization residuum from acetone-hexane obtains desired white powder product.
Embodiment 63 (method 39)
N-(4-{3-[3,5-two chloro-4-(2-dimethylamino-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide
At methylsulfonic acid 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2, the 6-dichlorophenoxy }-add dimethylamine agueous solution (8.8M, 0.5 milliliter), stirring at room mixture 5 days in tetrahydrofuran (THF) (6 milliliters) solution of ethyl ester (0.33 gram).Use ethyl acetate diluted mixture thing then,, use anhydrous magnesium sulfate drying with the saturated sodium-chloride water solution washing.After the removal of solvent under reduced pressure, with silica gel (with pure methyl alcohol as elutriant) chromatography residuum.The branch that washes out that contains product that reduction vaporization merges, recrystallization residuum from acetonitrile obtains desired white powder product.
Use said procedure and suitable parent material to prepare following compounds:
N-(4-{3-[3,5-two chloro-4-(2-dimethylamino-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide
Phenylformic acid 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2,6-two chloro-phenoxy groups }-ethyl ester
Embodiment 64 (method 40)
Furans-2-carboxylic acid (4-{3-[4-(1-amino-ethyl)-3-chloro-phenyl]-thioureido }-phenyl)-acid amides
In methyl alcohol (2.5 milliliters) solution of two hydration tin chlorides (II) (0.25 gram), add furans-2-carboxylic acid (4-{3-[4-(1-azido--ethyl)-3-chloro-phenyl]-thioureido-phenyl)-acid amides (0.22 gram), stirred solution is about 15 hours under the room temperature.Use the ethyl acetate diluting soln, with saturated sodium bicarbonate aqueous solution, saturated sodium-chloride water solution washing, use anhydrous sodium sulfate drying then continuously.After the solvent removed by evaporation at reduced pressure,, obtain desired yellow solid product with silica gel (with the dichloromethane solution that contains 1% triethylamine of 8% methyl alcohol as elutriant) chromatography residuum.
Embodiment 65 (method 41)
[1,2,3] thiadiazoles-4-carboxylic acid (4-isothiocyanic acid base-phenyl)-acid amides
1,1 '-add tetrahydrofuran (THF) (100 milliliters) solution of [1,2,3]-thiadiazoles-4-carboxylic acid (4-amino-phenyl) acid amides (9.0 gram) in the freezing solution of the tetrahydrofuran (THF) (50 milliliters) of thio-carbonyldiimidazole (7.28 gram).After about 1 hour, evaporation removes and desolvates, and residuum is dissolved in ethyl acetate.Add ether and precipitate crude product, collect crude product by filtering then, be dissolved in methylene dichloride, by the hydrated magnesium silicate pad.Except that after desolvating, go out residuum with ethyl acetate-hexane recrystallization, obtain desired faint yellow solid-state product.
Use said procedure and suitable parent material to prepare following compounds:
2-fluoro-N-(4-isothiocyanic acid base-phenyl)-benzamide
Furans-2-carboxylic acid (4-isothiocyanic acid base-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-isothiocyanic acid base-phenyl)-acid amides
Thiadiazoles-4-carboxylic acid (4-isothiocyanic acid base-phenyl)-acid amides
Embodiment 66 (method 42)
N, N-dimethyl-5-trifluoromethyl-benzene-1,3-diamines
Tetrahydrofuran solution (the 2M that in tetrahydrofuran (THF) (2 milliliters) solution of the degassing (argon) of 3-amino-5-bromo-phenylfluoroform (1.0 gram), adds two-(three-adjacent toluene phosphino-) palladiums (0.15 gram), dimethyl amine, 4.2 milliliter) and the tetrahydrofuran solution (1M, 10.4 milliliters) of two (TMS) lithamide.In sealed vessel, reaction mixture is heated to 100 ℃, about 2.5 hours, finishes reaction.Cooling mixture adds entry and comes the cancellation reaction to room temperature then, dilutes with ethyl acetate.Extraction product 3 times, in 5% hydrochloric acid, cooling on one side then is Yi Bian add the acid extraction thing that the alkalization of 5N aqueous sodium hydroxide solution merges.With this basic solution of ethyl acetate extraction, with the organic extract that the saturated sodium-chloride water solution washing merges, use anhydrous magnesium sulfate drying then, reduction vaporization is to doing.With silica gel (with the hexane solution of 20-30% ethyl acetate as the elutriant) residuum that chromatography obtains, obtain desired light brown solid product.
Use said procedure and suitable parent material to prepare following compounds:
3-(4-methyl-piperazine-1-yl)-5-trifluoromethyl-phenyl amine
3-morpholine-4-base-5-trifluoromethyl-phenyl amine
3-piperidines-1-base-5-trifluoromethyl-phenyl amine
3-tetramethyleneimine-1-base-5-trifluoromethyl-phenyl amine
N, N-dimethyl-5-trifluoromethyl-benzene-1,3-diamines
N-isobutyl--N-methyl-5-trifluoromethyl-benzene-1, the 3-diamines
N-butyl-N-methyl-5-trifluoromethyl-benzene-1, the 3-diamines
Embodiment 67 (method 43)
(3-isobutyl--5-trifluoromethyl-phenyl)-t-butyl carbamate
Bubbling fed iso-butylene about 5 minutes in the sealing test tube that contains tetrahydrofuran (THF) (5 milliliters) (envelope has the rubber diaphragm separator plug, and cools off in dry ice acetone bath).The tetrahydrofuran solution (0.5M, 11 milliliters) that adds assorted two ring [3.3.1] nonanes of 9-boron with tetrafluoroethylene cap closure container, is slowly to warm to room temperature, at room temperature is incubated about 2.5 hours.Again cooling mixture in dry ice-propanone is bathed replaces the tetrafluoroethylene cap with the diaphragm of rubber plug then, on one side exhaust, the argon gas bubbling is fed mixture on one side, remove excessive iso-butylene.Tetrahydrofuran (THF) (12 milliliters) solution that adds (3-bromo-5-trifluoromethyl-phenyl) t-butyl carbamate (1.7 gram), add [1 then, 1 '-two (diphenylphosphino)-ferrocene] Palladous chloride (II)-methylene dichloride mixture (0.12 gram), add the 3N aqueous sodium hydroxide solution then.Use tetrafluoroethylene cap sealed vessel once more, be heated to then 65 ℃ about 15 hours.Then mixture is cooled to room temperature, with the hexane dilution, anhydrous magnesium sulfate drying is used in water, saturated sodium-chloride water solution washing, and reduction vaporization.With silica gel (with the hexane solution of 5% ethyl acetate as the elutriant) oil that chromatography obtains, obtain desired white powder product.
Use said procedure and suitable parent material to prepare following compounds:
[3-(2-methyl-butyl)-5-trifluoromethyl-phenyl]-t-butyl carbamate
(3-isobutyl--5-trifluoromethyl-phenyl)-t-butyl carbamate
Embodiment 68 (method 44)
2-(3,5-two chloro-thiophenyls)-ethylamine
Add 0.61 milliliter of 10M dimethyl thioether borane complexes in 3.0 milliliters of ethylene glycol dimethyl ether solutions of (3,5-dichlorobenzene sulfenyl) acetonitrile (1.2 gram), heated mixt is to refluxing 0.5 hour.In ice bath, cool off reactant, add 2.0 ml waters and 2.0 milliliters of concentrated hydrochloric acids.Heat this compound to refluxing 0.5 hour.Cool off then and, use extracted with diethyl ether with 5N sodium hydroxide alkalization settled solution.With the dry ether extract of salt of wormwood, filter and concentrate, obtain 1.0 gram water white oils.
Use said procedure and suitable parent material to prepare following compounds:
2-(3-bromo-thiophenyl)-ethylamine
2-(4-bromo-phenoxy group)-ethylamine
2-(4-iodo-phenoxy group)-ethylamine
2-(3,4-two chloro-phenoxy groups)-ethylamine
2-(3-chloro-thiophenyl)-ethylamine
2-(3,4-two chloro-thiophenyls)-ethylamine
3-(4-bromo-phenyl)-propyl group amine
2-(2-fluoro-phenoxy group)-ethylamine
2-(2-chloro-phenoxy group)-ethylamine
2-(3-bromo-phenoxy group)-ethylamine
2-(3-fluoro-phenoxy group)-ethylamine
2-(3-iodo-phenoxy group)-ethylamine
2-(3,5-two chloro-thiophenyls)-ethylamine
2-thiophenyl-ethylamine
1-(2-chloro-phenyl)-ethylamine
Embodiment 69 (method 45)
N-(1-naphthalene-2-base-ethyl)-methane amide
In the mixture of 190 ℃ of heating 2 acetyl naphthalenes (3.0 gram), ammonium formiate (11.0 gram), formic acid (3.3 milliliters) and methane amide (3.5 milliliters) 3 hours.Cooling mixture is poured in the water, uses extracted with diethyl ether.With the dry ether extract of Anhydrous potassium carbonate, filter, concentrate, obtain yellow oil, it obtains white solid from toluene-hexane recrystallization, 1.97 grams.
Use said procedure and suitable parent material to prepare following compounds:
N-[1-(4-fluoro-phenyl)-2-methyl-propyl group]-methane amide
N-(1-naphthalene-2-base-ethyl)-methane amide
Embodiment 70 (method 46)
1-(2-naphthyl) ethylamine
The mixture of heating N-(1-naphthalene-2-base-ethyl)-methane amide (1.12 gram), ethanol (10 milliliters) and 5N sodium hydroxide (10 milliliters) is to refluxing 1 hour.Cooling mixture is poured in the water, uses extracted with diethyl ether.With the dry ethereal solution of Anhydrous potassium carbonate, filter and concentrate, obtain faint yellow oily product (0.95 gram).
Use said procedure and suitable parent material to prepare following compounds:
1-(3-trifluoromethyl-phenyl)-ethylamine
1-(4-fluoro-phenyl)-2-methyl-propyl group amine
[3-(1-amino-ethyl)-phenyl]-dimethyl-amine
3-(1-amino-ethyl)-benzonitrile
Embodiment 71 (method 47)
1-(3-trifluoromethyl-phenyl)-ethyl ketone (ethenone) O-methyl-oxime
Methoxy-amine hydrochloride (2.33 gram) is added to 3 '-ethanol (20 milliliters) and pyridine (2 milliliters) solution of (trifluoromethyl)-acetylbenzene (1.5 gram).Heated solution is to refluxing 45 minutes, reaction mixture then, and concentrating under reduced pressure distributes between water and ethyl acetate.Use the ethyl acetate extraction water layer.With the organic layer that the saturated sodium-chloride water solution washing merges, use anhydrous magnesium sulfate drying, and concentrating under reduced pressure, obtain desired colorless oil product (1.61 gram).
Use said procedure and suitable parent material to prepare following compounds:
3,5-di-trifluoromethyl-benzaldoxime
1-(4-fluoro-phenyl)-third-1-ketone O-methyloxime
1-(2-chloro-phenyl)-ethyl ketone O-methyloxime
1-(3-bromo-phenyl)-ethyl ketone O-methyloxime
1-(3-chloro-phenyl)-ethyl ketone O-methyloxime
1-p-methylphenyl-ethyl ketone O-methyloxime
1-(4-fluoro-phenyl)-penta-1-ketone O-methyloxime
1-(4-fluoro-phenyl)-2-phenyl-ethyl ketone O-methyloxime
1-o-tolyl-ethyl ketone O-methyloxime
Tolyl between 1--ethyl ketone O-methyloxime
1-(2-fluoro-phenyl)-ethyl ketone O-methyloxime
3-(1-methoxyimino-ethyl)-benzonitrile
4-(1-methoxyimino-ethyl)-benzonitrile
1-(4-methoxyl group-phenyl)-ethyl ketone O-methyloxime
1-(2-methoxyl group-phenyl)-ethyl ketone O-methyloxime
1-(4-dimethylamino-phenyl)-ethyl ketone O-methyloxime
1-(2-trifluoromethyl-phenyl)-ethyl ketone O-methyloxime
1-(3-methoxyl group-phenyl)-ethyl ketone O-methyloxime
1-(3-trifluoromethyl-phenyl)-ethyl ketone O-methyloxime
1-(4-trifluoromethyl-phenyl)-ethyl ketone O-methyloxime
1-furans-2-base-ethyl ketone O-methyloxime
1-pyridin-4-yl-ethyl ketone O-methyloxime
1-(1-methyl isophthalic acid H-pyrroles-2-yl)-ethyl ketone O-methyloxime
1-thiophene (thiophen)-3-base ethyl ketone O-methyloxime
(4-fluoro-phenyl)-phenyl-ketone O-methyloxime
1-(4-p-methoxy-phenyl) ethyl ketone O-methyloxime
1-(3-chloro-4-methoxyl group-phenyl)-ethyl ketone O-methyloxime
4-(1-methoxyimino-ethyl)-benzsulfamide
4-(1-methoxyimino-ethyl)-N, N-dimethyl-benzsulfamide
1-[4-(piperidines-1-alkylsulfonyl)-phenyl]-ethyl ketone O-methyloxime
4-(1-methoxyimino-ethyl)-N, N-dipropyl-benzsulfamide
2-fluoro-N-[4-(1-methoxyimino-ethyl)-phenyl]-benzamide
1-(3,5-di-trifluoromethyl-phenyl)-ethyl ketone O-methyloxime
1-[4-(1H-imidazoles-1-yl)-phenyl]-1-ethyl ketone O-methyloxime
1-[4-(trifluoromethyl)-phenyl]-1-ethyl ketone O-methyloxime
1-[1,1 '-xenyl]-4-base-1-ethyl ketone O-methyloxime
1-(4-aminomethyl phenyl)-1-ethyl ketone O-methyloxime
1-[4-fluoro-3-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-[3,5-two (trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-[4-chloro-3-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-[3-fluoro-5-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-[2-fluoro-4-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-[2-fluoro-5-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-(2,4 dichloro benzene base) ethyl ketone O-methyloxime
1-(2, the 4-3,5-dimethylphenyl) ethyl ketone O-methyloxime
1-[2,4-two (trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-(3-bromophenyl) ethyl ketone O-methyloxime
1-(3-aminomethyl phenyl) ethyl ketone O-methyloxime
1-[4-(4-morpholinyl) phenyl] ethyl ketone O-methyloxime
1-(2-chloro-4-fluorophenyl) ethyl ketone O-methyloxime
1-(4-bromo-2-fluorophenyl) ethyl ketone O-methyloxime
1-(3, the 4-difluorophenyl) ethyl ketone O-methyloxime
1-[3-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-[2-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-(2,4 difluorobenzene base) ethyl ketone O-methyloxime
1-[3-fluoro-4-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-(3, the 4-dichlorophenyl) ethyl ketone O-methyloxime
1-[4-fluoro-2-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-(3-chloro-4-fluorophenyl) ethyl ketone O-methyloxime
1-(4-chloro-3-fluorophenyl) ethyl ketone O-methyloxime
1-(2, the 5-difluorophenyl) ethyl ketone O-methyloxime
1-(2-bromo-4-fluorophenyl) ethyl ketone O-methyloxime
1-(3, the 4-dibromo phenyl) ethyl ketone O-methyloxime
1-(2-bromophenyl) ethyl ketone O-methyloxime
Embodiment 72 (method 48)
1-(2-trifluoromethyl-phenyl)-ethylamine
Sodium borohydride (1.17 gram) slowly is added in the flask of tetrahydrofuran (THF) (27 milliliters) solution that contains zirconium tetrachloride (1.8 gram).The solution that tetrahydrofuran (THF) (7.7 milliliters) solution that adds 1-(2-trifluoromethyl-phenyl)-ethyl ketone O-methyloxime (1.34 gram), 25 ℃ of stirrings obtain 12 hours.Reaction mixture is chilled to 0 ℃ then, slowly adds entry (16 milliliters).Add the excessive hydrogen ammonium oxide, use ethyl acetate extraction solution 2 times.With 1N salt acid elution organic layer 2 times.With alkalize water (acid) layer of sodium hydroxide, with ethyl acetate extraction 2 times.Wash organic layer with saturated sodium-chloride water solution then, and use anhydrous magnesium sulfate drying.Removal of solvent under reduced pressure obtains desired yellow oil product (0.20 gram).
Use said procedure and suitable parent material to prepare following compounds:
1-(3-methoxyl group-phenyl)-ethylamine
1-(4-fluoro-phenyl)-propyl group amine
1-naphthalene-2-base-ethylamine
4-(1-amino-ethyl)-benzonitrile
1-(4-trifluoromethyl-phenyl)-ethylamine
1-(4-methoxyl group-phenyl)-ethylamine
1-propine-2-base-tetramethyleneimine
1-(2-methoxyl group-phenyl)-ethylamine
Tolyl-ethylamine between 1-
1-(2-bromo-phenyl)-ethylamine
1-o-tolyl-ethylamine
C-(4-fluoro-phenyl)-C-phenyl-methylamine
1-(4-fluoro-phenyl)-amylamine
1-(4-fluoro-phenyl)-2-phenyl-ethylamine
1-(2-trifluoromethyl-phenyl)-ethylamine
1-(3-bromo-phenyl)-ethylamine
1-(3-chloro-phenyl)-ethylamine
[4-(1-amino-ethyl)-phenyl]-dimethyl-amine
1-(1-methyl isophthalic acid H-pyrroles-2-yl)-ethylamine
1-thiene-3-yl--ethylamine
1-[3,5-two (trifluoromethyl) phenyl] propyl group amine
1-[3,5-two (trifluoromethyl) phenyl]-1-butylamine or 1-[3,5-two (trifluoromethyl) phenyl] butylamine
1-[3,5-two (trifluoromethyl) phenyl]-the 1-amylamine
1-(4-aminomethyl phenyl) ethamine
1-[3-(trifluoromethyl) phenyl] ethylamine
1-[4-(trifluoromethyl) phenyl] ethylamine
1-(3-aminomethyl phenyl) ethamine
1-(3, the 4-dichlorophenyl) ethamine
1-(2-bromo-phenyl)-ethylamine
1-(2-trifluoromethyl-phenyl)-ethylamine
1-(3-bromo-phenyl)-ethylamine
1-(3-chloro-4-methoxyl group-phenyl)-ethylamine
4-(1-amino-ethyl)-N, N-dimethyl-benzsulfamide
1-[4-(piperidines-1-alkylsulfonyl)-phenyl]-ethylamine
1-quinoline-6-base-ethylamine
1-(3,5-di-trifluoromethyl-phenyl)-ethylamine
4-[(1S)-and the 1-amino-ethyl] benzonitrile
(S)-and Alpha-Methyl-3,5-two (trifluoromethyl)-benzene methanamine (S)-Alpha-Methyl-3,5-two (trifluoromethyl)-benzene methanamine
1-biphenyl-4-base-ethylamine
1-(4-fluoro-phenyl)-ethylamine
1-[4-fluoro-3-(trifluoromethyl) phenyl] ethamine
1-[4-chloro-3-(trifluoromethyl) phenyl] ethamine
N-{4-[(1R)-and the 1-amino-ethyl] phenyl }-1,2,3-thiadiazoles-4-carboxylic acid amides
N-{4-[(1S)-and the 1-amino-ethyl] phenyl }-1,2,3-thiadiazoles-4-carboxylic acid amides
1-[3-fluoro-5-(trifluoromethyl) phenyl] ethylamine
1-[2-fluoro-4-(trifluoromethyl) phenyl] ethylamine
1-[2-fluoro-5-(trifluoromethyl) phenyl] ethylamine
1-(2,4 dichloro benzene base)-ethylamine
1-(2, the 4-3,5-dimethylphenyl) ethylamine
1-[2,4-two (trifluoromethyl) phenyl] ethylamine
1-(2-chloro-4-fluorophenyl) ethylamine
1-(3, the 4-difluorophenyl) ethylamine
1-(4-bromo-2-fluorophenyl) ethylamine
1-(3-fluorophenyl) ethylamine
1-(2,4 difluorobenzene base) ethylamine
1-[3-fluoro-4-(trifluoromethyl) phenyl] ethylamine
1-[4-fluoro-2-(trifluoromethyl) phenyl] ethylamine
1-(3-chloro-4-fluorophenyl) ethylamine
1-(4-chloro-3-fluorophenyl) ethylamine
1-(2-bromo-4-fluorophenyl) ethamine 1-(2-bromo-4-fluorophenyl) ethylamine
Embodiment 73 (method 49)
(2-fluoro-5-trifluoromethyl-phenoxy group)-acetonitrile
Reagent grade acetone (0.55L) solution with solid carbonic acid potassium (7.7 gram) processing 2-fluoro-5-trifloro methyl phenol (25 gram) adds pure bromoacetonitrile (10 milliliters) then rapidly.About 20 hours of vigorous stirring heterogeneous mixture is poured in the water then, is extracted into ether.With the ether extract of saturated sodium-chloride washing merging, and use the Anhydrous potassium carbonate drying.Filter and concentrating under reduced pressure, obtain greenish orange look solid, use silica gel column chromatography then, use the methylene dichloride wash-out, obtain desired white solid state product (28.3 gram).
Use said procedure and suitable parent material to prepare following compounds:
(3-bromo-thiophenyl)-acetonitrile
(3-chloro-thiophenyl)-acetonitrile
(4-iodo-phenoxy group)-acetonitrile
(3-trifluoromethyl-thiophenyl)-acetonitrile
(3,5-two chloro-thiophenyls)-acetonitrile
(3,4-two chloro-thiophenyls)-acetonitrile
(3,4-two chloro-phenoxy groups)-acetonitrile
(2-fluoro-phenoxy group)-acetonitrile
(3-fluoro-phenoxy group)-acetonitrile
(2-chloro-phenoxy group)-acetonitrile
(3-bromo-phenoxy group)-acetonitrile
(2-fluoro-5-trifluoromethyl-phenoxy group)-acetonitrile
(3-iodo-phenoxy group)-acetonitrile
(4-bromo-phenoxy group)-acetonitrile
Embodiment 74 (method 50)
Toluenesulphonic acids 3-fluoro-5-trifluoromethylbenzene ethylamine
At room temperature,, use 200 milligram of 10% palladium-carbon catalyst, 75 milliliters of methyl glycol solution of hydrogenation 2.5 gram 3-fluoro-5-trifluoromethyl acetonitriles and 2.34 gram (12.3 mmole) tosic acid 3 hours with 40psi.The elimination catalyzer, evaporating solvent to volume half.After the placement, the tosilate crystallization of desired 3-fluoro-5-trifluoromethylbenzene ethylamine.Filter and collect white crystal 4.26 grams (91%).
Use said procedure and suitable parent material to prepare following compounds:
2-(3,5-two fluoro-phenyl)-ethylamine
2-(4-trifluoromethyl-phenyl)-ethylamine
2-(3,4-two fluoro-phenyl)-ethylamine
2-(2-fluoro-phenyl)-ethylamine
2-(3-fluoro-5-trifluoromethyl-phenyl)-ethylamine
2-(2-fluoro-3-trifluoromethyl-phenyl)-ethylamine
2-(2,4-di-trifluoromethyl-phenyl)-ethylamine
2-(4-fluoro-3-trifluoromethyl-phenyl)-ethylamine
Embodiment 75 (method 51)
(4-amino methyl-2-trifluoromethyl-phenyl)-dimethyl-amine
Tetrahydrofuran (THF) (2 milliliters) solution of 4-dimethylamino-3-trifluoromethyl benzonitrile (0.35 gram) in 0 ℃ of tetrahydrofuran (THF) (2 milliliters) suspension that slowly is added to lithium aluminium hydride (0.1 gram), and was stirred 2 hours under argon gas.Slowly adding entry (0.1 milliliter) at 0 ℃, is 5% sodium hydroxide (0.1 milliliter) and water (0.3 milliliter) then.The gray solid that filtration obtains is washed with tetrahydrofuran (THF).Collect filtrate, concentrating under reduced pressure with silica gel (with the dichloromethane solution of 15% methyl alcohol as the elutriant) oil that chromatography obtains, obtains desired greenish orange look oily product (0.164 restrains).
Use said procedure and suitable parent material to prepare following compounds:
4-piperidines-1-base-3-trifluoromethyl-benzyl amine
(4-amino methyl-2-trifluoromethyl-phenyl)-dimethyl-amine
4-(4-methyl-piperazine-1-yl)-3-trifluoromethyl-benzyl amine
(3-amino methyl-5-trifluoromethyl-phenyl)-dimethyl-amine
[3-(2-amino-ethyl)-5-trifluoromethyl-phenyl]-dimethyl-amine
[4-(2-amino-ethyl)-2-methyl-phenyl]-dimethyl-amine
Embodiment 76 (method 52)
3-dimethylamino-5-trifluoromethyl-phenyl aldehyde
Diisobutyl aluminium hydride (10 milliliters of 1M dichloromethane solutions) in 0 ℃ of methylene dichloride (25 milliliters) solution that is added drop-wise to 3-dimethylamino-5-trifluoromethyl benzonitrile (1.06 gram), was stirred the mixture 2 hours.At 0 ℃, slowly add saturated sodium tartrate aqueous solutions of potassium (8 milliliters), stirred solution 1.5 hours.Use the ethyl acetate extraction reaction mixture then, use anhydrous magnesium sulfate drying, concentrating under reduced pressure obtains desired yellow solid product (0.97 gram).
Use said procedure and suitable parent material to prepare following compounds:
3-dimethylamino-5-trifluoromethyl-phenyl aldehyde
4-dimethylamino-3-methyl-phenyl aldehyde
Embodiment 77 (method 53)
Dimethyl-[3-(2-nitro-vinyl)-5-trifluoromethyl-phenyl]-amine
Nitromethane 99Min. (0.473 gram) is added in acetate (3.4 milliliters) solution of 3-dimethylamino-5-trifluoromethyl-phenyl aldehyde (0.885 gram) and ammonium acetate (0.339 restrains) 110 ℃ of heated solutions 6 hours.Reaction mixture is cooled to 0 ℃, leaches the solid of formation, with water-acetate washing in 1: 1.This solid recrystallization from ethanol obtains desired red solid product (0.39 gram).
Use said procedure and suitable parent material to prepare following compounds:
Dimethyl-[3-(2-nitro-vinyl)-5-trifluoromethyl-phenyl]-amine
Dimethyl-[2-methyl-4-(2-nitro-vinyl)-phenyl]-amine
Embodiment 78 (method 54)
3-(4-bromo-phenyl)-propionitrile
With diethylazodicarboxylate (5.2 gram) in the solution of 0 ℃ of ether (16 milliliters) that is added drop-wise to 4-bromo-styroyl alcohol (2.01 gram) and triphenyl phosphine (7.9 restrain).Stirred reaction mixture 10 minutes, ether (10 milliliters) solution of adding acetone cyanohydrin (2.6 gram).0 ℃ was stirred clear orange solution 5 minutes, stirred 12 hours at 25 ℃ then.Filter reaction mixture washs with ether then.Concentrating under reduced pressure filtrate with silica gel (with 10% ethyl acetate-hexane as elutriant) chromatography, obtains desired faint yellow oily product (2.04 restrain).
Embodiment 79 (method 55)
3-dimethylamino-2-isocyano--ethyl propenoate
Drip N in ethanol (100 milliliters) solution of isocyano acid B ester (5.0 gram), N-dimethyl-methane amide dimethylacetal (6.5 gram) stirs more than 10 minutes.Reaction stirred 24 hours, ethanol evaporation.The oil that obtains uses 50% ethyl acetate-hexane as eluent by Magnesium Silicate q-agent.Remove and desolvate, the oil that recrystallization obtains from ethyl acetate-hexane obtains faint yellow spicule, 3.0 grams.
Embodiment 80 (method 56)
4-ethoxy carbonyl thiazole
Tetrahydrofuran (THF) (30 milliliters) solution with hydrogen sulfide processing 3-dimethylamino-2-isocyano--ethyl propenoate (1.0 gram) and triethylamine (3.0 gram) has been consumed up to parent material.Enriched mixture is used column chromatography purification to oily, uses silicon-dioxide and 25% ethyl acetate-hexane as elutriant.The material (0.61 gram) that separates the buttery purifying.
Embodiment 81 (method 34)
N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-urea groups]-phenyl }-2-fluoro-benzamide
With 5-chloro-2,4-dimethoxy benzene based isocyanate (0.40 gram) is handled acetonitrile (4 milliliters) suspension of N-(4-amino-phenyl)-2-fluoro-benzamide (0.43 gram).Mixture becomes solution, places 12 hours.Form white solid, filter and collect (0.79 gram).[M+H]444。
Use said procedure and suitable parent material to prepare following compounds:
Embodiment number | ?M+H | The compound title |
81 | ?445 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-urea groups]-phenyl }-2-fluoro-benzamide |
82 | ?441 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-urea groups]-phenyl }-2-methyl-benzamide |
83 | ?435 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-urea groups]-phenyl }-acid amides |
84 | ?443 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-urea groups]-phenyl }-acid amides |
85 | ?453 | N-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-urea groups]-phenyl }-2-fluoro-benzamide |
86 | ?409 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-urea groups]-phenyl }-acid amides |
87 | ?486 | N-{4-[3-(3,5-di-trifluoromethyl-phenyl)-urea groups]-phenyl }-2-fluoro-benzamide |
88 | ?458 | Furans-2-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-urea groups]-phenyl }-acid amides |
89 | ?476 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-urea groups]-phenyl }-acid amides |
90 | ?423 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-urea groups]-phenyl }-acid amides |
Embodiment 91 (method 31)
N-(5-{[({ (1S)-1-[3,5-two (trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl]-amino }-the 2-pyridyl)-1,3-thiazoles-4-carboxylic acid amides
With N-(5-isothiocyanic acid base-2-pyridyl)-1,3-thiazoles-4-carboxylic acid amides (0.36 gram) and (S)-[methyl-3, mixture and the acetonitrile (10 milliliters) of 5-two (trifluoromethyl)-benzene methanamine (0.36 restrains) heat α together, dissolve up to all solids.Place solution and formed white solid in 12 hours, filter and collect (0.40 gram).[M+H]520。
Use said procedure and suitable parent material to prepare following compounds:
Embodiment number | ?M+H | The compound title |
92 | ?506 | [3-chloro-5-(3-{4-([1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-thioureido)-phenyl]-t-butyl carbamate |
93 | ?409 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(4-morpholine-4-base-phenyl)-thiocarbamide |
94 | ?370 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(4-methylthio group-phenyl)-thiocarbamide |
95 | ?338 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-p-methylphenyl-thiocarbamide |
96 | ?414 | 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-thiophenyl }-acetate |
97 | ?384 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-[4-(2-hydroxyl-oxyethyl group)-phenyl]-thiocarbamide |
98 | ?340 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(4-hydroxyl-phenyl)-thiocarbamide |
99 | ?395 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-N-methyl-ethanamide |
100 | ?381 | N-{3-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
101 | ?411 | 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-urethanum |
102 | ?319 | 1-(2,4-dimethoxy-phenyl)-3-(4-methoxyl group-phenyl)-thiocarbamide |
103 | ?346 | N-{4-[3-(2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
104 | ?316 | N-{4-[3-(4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
105 | ?316 | N-{4-[3-(2-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
106 | ?351 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
107 | ?351 | N-{4-[3-(5-chloro-2-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
108 | ?371 | N-{4-[3-(3,5-two chloro-4-hydroxyl-phenyl)-thioureido]-phenyl }-ethanamide |
109 | ?385 | N-{4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
110 | ?381 | N-{4-[3-(4-chloro-2,5-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
111 | ?389 | N-{4-[3-(2-chloro-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-ethanamide |
112 | ?389 | N-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-ethanamide |
113 | ?422 | Phenylformic acid 4-[3-(4-acetylamino-phenyl)-thioureido]-3-hydroxyl-phenyl ester |
114 | ?457 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-methyl-benzamide |
115 | ?501 | Acetate 2-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl-formamyl }-phenyl ester |
116 | ?461 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-4-fluoro-benzamide |
117 | ?461 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-fluoro-benzamide |
118 | ?461 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
119 | ?473 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-methoxyl group-benzamide |
120 | ?473 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-methoxyl group-benzamide |
121 | ?473 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-4-methoxyl group-benzamide |
122 | ?443 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide |
123 | ?417 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-methane-sulphonamide |
124 | ?331 | N-{4-[3-(3-nitro-phenyl)-thioureido]-phenyl }-ethanamide |
?125 | ??339 | 1-(3-chloro-4-methoxyl group-phenyl)-3-(3-nitro-phenyl)-thiocarbamide |
?126 | ??337 | N-{4-[3-(5-chloro-2-hydroxyl-phenyl)-thioureido]-phenyl }-ethanamide |
?127 | ??439 | 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-t-butyl carbamate |
?128 | ??351 | N-{4-[3-(3-chloro-4-hydroxy-5-methyl base-phenyl)-thioureido]-phenyl }-ethanamide |
?129 | ??385 | N-{4-[3-(3,5-two chloro-4-hydroxy-2-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
?130 | ??318 | N-{4-[3-(2,4-dihydroxyl-phenyl)-thioureido]-phenyl }-ethanamide |
?131 | ??414 | N-{4-[3-(2,4-dimethoxy-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-ethanamide |
?132 | ??332 | N-{4-[3-(2-hydroxyl-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
?133 | ??465 | N-{4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-4-fluoro-benzamide |
?134 | ??500 | 3-acetylamino-N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide |
?135 | ??488 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-nitro-benzamide |
?136 | ??486 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-dimethylamino-benzamide |
?137 | ??536 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-methane-alkylsulfonyl-amino-benzamide |
?138 | ??511 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-three fluoro-methyl-benzamide |
?139 | ??459 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-hydroxyl-benzamide |
?140 | ??479 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
?141 | ??477 | 2-chloro-N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide |
?142 | ??522 | 2-bromo-N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide |
?143 | ??488 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-nitro-benzamide |
?144 | ??445 | Pyrazine-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
?145 | ??463 | 5-methyl-thiophene-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
?146 | ??494 | Quinoline-8-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
?147 | ??446 | 1-methyl isophthalic acid H-pyrroles-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
?148 | ??369 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(2-nitro-phenyl)-thiocarbamide |
?149 | ??369 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(4-nitro-phenyl)-thiocarbamide |
?150 | ??425 | N-{4-[3-(5-bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
?151 | ??376 | N-{4-[3-(3,4,5-trimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
?152 | ??399 | N-{4-[3-(3,5-two chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
?153 | ??499 | Benzo [b] thiophene-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
154 | ?483 | Cumarone-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
155 | ?444 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-Isonicotinamide |
156 | ?493 | Naphthalene-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
157 | ?493 | Naphthalene-1-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
158 | ?494 | Isoquinoline 99.9-1-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
159 | ?494 | The quinaldic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
160 | ?444 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-niacinamide |
161 | ?478 | 5-nitro-furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acyl ammonia |
162 | ?459 | 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-phenyl carbamate |
163 | ?467 | 5-chloro-furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
164 | ?439 | 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-isobutyl carbamate |
165 | ?397 | 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-Urethylane |
166 | ?433 | Furans-3-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
167 | ?447 | 3-methyl-furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
168 | ?512 | 5-bromo-furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
169 | ?512 | 4-bromo-furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
170 | ?433 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
171 | ?467 | 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-the own ester of carboxylamine |
172 | ?494 | Isoquinoline 99.9-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
173 | ?451 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
174 | ?434 | 1H-[1,2,3] triazole-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
175 | ?528 | 3-bromo-thiophene-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
176 | ?399 | N-{4-[3-(3,5-two chloro-4-oxyethyl group-phenyl)-thioureido]-phenyl }-ethanamide |
177 | ?427 | N-{4-[3-(4-butoxy-3,5-two chloro-phenyl)-thioureido]-phenyl }-ethanamide |
178 | ?461 | N-{4-[3-(4-benzyloxy-3,5-two chloro-phenyl)-thioureido]-phenyl }-ethanamide |
179 | ?381 | N-{4-[3-(3-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
180 | ?530 | (3-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-the phenyl amino formyl radical }-phenyl)-urethanum |
181 | ?458 | 2-amino-N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide |
182 | ?519 | Diphenyl-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??183 | ??469 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-[4-(1,3-dioxo-1,3-dihydro-isoindole-2-yl)-phenyl]-thiocarbamide |
??184 | ??487 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-phthalamic acid |
??185 | ??473 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-hydroxyl-methyl-benzamide |
??186 | ??479 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2,3-two fluoro-benzamide |
??187 | ??479 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2,5-two fluoro-benzamide |
??188 | ??479 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2,4-two fluoro-benzamide |
??189 | ??500 | 2-acetylamino-N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide |
??190 | ??441 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(6-oxo-5,6-dihydro-phenanthridines-2-yl)-thiocarbamide |
??191 | ??536 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-methylsulfonyl amino-benzamide |
??192 | ??497 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2,3,4-three fluoro-benzamide |
??193 | ??533 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2,3,4,5,6-five fluoro-benzamide |
??194 | ??489 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-methylthio group-benzamide |
??195 | ??431 | 5-methyl-furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-urea groups]-phenyl }-acid amides |
??196 | ??467 | 5-difluoromethyl-furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-urea groups]-phenyl }-acid amides |
??197 | ??472 | N-{4-[3-(5-iodo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
??198 | ??364 | N-{4-[3-(5-fluoro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
??199 | ??365 | N-{4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
??200 | ??459 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
??201 | ??455 | 1,2,3] thiadiazoles-4-carboxylic acid { 4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-acid amides |
??202 | ??392 | N-{4-[3-(3-chloro-4-diethylamino-phenyl)-thioureido]-phenyl }-ethanamide |
??203 | ??432 | N-(4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-ethanamide |
??204 | ??506 | 1-hydroxyl-naphthalene-2-carboxylic acid 4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-acid amides |
??205 | ??406 | N-{4-[3-(3-chloro-4-morpholine-4-base-phenyl)-thioureido]-phenyl }-ethanamide |
??206 | ??443 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(3-chloro-4-morpholine-4-base-phenyl)-thiocarbamide |
??207 | ??372 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-chloro-2-methyl-phenyl)-thiocarbamide |
??208 | ??501 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-the isophthalamic acid methyl esters |
??209 | ??487 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-isophthalamic acid |
??210 | ??549 | 3-benzyloxy-N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide |
??211 | ??434 | N-(4-{3-[5-chloro-2-methoxyl group-4-(4-nitrilo-butoxy)-phenyl]-thioureido }-phenyl)-ethanamide |
212 | ?406 | N-(4-{3-[5-chloro-2-methoxyl group-4-(2-nitrilo-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide |
213 | ?406 | N-(4-{3-[5-chloro-4-methoxyl group-2-(2-nitrilo-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide |
214 | ?411 | N-(4-{3-[5-chloro-2-(2-hydroxyl-oxyethyl group)-4-methoxyl group-phenyl]-thioureido }-phenyl)-ethanamide |
215 | ?411 | N-(4-{3-[5-chloro-4-(2-hydroxyl-oxyethyl group)-2-methoxyl group-phenyl]-thioureido }-phenyl)-ethanamide |
216 | ?481 | 4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-5-methoxyl group-phenoxy group }-tert.-butyl acetate |
217 | ?439 | 4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-5-methoxyl group-phenoxy group }-methyl acetate |
218 | ?481 | { [2-[3-(4-acetylamino-phenyl)-thioureido]-4-chloro-5-methoxyl group-phenoxy group }-tert.-butyl acetate |
219 | ?515 | 3-butoxy-N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide |
220 | ?505 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-methanesulfinyl-benzamide |
221 | ?545 | (3-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-the phenyl amino formyl radical }-phenoxy group)-ethyl acetate |
222 | ?517 | (3-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-the phenyl amino formyl radical }-phenoxy group)-acetate |
223 | ?367 | N-{4-[3-(5-chloro-4-hydroxyl-2-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
224 | ?444 | Pyridine-2-carboxylic acids 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
225 | ?494 | The Cinchonic Acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
226 | ?436 | N-{4-[3-(5-chloro-4-methoxyl group-2-morpholine-4-base-phenyl)-thioureido]-phenyl }-ethanamide |
227 | ?394 | N-{4-[3-(5-chloro-2-methylamino-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
228 | ?420 | N-{4-[3-(5-chloro-4-methoxyl group-2-tetramethyleneimine-1-base-phenyl)-thioureido]-phenyl }-ethanamide |
229 | ?434 | N-{4-[3-(5-chloro-4-methoxyl group-2-piperidines-1-base-phenyl)-thioureido]-phenyl }-ethanamide |
230 | ?405 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-acid amides |
231 | ?415 | N-{4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
232 | ?427 | N-{4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-3-methoxyl group-benzamide |
233 | ?387 | Furans-2-carboxylic acid 4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-acid amides |
234 | ?411 | N-{4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-2-methyl-benzamide |
235 | ?433 | N-{4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
236 | ?398 | Pyridine-2-carboxylic acids 4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-acid amides |
237 | ?502 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl }-acid amides |
238 | ?512 | N-(4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
239 | ?404 | N-{4-[3-(3-chloro-4-piperidines-1-base-phenyl)-thioureido]-phenyl }-ethanamide |
240 | ?364 | N-{4-[3-(3-chloro-4-dimethylamino-phenyl)-thioureido]-phenyl }-ethanamide |
241 | ?426 | N-{4-[3-(4-benzylamino-3-chloro-phenyl)-thioureido]-phenyl }-ethanamide |
242 | ?390 | N-{4-[3-(3-chloro-4-tetramethyleneimine-1-base-phenyl)-thioureido]-phenyl }-ethanamide |
243 | ?419 | N-(4-{3-[3-chloro-4-(4-methyl-piperazine-1-yl)-phenyl]-thioureido }-phenyl)-ethanamide |
244 | ?469 | N-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
245 | ?422 | N-{4-[3-(2-benzylamino-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
246 | ?484 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-acid amides |
247 | ?508 | N-(4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-2-methyl-benzamide |
248 | ?530 | N-(4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-2,6-two fluoro-benzamide |
249 | ?495 | Pyridine-2-carboxylic acids (4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-acid amides |
250 | ?524 | N-(4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-3-methoxyl group-benzamide |
251 | ?376 | N-(4-{3-[3-chloro-4-(2-nitrilo-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide |
252 | ?393 | N-{4-[3-(4-sec-butoxy-3-chloro-phenyl)-thioureido]-phenyl }-ethanamide |
253 | ?501 | Acetate 3-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl-formamyl }-phenyl ester |
254 | ?459 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-hydroxyl-benzamide |
255 | ?487 | Benzo [1,3] dioxole-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
256 | ?527 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-fluoro-methoxyl group-benzamide |
257 | ?530 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-(2-dimethylamino-oxyethyl group)-benzamide |
258 | ?572 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-(2-morpholine-4-base-oxyethyl group)-benzamide |
259 | ?406 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-cyano group-phenyl }-ethanamide |
260 | ?521 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2,5-dimethoxy-phenyl }-2-fluoro-benzamide |
261 | ?441 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2,5-dimethoxy-phenyl }-ethanamide |
262 | ?527 | 2-{4-[3-(4-acetylamino-phenyl }-thioureido]-2-chloro-phenoxy group }-5-chloro-Phenylsulfonic acid |
263 | ?562 | 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenoxy group }-4,5-two chloro-Phenylsulfonic acids |
264 | ?527 | 4-phenyl-[1.2,3] thiadiazoles-5-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
265 | ?381 | N-(4-{3-[3-chloro-4-(2-hydroxyl-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide |
266 | ?393 | N-{4-[3-(4-butoxy-3-chloro-phenyl)-thioureido]-phenyl }-ethanamide |
267 | ?446 | N-(4-{3-[3-chloro-4-(cyclohexyl-ethyl-amino)-phenyl]-thioureido }-phenyl)-ethanamide |
268 | ?365 | N-{4-[3-(3-chloro-4-oxyethyl group-phenyl)-thioureido]-phenyl }-ethanamide |
269 | ?427 | N-{4-[3-(4-benzyloxy-3-chloro-phenyl)-thioureido]-phenyl }-ethanamide |
270 | ?317 | 4-[(3-methyl-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate |
271 | ?456 | N-{4-[3-(2-benzylamino-5-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
272 | ?420 | N-{4-[3-(3-chloro-4-dipropyl amino-phenyl)-thioureido]-phenyl }-ethanamide |
273 | ?458 | N-(4-{3-[4-(allyl group-cyclohexyl-amino)-3-chloro-phenyl]-thioureido }-phenyl)-ethanamide |
274 | ?411 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-the 2-p-methoxy-phenyl }-ethanamide |
275 | ?415 | N-{2-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
276 | ?493 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido] and-2,5-dimethoxy-phenyl }-acid amides |
277 | ?486 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-cyano group-phenyl }-2-fluoro-benzamide |
278 | ?495 | N-{2-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
279 | ?465 | 5-methyl-[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
280 | ?517 | 5-furans-3-base-[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
281 | ?527 | 5-phenyl-[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
282 | ?458 | N-(4-{3-[3-chloro-4-(octahydro quinoline-1-yl)-phenyl]-thioureido }-phenyl)-ethanamide |
283 | ?458 | N-[5-[[[(5-chloro-2,4-dimethoxy-phenyl) amino] sulphomethyl] amino]-the 2-pyridyl]-the 2-methyl benzamide |
284 | ?434 | Furans-2-carboxylic acid 5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridine-2-yl }-acid amides |
285 | ?425 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methoxyl group-5-methyl-phenyl }-ethanamide |
286 | ?505 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methoxyl group-5-methyl-phenyl }-2-fluoro-benzamide |
287 | ?477 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methoxyl group-5-methyl-phenyl }-acid amides |
288 | ?517 | 4-furans-3-base-[1,2,3] thiadiazoles-5-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
289 | ?462 | N-{5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridine-2-yl }-2-fluoro-benzamide |
290 | ?384 | N-{4-[3-(4-methoxyl group-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-ethanamide |
291 | ?394 | N-[4-(3-{3-chloro-4-[(2-hydroxyl-ethyl)-methyl-amino]-phenyl }-thioureido)-phenyl]-ethanamide |
292 | ?485 | N-{2-benzoyl-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
293 | ?565 | N-{2-benzoyl-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
294 | ?537 | Furans-2-carboxylic acid 2-benzoyl-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
295 | ?475 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methyl-phenyl }-2-fluoro-benzamide |
296 | ?447 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methyl-phenyl }-acid amides |
297 | ?395 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methyl-phenyl }-ethanamide |
298 | ?435 | N-[4-(3-{3-chloro-4-[(3-dimethylamino-propyl group)-methyl-amino]-phenyl }-thioureido)-phenyl]-ethanamide |
299 | ?418 | N-{4-[3-(3-chloro-4-cyclohexyl amino-phenyl)-thioureido]-phenyl }-ethanamide |
300 | ?421 | N-[4-(3-{3-chloro-4-[(2-dimethylamino-ethyl)-methyl-amino]-phenyl }-thioureido)-phenyl]-ethanamide |
301 | ?580 | 5-[[[(5-chloro-2, the 4-Dimethoxyphenyl) amino] sulphomethyl] amino]-the 2-[(2-fluoro benzoyl) amino]-N-phenyl-benzamide |
302 | ?552 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-phenyl amino formyl radical-phenyl }-acid amides |
303 | ?491 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-the 2-p-methoxy-phenyl }-2-fluoro-benzamide |
304 | ?463 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methoxyl group-phenyl }-acid amides |
305 | ?449 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-trifluoromethyl-phenyl }-ethanamide |
306 | ?458 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-cyano group-phenyl }-acid amides |
307 | ?467 | Furans-2-carboxylic acid 2-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
308 | ?501 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-trifluoromethyl-phenyl }-acid amides |
309 | ?395 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-ethanamide |
310 | ?475 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-2-fluoro-benzamide |
311 | ?447 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-acid amides |
312 | ?378 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-ethanamide |
313 | ?408 | 4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-urethanum |
314 | ?382 | N-{5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridine-2-yl }-ethanamide |
315 | ?509 | N-(4-{3-[4-(1-benzyl-piperidin-4-yl amino)-3-chloro-phenyl]-thioureido }-phenyl)-ethanamide |
316 | ?407 | N-(4-{3-[3-chloro-4-(2-dimethylamino-ethylamino)-phenyl]-thioureido }-phenyl)-ethanamide |
317 | ?408 | N-[4-(3-{3-chloro-4-[(2-methoxyl group-ethyl)-methyl-amino]-phenyl }-thioureido)-phenyl]-ethanamide |
318 | ?421 | N-(4-{3-[3-chloro-4-(3-dimethylamino-propyl group amino)-phenyl]-thioureido }-phenyl)-ethanamide |
319 | ?495 | N-(4-{3-[4-(1-benzyl-tetramethyleneimine-3-base is amino)-3-chloro-phenyl]-thioureido }-phenyl)-ethanamide |
320 | ?483 | Furans-2-carboxylic acid 5-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-hydroxyl-phenyl }-acid amides |
321 | ?431 | N-{5-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-hydroxyl-phenyl }-ethanamide |
322 | ?511 | (5H, 11H-benzo [e] pyrrolo-[1,2-a] [1,4] two azepines-10-yl)-(2-chloro-4-imidazoles-1-base-phenyl)-ketone |
323 | ?451 | [1,2,3] thiadiazoles-5-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
324 | ?483 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-naphthalene-1-yl }-acid amides |
325 | ?511 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-naphthalene-1-yl }-2-fluoro-benzamide |
326 | ?429 | N-{5-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-ethanamide |
327 | ?509 | N-{5-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-2-fluoro-benzamide |
328 | ?481 | Furans-2-carboxylic acid 5-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-acid amides |
329 | ?431 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-naphthalene-1-yl }-ethanamide |
330 | ?416 | Furans-2-carboxylic acid 4-[3-(3-chloro-4-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
331 | ?561 | Furans-2-carboxylic acid [4-(3-{4-[(1-benzyl-tetramethyleneimine-3-yl)-methyl-amino]-3-chloro-phenyl }-thioureido)-phenyl]-acid amides |
332 | ?513 | N-[4-(3-{3-chloro-4-[methyl-(1-methyl-tetramethyleneimine-3-yl)-amino]-phenyl }-thioureido)-phenyl]-2-fluoro-benzamide |
333 | ?463 | N-{4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
334 | ?420 | N-(4-{3-[3-chloro-4-(1-methyl-tetramethyleneimine-3-base oxygen base)-phenyl]-thioureido }-phenyl)-ethanamide |
335 | ?434 | N-(4-{3-[3-chloro-4-(1-methyl-piperidin-4-yl oxygen base)-phenyl]-thioureido }-phenyl)-ethanamide |
336 | ?422 | N-(4-{3-[3-chloro-4-(3-dimethylamino-propoxy-)-phenyl]-thioureido }-phenyl)-ethanamide |
337 | ?425 | 2-acetylamino-5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenylformic acid |
338 | ?505 | 5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-(2-fluoro-benzoyl-amido)-phenylformic acid |
339 | ?477 | 5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-[(furans-2-carbonyl)-amino]-phenylformic acid |
340 | ?545 | N-[4-(3-{3-chloro-4-[methyl-(1-methyl-piperidin-4-yl)-amino]-phenyl }-thioureido)-phenyl]-2,6-two fluoro-benzamide |
341 | ?503 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-{3-chloro-4-[methyl-(1-methyl-tetramethyleneimine-3-yl)-amino]-phenyl }-thioureido)-phenyl]-acid amides |
342 | ?443 | N-{4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-phenyl }-2-methyl-benzamide |
343 | ?408 | N-(4-{3-[3-chloro-4-(2-dimethylamino-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide |
344 | ?499 | Furans-2-carboxylic acid [4-(3-{3-chloro-4-[methyl-(1-methyl-piperidin-4-yl)-amino]-phenyl }-thioureido)-phenyl]-acid amides |
345 | ?419 | N-{4-[3-(3-chloro-4-cyclohexyl oxygen base-phenyl)-thioureido]-phenyl }-ethanamide |
346 | ?440 | N-{4-[3-(3-chloro-4-dimethylamino-phenyl)-thioureido]-phenyl }-2-methyl-benzamide |
347 | ?493 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methyl-phenyl }-2,6-two fluoro-benzamide |
348 | ?462 | N-{4-[3-(3-chloro-4-dimethylamino-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
349 | ?531 | N-[4-(3-{3-chloro-4-[methyl-(1-methylpyrrolidin-3-yl)-amino]-phenyl }-thioureido)-phenyl]-2,6-two fluoro-benzamide |
350 | ?427 | Pyridine-2-carboxylic acids 4-[3-(3-chloro-4-dimethylamino-phenyl }-thioureido)-phenyl }-acid amides |
351 | ?430 | Pyridine-2-carboxylic acids 4-[3-(3-chloro-4-methylthio group-phenyl }-thioureido)-phenyl }-acid amides |
352 | ?428 | Pyridine-2-carboxylic acids 4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl }-thioureido)-phenyl }-acid amides |
353 | ?417 | Furans-2-carboxylic acid 4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl }-thioureido)-phenyl }-acid amides |
354 | ?496 | Pyridine-2-carboxylic acids [4-(3-{3-chloro-4-[methyl-(1-methyl-tetramethyleneimine-3-yl)-amino]-phenyl }-thioureido)-phenyl]-acid amides |
355 | ?495 | N-{3-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
356 | ?467 | Furans-2-carboxylic acid 3-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
357 | ?515 | N-{4-[3-(3-chloro-4-encircles sulfenyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
358 | ?449 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-trifluoromethyl-phenyl }-ethanamide |
359 | ?529 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-trifluoromethyl-phenyl }-2-fluoro-benzamide |
360 | ?421 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-dimethyl-amino-ethanamide |
361 | ?473 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(2-dimethylamino-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides |
362 | ?501 | N-(4-{3-[3-chloro-4-(2-dimethylamino-acetylamino)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
363 | ?461 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-piperidines-1-base-ethanamide |
364 | ?541 | N-(4-{3-[3-chloro-4-(2-piperidines-1-base-acetylamino)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
365 | ?513 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(2-piperidines-1-base-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides |
366 | ?463 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-morpholine-4-base-ethanamide |
367 | ?543 | N-(4-{3-[3-chloro-4-(2-morpholine-4-base-acetylamino)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
368 | ?515 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(2-morpholine-4-base-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides |
369 | ?414 | N-{4-[3-(3-chloro-4-methylsulfonyl amino-phenyl)-thioureido]-phenyl }-ethanamide |
370 | ?494 | N-{4-[3-(3-chloro-4-methylsulfonyl amino-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
371 | ?466 | Furans-2-carboxylic acid 4-[3-(3-chloro-4-methylsulfonyl amino-phenyl)-thioureido]-phenyl }-ethanamide |
372 | ?481 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-(2-dimethylamino-ethylmercapto group)-ethanamide |
373 | ?561 | N-[4-(3-{3-chloro-4-[2-(2-dimethylamino-ethylmercapto group)-acetylamino]-phenyl }-thioureido)-phenyl]-2-fluoro-benzamide |
374 | ?585 | N-[4-(3-{4-[(1-benzyl-tetramethyleneimine-3-yl)-methyl-amino]-3-chloro-phenyl }-thioureido)-phenyl]-2-methyl-benzamide |
375 | ?523 | N-[4-(3-{3-chloro-4-[methyl-(1-methyl-piperidin-4-yl)-amino]-phenyl }-thioureido)-phenyl]-2-methyl-benzamide |
376 | ?510 | Pyridine-2-carboxylic acids [4-(3-{3-chloro-4-[methyl-(1-methyl-piperidin-4-yl)-amino]-phenyl }-thioureido)-phenyl]-acid amides |
377 | ?347 | N-{4-[3-(3-chloro-4-vinyl-phenyl)-thioureido]-phenyl }-ethanamide |
378 | ?441 | Furans-2-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
379 | ?452 | Pyridine-2-carboxylic acids 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
380 | ?487 | N-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
381 | ?486 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-cyano group-phenyl }-2-fluoro-benzamide |
382 | ?458 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-cyano group-phenyl }-acid amides |
383 | ?406 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-cyano group-phenyl }-ethanamide |
384 | ?395 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-2-methyl-isothioureido]-phenyl }-ethanamide |
385 | ?396 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-2-methyl-isothioureido]-phenyl }-ethanamide |
386 | ?461 | N-{4-[3-(3-chloro-4-ethylmercapto group-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
387 | ?489 | N-{4-[3-(4-butylthio-3-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
388 | ?411 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methoxyl group-phenyl }-ethanamide |
389 | ?491 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methoxyl group-phenyl }-2-fluoro-benzamide |
390 | ?463 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methoxyl group-phenyl }-acid amides |
391 | ?531 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-chloro-4-(2-piperidines-1-base-ethanoyl-amino)-phenyl]-thioureido } phenyl)-acid amides |
392 | ?481 | N-{4-[3-(3-chloro-4-methanesulfinyl-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
393 | ?497 | N-{4-[3-(3-chloro-4-methylsulfonyl-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
394 | ?459 | N-{4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-2-methyl-phenyl }-2-fluoro-benzamide |
395 | ?429 | N-{4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-2-methyl-phenyl }-2-fluoro-benzamide |
396 | ?533 | Furans-2-carboxylic acid [4-(3-{3-chloro-4-[2-(2-dimethylamino-ethylmercapto group)-acetylamino]-phenyl }-thioureido)-phenyl]-acid amides |
397 | ?458 | N-{4-[3-(4-acetylamino-3-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
398 | ?460 | [2-chloro-4-(3-{4-[(furans-2-carbonyl)-amino]-phenyl }-thioureido)-phenyl]-urethanum |
390 | ?488 | (2-chloro-4-{3-[4-(2-fluoro-benzoyl-amido)-phenyl]-thioureido }-phenyl]-urethanum |
400 | ?440 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-benzamide |
401 | ?520 | N-{4-[({[4-(benzoyl-amido)-3-chloro-phenyl]-amino }-sulphomethyl)-amino]-phenyl }-2-fluoro-benzamide |
402 | ?529 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-trifluoromethyl-phenyl }-2-fluoro-benzamide |
403 | ?492 | Furans-2-carboxylic acid 4-[3-(4-benzoyl-amido-3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
404 | ?416 | N-{4-[3-(4-amino-3-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
405 | ?479 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-thiomorpholine-4-base-ethanamide |
406 | ?531 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(2-thiomorpholine-4-base-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides |
407 | ?559 | N-(4-{3-[3-chloro-4-(2-thiomorpholine-4-base-acetylamino)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
408 | ?461 | N-{4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-2-methyl-phenyl }-2-fluoro-benzamide |
409 | ?430 | Furans-2-carboxylic acid 4-[3-(4-acetylamino-3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
410 | ?477 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-dipropyl amino-ethanamide |
411 | ?529 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(2-dipropyl amino-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides |
412 | ?449 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-diethylamino-ethanamide |
413 | ?501 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(2-diethylamino-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides |
414 | ?529 | N-(4-{3-[3-chloro-4-(2-diethylamino-acetylamino)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
415 | ?447 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-tetramethyleneimine-1-base-ethanamide |
416 | ?499 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(2-tetramethyleneimine-1-base-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides |
417 | ?527 | N-(4-{3-[3-chloro-4-(2-tetramethyleneimine-1-base-acetylamino)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
418 | ?475 | N-{4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-3-methoxyl group-phenyl }-2-fluoro-benzamide |
419 | ?445 | N-{4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-3-methoxyl group-phenyl }-2-fluoro-benzamide |
420 | ?477 | N-{4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-3-methoxyl group-phenyl }-2-fluoro-benzamide |
421 | ?388 | Furans-2-carboxylic acid 4-[3-(4-amino-3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
422 | ?527 | Furans-2-carboxylic acid (4-{3-[4-(2-nitrogen heterocyclic heptan-1-base-acetylamino)-3-chloro-phenyl]-thioureido }-phenyl)-acid amides |
423 | ?555 | N-(4-{3-[4-(2-nitrogen heterocyclic heptan-1-base-acetylamino)-3-chloro-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
424 | ?527 | Furans-2-carboxylic acid [4-(3-{3-chloro-4-[2-(2-methyl-piperidines-1-yl)-ethanoyl-amino]-phenyl }-thioureido)-phenyl]-acid amides |
425 | ?555 | N-[4-(3-{3-chloro-4-[2-(2-methyl-piperidines-1-yl)-ethanoyl-amino]-phenyl }-thioureido)-phenyl]-2-fluoro-benzamide |
426 | ?339 | Furans-2-carboxylic acid [4-(3-pyridine-2-base-thioureido)-phenyl]-acid amides |
427 | ?339 | Furans-2-carboxylic acid [4-(3-pyridin-4-yl-thioureido)-phenyl]-acid amides |
428 | ?367 | 2-fluoro-N-[4-(3-pyridin-3-yl-thioureido)-phenyl]-benzamide |
429 | ?339 | Furans-2-carboxylic acid [4-(3-pyridin-3-yl-thioureido)-phenyl]-acid amides |
430 | ?353 | Furans-2-carboxylic acid 4-[3-(3-amino-phenyl)-thioureido]-phenyl }-acid amides |
431 | ?406 | Furans-2-carboxylic acid 4-[3-(3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
432 | ?380 | 2-fluoro-N-[4-(tolyl-thioureido between 3-)-phenyl]-benzamide |
433 | ?434 | 2-fluoro-N-{4-[3-(3-trifluoromethyl-phenyl)-thioureido]-phenyl }-benzamide |
434 | ?381 | N-{4-[3-(3-amino-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
435 | ?388 | Furans-2-carboxylic acid 4-[3-(3-amino-5-chloro-phenyl)-thioureido]-phenyl }-acid amides |
436 | ?352 | Furans-2-carboxylic acid [4-(tolyl-thioureido between 3-)-phenyl]-acid amides |
437 | ?416 | N-{4-[3-(2-amino-5-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
438 | ?571 | [2-chloro-4-{3-[4-(2-fluoro-benzoyl-amido)-phenyl]-thioureido }-phenyl)-carboxylamine 2-piperidines-1-base-ethyl ester |
439 | ?543 | [2-chloro-4-(3-{4-[(furans-2-carbonyl)-amino]-phenyl }-thioureido)-phenyl]-carboxylamine 2-piperidines-1-base-ethyl ester |
440 | ?388 | Furans-2-carboxylic acid 4-[3-(2-amino-5-chloro-phenyl)-thioureido]-phenyl }-acid amides |
441 | ?363 | Furans-2-carboxylic acid 4-[3-(3-cyano group-phenyl)-thioureido]-phenyl }-acid amides |
442 | ?416 | N-{4-[3-(3-amino-5-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
443 | ?367 | 2-fluoro-N-[4-(3-pyridine-2-base-thioureido)-phenyl]-benzamide |
444 | ?367 | 2-fluoro-N-[4-(3-pyridin-4-yl-thioureido)-phenyl]-benzamide |
445 | ?374 | Furans-2-carboxylic acid 4-[3-(6-chloro-pyridin-3-yl)-thioureido]-phenyl }-acid amides |
446 | ?388 | Furans-2-carboxylic acid 4-[3-(2-amino-3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
447 | ?396 | Furans-2-carboxylic acid 4-[3-(3-diazanyl carbonyl-phenyl)-thioureido]-phenyl }-acid amides |
448 | ?410 | 2-fluoro-N-(4-{3-[3-(1-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-benzamide |
449 | ?414 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-diazanyl carbonyl-phenyl)-thioureido]-phenyl }-acid amides |
450 | ?399 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-sec.-propyl-phenyl)-thioureido]-phenyl }-acid amides |
451 | ?380 | Furans-2-carboxylic acid 4-[3-(3-sec.-propyl-phenyl)-thioureido]-phenyl }-acid amides |
452 | ?409 | 2-fluoro-N-{4-[3-(3-sec.-propyl-phenyl)-thioureido]-phenyl }-benzamide |
453 | ?381 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-cyano group-phenyl)-thioureido]-phenyl }-acid amides |
454 | ?410 | N-{4-[3-(3-dimethylamino-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
455 | ?381 | Furans-2-carboxylic acid 4-[3-(3-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
456 | ?370 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(tolyl-thioureido between 3-)-phenyl]-acid amides |
457 | ?424 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
458 | ?479 | N-{3-chloro-4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
459 | ?449 | N-{3-chloro-4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
460 | ?481 | N-{3-chloro-4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
461 | ?391 | N-{4-[3-(3-cyano group-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
462 | ?395 | Furans-2-carboxylic acid 4-[3-(3-acetylamino-phenyl)-thioureido]-phenyl }-acid amides |
463 | ?424 | 2-fluoro-N-{4-[3-(3-diazanyl carbonyl-phenyl)-thioureido]-phenyl }-benzamide |
464 | ?400 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(1-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-acid amides |
465 | ?434 | N-{4-[3-(2-amino-3-chloro-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
466 | ?406 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-amino-5-chloro-phenyl)-thioureido]-phenyl }-acid amides |
467 | ?398 | Furans-2-carboxylic acid 4-[3-(3,5-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
468 | ?416 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
469 | ?454 | 5-(3-{4-[(furans-2-carbonyl)-amino]-phenyl }-thioureido)-dimethyl isophthalate |
470 | ?434 | Isoxazole-5-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
471 | ?392 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(6-chloro-pyridin-3-yl)-thioureido]-phenyl }-acid amides |
472 | ?382 | Furans-2-carboxylic acid (4-{3-[3-(1-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-acid amides |
473 | ?368 | Furans-2-carboxylic acid 4-[3-(3-methoxyl group-phenyl)-thioureido]-phenyl }-acid amides |
474 | ?354 | Furans-2-carboxylic acid 4-[3-(3-hydroxyl-phenyl)-thioureido]-phenyl }-acid amides |
475 | ?382 | 2-fluoro-N-{4-[3-(3-hydroxyl-phenyl)-thioureido]-phenyl }-benzamide |
476 | ?396 | 2-fluoro-N-{4-[3-(3-hydroxymethyl-phenyl)-thioureido]-phenyl }-benzamide |
477 | ?423 | N-{4-[3-(3-acetylamino-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
478 | ?413 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-acetylamino-phenyl)-thioureido]-phenyl }-acid amides |
479 | ?400 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
480 | ?340 | Furans-2-carboxylic acid [4-(3-pyrimidine-4-base-thioureido)-phenyl]-acid amides |
481 | ?378 | Furans-2-carboxylic acid 4-[3-(1H-indazole-5-yl)-thioureido]-phenyl }-acid amides |
482 | ?395 | Furans-2-carboxylic acid [4-(3-benzothiazole-5-base-thioureido)-phenyl]-acid amides |
483 | ?406 | 2-fluoro-N-{4-[3-(1H-indazole-5-yl)-thioureido]-phenyl }-benzamide |
484 | ?424 | N-[4-(3-benzothiazole-5-base-thioureido)-phenyl]-2-fluoro-benzamide |
485 | ?473 | 5-(3-{4-[([1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-thioureido)-dimethyl isophthalate |
486 | ?442 | Furans-2-carboxylic acid (4-{3-[4-(1-azido-ethyl)-3-chloro-phenyl]-thioureido }-phenyl)-acid amides |
487 | ?396 | 2-fluoro-N-{4-[3-(3-methoxyl group-phenyl)-thioureido]-phenyl }-benzamide |
488 | ?368 | Furans-2-carboxylic acid 4-[3-(3-hydroxymethyl-phenyl)-thioureido]-phenyl }-acid amides |
489 | ?416 | Furans-2-carboxylic acid 4-[3-(5-chloro-2-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
490 | ?444 | N-{4-[3-(5-chloro-2-dimethylamino-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
491 | ?506 | [3-chloro-5-(3-{4-[([1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-thioureido)-phenyl]-t-butyl carbamate |
492 | ?506 | N-(4-{3-[4-(1-azido-ethyl)-3-chloro-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
493 | ?337 | Furans-2-carboxylic acid [4-(the 1H-thiazole is [5,4-b] pyridine-2-alkenyl amino also)-phenyl]-acid amides |
494 | ?378 | Furans-2-carboxylic acid 4-[3-(1H-benzoglyoxaline-5-yl)-thioureido]-phenyl }-acid amides |
495 | ?392 | Furans-2-carboxylic acid 4-[3-(2-methyl isophthalic acid H-benzoglyoxaline-5-yl)-thioureido]-phenyl }-acid amides |
496 | ?406 | N-{4-[3-(1H-benzoglyoxaline-5-yl)-thioureido]-phenyl }-2-fluoro-benzamide |
497 | ?420 | 2-fluoro-N-{4-[3-(2-methyl isophthalic acid H-benzoglyoxaline-5-yl)-thioureido]-phenyl }-benzamide |
498 | ?452 | [1,2,3] thiadiazoles-4-carboxylic acid 5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridine-2-yl }-acid amides |
499 | ?445 | Pyridine-2-carboxylic acids 5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridine-2-yl }-acid amides |
500 | ?434 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
501 | ?484 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[4-(2-amino-pyrimidine-4-yl)-3-chloro-phenyl]-thioureido }-phenyl)-acid amides |
502 | ?494 | N-(4-{3-[4-(2-amino-pyrimidine-4-yl)-3-chloro-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
503 | ?434 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-2-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
504 | ?462 | N-{4-[3-(3-chloro-2-dimethylamino-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
505 | ?416 | Furans-2-carboxylic acid 4-[3-(3-chloro-2-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
506 | ?445 | Pyridine-2-carboxylic acids 6-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridin-3-yl }-acid amides |
507 | ?462 | N-{6-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridin-3-yl }-2-fluoro-benzamide |
508 | ?482 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-iodo-phenyl)-thioureido]-phenyl }-acid amides |
509 | ?413 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(the 3-tertiary butyl-phenyl)-thioureido]-phenyl }-acid amides |
510 | ?387 | Furans-2-carboxylic acid 4-[3-(3-chloro-benzyl)-thioureido]-phenyl }-acid amides |
511 | ?415 | N-{4-[3-(3-chloro-benzyl)-thioureido]-phenyl }-2-fluoro-benzamide |
512 | ?434 | Furans-2-carboxylic acid 6-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridin-3-yl }-acid amides |
513 | ?435 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-bromo-phenyl)-thioureido]-phenyl }-acid amides |
514 | ?452 | [1,2,3] thiadiazoles-4-carboxylic acid 6-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridin-3-yl }-acid amides |
515 | ?426 | [1,2,3] thiadiazoles-4-carboxylic acid 5-[3-(3,5-two chloro-phenyl)-thioureido]-pyridine-2-yl }-acid amides |
516 | ?474 | Furans-2-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
517 | ?502 | N-{4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
518 | ?450 | N-{4-[3-(4-amino-3,5-two chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
519 | ?539 | N-{4-[3-(4-amino-3,5-two bromo-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
520 | ?392 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-pyridin-3-yl)-thioureido]-phenyl }-acid amides |
521 | ?529 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-amino-3,5-two bromo-phenyl)-thioureido]-phenyl }-acid amides |
522 | ?434 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-5-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
523 | ?444 | N-{4-[3-(3-chloro-5-dimethylamino-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
524 | ?416 | Furans-2-carboxylic acid 4-[3-(3-chloro-5-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
525 | ?436 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-bromo-pyridin-3-yl)-thioureido]-phenyl }-acid amides |
526 | ?379 | Furans-2-carboxylic acid 4-[3-(1H-benzotriazole-5-yl)-thioureido]-phenyl }-acid amides |
527 | ?425 | N-{4-[3-(1H-benzotriazole-5-yl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
528 | ?388 | N-[4-({ [2-(3-chloro-phenyl)-diazanyl]-sulphomethyl }-amino)-phenyl]-furans-2-carboxylic acid amides |
529 | ?416 | N-[4-({ [2-(3-chloro-phenyl)-diazanyl]-sulphomethyl }-amino)-phenyl]-2-fluoro-benzamide |
530 | ?456 | Furans-2-carboxylic acid 4-[3-(2-amino-3-chloro-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
531 | ?513 | N-{4-[3-(3-bromo-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
532 | ?503 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-bromo-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
533 | ?374 | 4-[(furans-2-carbonyl)-amino]-phenyl }-thiocarbamate O-(3-chloro-phenyl) ester |
534 | ?474 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-amino-3-chloro-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
535 | ?508 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-piperidines-1-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
536 | ?380 | N-[4-(3-benzyl-thioureido)-phenyl]-2-fluoro-benzamide |
537 | ?439 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-acid amides |
538 | ?449 | N-{4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-2-fluoro-benzamide |
539 | ?370 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3 benzyls-thioureido)-phenyl]-acid amides |
540 | ?424 | N-[4-(3-benzo [1,3] dioxole-5-ylmethyl-thioureido)-phenyl]-2-fluoro-benzamide |
541 | ?414 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-benzo [1,3] dioxole-5-ylmethyl-thioureido)-phenyl]-acid amides |
542 | ?506 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
543 | ?516 | N-{4-[3-(3,5-di-trifluoromethyl-benzyl)-thioureido]-phenyl }-2-fluoro-benzamide |
544 | ?352 | Furans-2-carboxylic acid [4-(3-benzyl-thioureido)-phenyl]-acid amides |
545 | ?421 | Furans-2-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-acid amides |
546 | ?396 | Furans-2-carboxylic acid [4-(3-benzo [1,3] dioxole-5-ylmethyl-thioureido)-phenyl]-acid amides |
547 | ?488 | Furans-2-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
548 | ?503 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-bromo-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
549 | ?529 | N-{4-[3-(3-bromo-4-trifluoromethoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
550 | ?519 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-bromo-4-trifluoromethoxy-phenyl)-thioureido]-phenyl }-acid amides |
551 | ?473 | Furans-2-carboxylic acid 4-[3-(3-chloro-4-trifluoromethylthio-phenyl)-thioureido]-phenyl }-acid amides |
552 | ?412 | 2-fluoro-N-(4-{3-[2-(3-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
553 | ?412 | 2-fluoro-N-(4-{3-[2-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
554 | ?402 | [1,2,3]-thiadiazoles-4-carboxylic acid (4-{3-[2-(3-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
555 | ?402 | [1,2,3]-thiadiazoles-4-carboxylic acid (4-{3-[2-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
556 | ?495 | [1,2,3]-thiadiazoles-4-carboxylic acid (4-{3-[2-(2-methyl-butyl)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides |
557 | ?481 | [1,2,3]-thiadiazoles-4-carboxylic acid 4-[3-(3-isobutyl--5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
558 | ?523 | [1,2,3]-thiadiazoles-4-carboxylic acid (4-{3-[3-(4-methyl-piperazine-1 base)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides |
559 | ?510 | [1,2,3]-thiadiazoles-4-carboxylic acid 4-[3-(3-morpholine-4-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
560 | ?494 | [1,2,3]-thiadiazoles-4-carboxylic acid 4-[3-(3-tetramethyleneimine-1-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
561 | ?384 | Furans-2-carboxylic acid (4-{3-[2-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
562 | ?419 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
563 | ?429 | N-(4-{3-[2-(3-chloro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
564 | ?401 | Furans-2-carboxylic acid (4-{3-[2-(3-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
565 | ?402 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
566 | ?504 | 2-fluoro-N-{4-[3-(3-tetramethyleneimine-1-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-benzamide |
567 | ?477 | N-{4-[3-(3-dimethylamino-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
568 | ?520 | 2-fluoro-N-{4-[3-(3-morpholine-4-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-benzamide |
569 | ?533 | 2-fluoro-N-(4-{3-[3-(4-methyl-piperazine-1-yl)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-benzamide |
570 | ?518 | 2-fluoro-N-{4-[3-(3-piperidines-1-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-benzamide |
571 | ?468 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-dimethylamino-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
572 | ?405 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-benzyl)-thioureido]-phenyl }-acid amides |
573 | ?384 | Furans-2-carboxylic acid (4-{3-[2-(3-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
574 | ?366 | Furans-2-carboxylic acid [4-(3-styroyl-thioureido)-phenyl]-acid amides |
575 | ?384 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-styroyl-thioureido)-phenyl]-acid amides |
576 | ?394 | 2-fluoro-N-[4-(3-styroyl-thioureido)-phenyl]-benzamide |
577 | ?505 | 2-fluoro-N-(4-{3-[3-(2-methyl-butyl)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-benzamide |
578 | ?491 | 2-fluoro-N-{4-[3-(3-isobutyl--5-trifluoromethyl-phenyl)-thioureido]-phenyl }-benzamide |
579 | ?388 | Furans-2-carboxylic acid 4-[3-(3,5-two fluoro-benzyls)-thioureido]-phenyl }-acid amides |
580 | ?416 | N-{4-[3-(3,5-two fluoro-benzyls)-thioureido]-phenyl }-2-fluoro-benzamide |
581 | ?406 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two fluoro-benzyls)-thioureido]-phenyl }-acid amides |
582 | ?421 | Furans-2-carboxylic acid 4-[3-(3,5-two chloro-benzyls)-thioureido]-phenyl }-acid amides |
583 | ?449 | N-{4-[3-(3,5-two chloro-benzyls)-thioureido]-phenyl }-2-fluoro-benzamide |
584 | ?439 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-benzyls)-thioureido]-phenyl }-acid amides |
585 | ?438 | Furans-2-carboxylic acid 4-[3-(3-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
586 | ?466 | 2-fluoro-N-{4-[3-(3-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-benzamide |
587 | ?456 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
588 | ?384 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(1-phenylethyl)-thioureido]-phenyl }-acid amides |
589 | ?394 | 2-fluoro-N-{4-[3-(1-phenyl-ethyl)-thioureido]-phenyl }-benzamide |
590 | ?366 | Furans-2-carboxylic acid 4-[3-(1-phenyl-ethyl)-thioureido]-phenyl }-benzamide |
591 | ?412 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
592 | ?384 | Furans-2-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
593 | ?413 | N-{4-[3-(the 1-tertiary butyl-1H-imidazoles-2-yl)-thioureido]-phenyl }-2-fluoro-benzamide |
594 | ?510 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(isobutyl--methyl-amino)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides |
595 | ?510 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(3-hydroxyl-tetramethyleneimine-1-yl)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides |
596 | ?520 | 2-fluoro-N-(4-{3-[3-(isobutyl--methyl-amino)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-benzamide |
597 | ?510 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(butyl-methyl-amino)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides |
598 | ?520 | N-(4-{3-[3-(butyl-methyl-amino)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
599 | ?520 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,5-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
600 | ?442 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-fluoro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
601 | ?522 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-piperidines-1-base-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
602 | ?482 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-dimethylamino-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
603 | ?381 | Furans-2-carboxylic acid (4-{3-[2-(4-amino-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
604 | ?445 | Furans-2-carboxylic acid (4-{3-[2-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
605 | ?380 | Furans-2-carboxylic acid 4-[3-(2-p-methylphenyl-ethyl)-thioureido]-phenyl }-acid amides |
606 | ?463 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
607 | ?396 | Furans-2-carboxylic acid (4-{3-[2-(3-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
608 | ?403 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(the 1-tertiary butyl-1H-imidazoles-2-yl)-thioureido]-phenyl }-acid amides |
609 | ?384 | Furans-2-carboxylic acid 4-[3-(the 1-tertiary butyl-1H-imidazoles-2-yl)-thioureido]-phenyl }-acid amides |
610 | ?492 | N-{4-[3-(4-dimethylamino-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-2-fluoro-benzamide |
611 | ?427 | Furans-2-carboxylic acid (4-{3-[2-(3,4-dimethoxy-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
612 | ?380 | Furans-2-carboxylic acid 4-[3-(3-phenyl-propyl group)-thioureido]-phenyl }-acid amides |
613 | ?399 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-phenyl-propyl group)-thioureido]-phenyl }-acid amides |
614 | ?502 | Furans-2-carboxylic acid (4-{3-[2-(3,5-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
615 | ?550 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-iodo-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
616 | ?532 | 2-fluoro-N-{4-[3-(4-piperidines-1-base-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-benzamide |
617 | ?537 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[4-(4-methyl-piperazine-1-yl)-3-trifluoromethyl-benzyl]-the thioureido methyl }-phenyl)-acid amides |
618 | ?482 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-dimethylamino-5-trifluoromethyl-benzyl)-thioureido methyl]-phenyl }-acid amides |
619 | ?488 | Furans-2-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido methyl]-phenyl }-acid amides |
620 | ?421 | Furans-2-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido methyl]-phenyl }-acid amides |
621 | ?421 | Furans-2-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido methyl]-phenyl }-acid amides |
622 | ?455 | Furans-2-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido methyl]-phenyl }-acid amides |
623 | ?466 | 2-fluoro-N-{4-[3-(4-fluoro-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-benzamide |
624 | ?456 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-fluoro-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
625 | ?410 | 2-fluoro-N-{4-[3-(2-phenoxy group-ethyl)-thioureido]-phenyl }-benzamide |
626 | ?382 | Furans-2-carboxylic acid 4-[3-(2-phenoxy group-ethyl)-thioureido]-phenyl }-acid amides |
627 | ?400 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-phenoxy group-ethyl)-thioureido]-phenyl }-acid amides |
628 | ?409 | 2-fluoro-N-{4-[3-(3-phenyl-propyl group)-thioureido]-phenyl }-benzamide |
629 | ?425 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-trifluoromethyl-pyridin-3-yl)-thioureido]-phenyl }-acid amides |
630 | ?439 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido methyl]-phenyl }-acid amides |
631 | ?473 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido methyl]-phenyl }-acid amides |
632 | ?381 | 2-fluoro-N-[4-(3-pyridin-3-yl methyl-thioureido)-phenyl]-benzamide |
633 | ?353 | Furans-2-carboxylic acid [4-(3-pyridin-3-yl methyl-thioureido)-phenyl]-acid amides |
634 | ?371 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-pyridin-3-yl methyl-thioureido)-phenyl]-acid amides |
635 | ?439 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido methyl]-phenyl }-acid amides |
636 | ?492 | N-{4-[3-(3-dimethylamino-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-2-fluoro-benzamide |
637 | ?415 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-methoxyl group-phenyl)-ethyl] thioureido }-phenyl)-acid amides |
638 | ?399 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-p-methylphenyl-ethyl)-thioureido]-phenyl }-acid amides |
639 | ?445 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-dimethoxy-phenyl)-ethyl] thioureido }-phenyl)-acid amides |
640 | ?506 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido methyl]-phenyl }-acid amides |
641 | ?516 | N-{4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido methyl]-phenyl }-2-fluoro-benzamide |
642 | ?449 | N-{4-[3-(3,5-two chloro-phenyl)-thioureido methyl]-phenyl }-2-fluoro-benzamide |
643 | ?449 | N-{4-[3-(3,4-two chloro-phenyl)-thioureido methyl]-phenyl }-2-fluoro-benzamide |
644 | ?448 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-acetylamino-5-chloro-phenyl)-thioureido]-phenyl }-acid amides |
645 | ?453 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two chloro-phenyl)-ethyl] thioureido }-phenyl)-acid amides |
646 | ?413 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(1-methyl-3-phenyl-propyl group)-thioureido]-phenyl }-acid amides |
647 | ?463 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl] thioureido }-phenyl)-acid amides |
648 | ?413 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-phenyl-butyl)-thioureido]-phenyl }-acid amides |
649 | ?397 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-indane-1-base-thioureido)-phenyl]-acid amides |
650 | ?400 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-methoxyl group-benzyl)-thioureido]-phenyl }-acid amides |
651 | ?415 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-methoxyl group-phenyl)-ethyl] thioureido }-phenyl)-acid amides |
652 | ?415 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-methoxyl group-phenyl)-ethyl] thioureido }-phenyl)-acid amides |
653 | ?506 | N-(4-{3-[2-(3-dimethylamino-5-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
654 | ?510 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(3-dimethylamino-propyl group)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides |
655 | ?417 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-thiophenyl-ethyl)-thioureido]-phenyl }-acid amides |
656 | ?427 | 2-fluoro-N-{4-[3-(2-thiophenyl-ethyl)-thioureido]-phenyl }-benzamide |
657 | ?399 | Furans-2-carboxylic acid 4-[3-(2-thiophenyl-ethyl)-thioureido]-phenyl }-benzamide |
658 | ?381 | 2-fluoro-N-[4-(3-pyridin-4-yl methyl-thioureido)-phenyl]-benzamide |
659 | ?353 | Furans-2-carboxylic acid [4-(3-pyridin-4-yl methyl-thioureido)-phenyl]-acid amides |
660 | ?371 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-pyridin-4-yl methyl-thioureido)-phenyl]-acid amides |
661 | ?506 | 2-fluoro-N-{4-[3-(3-iodo-benzyl)-thioureido]-phenyl }-benzamide |
662 | ?478 | Furans-2-carboxylic acid 4-[3-(3-iodo-benzyl)-thioureido]-phenyl }-acid amides |
663 | ?496 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-iodo-benzyl)-thioureido]-phenyl }-acid amides |
664 | ?479 | N-(4-{3-[2-(3,5-two chloro-phenoxy groups)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
665 | ?451 | Furans-2-carboxylic acid (4-{3-[2-(3,5-two chloro-phenoxy groups)-ethyl]-thioureido }-phenyl)-acid amides |
666 | ?445 | N-(4-{3-[2-(3-chloro-phenoxy group)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
667 | ?417 | Furans-2-carboxylic acid (4-{3-[2-(3-chloro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
668 | ?435 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-chloro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
669 | ?466 | 2-fluoro-N-{4-[3-(2-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-benzamide |
670 | ?438 | Furans-2-carboxylic acid 4-[3-(2-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
671 | ?456 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
672 | ?416 | N-{4-[3-(3,4-two fluoro-benzyls)-thioureido]-phenyl }-2-fluoro-benzamide |
673 | ?452 | N-(4-{3-[2-(4-dimethylamino-3-methyl-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
674 | ?496 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-dimethylamino-5-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
675 | ?388 | Furans-2-carboxylic acid 4-[3-(3,4-two fluoro-benzyls)-thioureido]-phenyl }-acid amides |
676 | ?406 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two fluoro-benzyls)-thioureido]-phenyl }-acid amides |
677 | ?433 | N-{4-[3-(3-chloro-4-fluoro-benzyl)-thioureido]-phenyl }-2-fluoro-benzamide |
678 | ?495 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-thiophenyl)-ethyl]-thioureido }-phenyl)-acid amides |
679 | ?477 | Furans-2-carboxylic acid (4-{3-[2-(3-bromo-thiophenyl)-ethyl]-thioureido }-phenyl)-acid amides |
680 | ?505 | N-(4-{3-[2-(3-bromo-thiophenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
681 | ?493 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-4-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
682 | ?493 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(5-bromo-4-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
683 | ?419 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
684 | ?402 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
685 | ?419 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
686 | ?475 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,3-phenylbenzene-propyl group)-thioureido]-phenyl }-acid amides |
687 | ?547 | 2-fluoro-N-(4-{3-[4-(4-methyl-piperazine-1-yl)-3-trifluoromethyl-benzyl]-thioureido }-phenyl)-benzamide |
688 | ?469 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,5-two chloro-phenoxy groups)-ethyl]-thioureido }-phenyl)-acid amides |
689 | ?423 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-fluoro-benzyl)-thioureido]-phenyl }-acid amides |
690 | ?427 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(the 4-tertiary butyl-benzyl)-thioureido]-phenyl }-acid amides |
691 | ?399 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-dimethyl-benzyl)-thioureido]-phenyl }-acid amides |
692 | ?442 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-dimethylamino-3-methyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
693 | ?479 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-bromo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
694 | ?526 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-iodo-phenoxy group)-ethyl]-thioureido)-phenyl)-acid amides |
695 | ?489 | N-(4-{3-[2-(4-bromo-phenoxy group)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
696 | ?536 | 2-fluoro-N-(4-{3-[2-(4-iodo-phenoxy group)-ethyl]-thioureido }-phenyl)-benzamide |
697 | ?461 | Furans-2-carboxylic acid (4-{3-[2-(4-bromo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
698 | ?508 | Furans-2-carboxylic acid (4-{3-[2-(4-iodo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
699 | ?408 | Oxazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
700 | ?424 | The thiazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
701 | ?491 | The thiazole-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
702 | ?408 | Oxazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
703 | ?469 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two chloro-phenoxy groups)-ethyl]-thioureido }-phenyl)-acid amides |
704 | ?424 | The thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
705 | ?458 | The thiazole-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
706 | ?400 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-phenyl amino-ethyl)-thioureido]-phenyl }-acid amides |
707 | ?453 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2,4-two chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
708 | ?452 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
709 | ?453 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2,6-two chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
710 | ?485 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two chloro-thiophenyls)-ethyl]-thioureido }-phenyl)-acid amides |
711 | ?503 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-5-trifluoromethyl-thiophenyl)-ethyl]-thioureido }-phenyl)-acid amides |
712 | ?668 | N-(4-{3-[3-chloro-5-(3-{4-[([1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-thioureido)-phenyl]-thioureido }-phenyl)-[1,2,3] thiadiazoles-4-carboxylic acid amides |
713 | ?413 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-ethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
714 | ?442 | Oxazole-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
715 | ?475 | Oxazole-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
716 | ?420 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
717 | ?452 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
718 | ?435 | Furans-2-carboxylic acid (4-{3-[2-(3,4-two chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
719 | ?463 | N-(4-{3-[2-(3,4-two chloro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
720 | ?420 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,5-two fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
721 | ?412 | 2-fluoro-N-(4-{3-[2-(2-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
722 | ?429 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-nitro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
723 | ?399 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(1-methyl-2-phenyl-ethyl)-thioureido]-phenyl }-acid amides |
724 | ?437 | N-{4-[3-(the 4-tertiary butyl-benzyl)-thioureido]-phenyl }-2-fluoro-benzamide |
725 | ?409 | N-{4-[3-(3,5-dimethyl-benzyl)-thioureido]-phenyl }-2-fluoro-benzamide |
726 | ?400 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-hydroxyl-1-phenyl-ethyl)-thioureido]-phenyl }-acid amides |
727 | ?409 | 2-fluoro-N-{4-[3-(1-methyl isophthalic acid-phenyl-ethyl)-thioureido]-phenyl }-benzamide |
728 | ?399 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(1-methyl isophthalic acid-phenyl-ethyl)-thioureido]-phenyl }-acid amides |
729 | ?405 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-chloro-benzyl)-thioureido]-phenyl }-acid amides |
730 | ?388 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-fluoro-benzyl)-thioureido]-phenyl }-acid amides |
731 | ?438 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
732 | ?388 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-fluoro-benzyl)-thioureido]-phenyl }-acid amides |
733 | ?435 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-chloro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
734 | ?479 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
735 | ?418 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
736 | ?418 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-chloro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
737 | ?486 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-5-trifluoromethyl-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
738 | ?384 | Furans-2-carboxylic acid (4-{3-[2-(2-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
739 | ?435 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-bromo-phenyl)-thioureido]-phenyl }-acid amides |
740 | ?374 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-fluoro-phenyl)-thioureido]-phenyl }-acid amides |
741 | ?388 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-fluoro-benzyl)-thioureido]-phenyl }-acid amides |
742 | ?405 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-benzyl)-thioureido]-phenyl }-acid amides |
743 | ?449 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-bromo-benzyl)-thioureido]-phenyl }-acid amides |
744 | ?332 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-ethanamide |
745 | ?438 | The thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-acid amides |
746 | ?455 | The thiazole-4-carboxylic acid 4-[3-(2-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
747 | ?426 | The thiazole-4-carboxylic acid 4-[3-(the 4-tertiary butyl-benzyl)-thioureido]-phenyl }-acid amides |
748 | ?374 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-fluoro-phenyl)-thioureido]-phenyl }-acid amides |
749 | ?374 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-fluoro-phenyl)-thioureido]-phenyl }-acid amides |
750 | ?526 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-iodo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
751 | ?409 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-phenyl-ethanamide |
752 | ?425 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-methoxyl group-benzamide |
753 | ?425 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-3-methoxyl group-benzamide |
754 | ?425 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-4-methoxyl group-benzamide |
755 | ?429 | 2-chloro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
756 | ?429 | 4-chloro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
757 | ?453 | Acetate 4-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-the phenyl amino formyl radical)-phenyl ester |
758 | ?394 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
759 | ?395 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-Isonicotinamide |
760 | ?410 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-4-hydroxyl-benzamide |
761 | ?429 | 3-chloro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
762 | ?470 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-fluoro-5-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
763 | ?520 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2,4-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
764 | ?470 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-fluoro-3-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
765 | ?438 | 4-dimethylamino-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
766 | ?470 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-3-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
767 | ?470 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-5-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
768 | ?510 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-iodo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
769 | ?470 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-fluoro-2-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
770 | ?463 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
771 | ?427 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-propyl group]-thioureido }-phenyl)-benzamide |
772 | ?475 | 2-fluoro-N-(4-{3-[(4-fluoro-phenyl)-phenyl-methyl]-thioureido }-phenyl)-benzamide |
773 | ?455 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-amyl group]-thioureido }-phenyl)-benzamide |
774 | ?489 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-2-phenyl-ethyl]-thioureido }-phenyl)-benzamide |
775 | ?409 | 2-fluoro-N-{4-[3-(1-o-tolyl-ethyl)-thioureido]-phenyl }-benzamide |
776 | ?409 | 2-fluoro-N-{4-[3-(tolyl-ethyl between 1-)-thioureido]-phenyl }-benzamide |
777 | ?425 | 2-fluoro-N-(4-{3-[1-(4-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
778 | ?412 | 2-fluoro-N-(4-{3-[1-(2-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
779 | ?429 | N-(4-{3-[1-(3-chloro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
780 | ?473 | N-(4-{3-[1-(3-bromo-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
781 | ?429 | N-(4-{3-[1-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
782 | ?409 | 2-fluoro-N-{4-[3-(1-p-methylphenyl-ethyl)-thioureido]-phenyl }-benzamide |
783 | ?473 | N-(4-{3-[1-(2-bromo-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
784 | ?429 | N-(4-{3-[1-(2-chloro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
785 | ?462 | 2-fluoro-N-(4-{3-[1-(2-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
786 | ?462 | 2-fluoro-N-(4-{3-[1-(3-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
787 | ?462 | 2-fluoro-N-(4-{3-[1-(4-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
788 | ?425 | 2-fluoro-N-(4-{3-[1-(2-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
789 | ?425 | 2-fluoro-N-(4-{3-[1-(3-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
790 | ?441 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-2-methyl-propyl group]-thioureido }-phenyl)-benzamide |
791 | ?419 | N-(4-{3-[1-(3-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
792 | ?419 | N-(4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
793 | ?438 | N-(4-{3-[1-(4-dimethylamino-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
794 | ?438 | N-(4-{3-[1-(3-methylamino-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
795 | ?473 | 2-bromo-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
796 | ?446 | The quinaldic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
797 | ?410 | 2-fluoro-N-{4-[3-(2-hydroxyl-1-phenyl-ethyl)-thioureido]-phenyl }-benzamide |
798 | ?332 | 2-fluoro-N-[4-(3-sec.-propyl-thioureido)-phenyl]-benzamide |
799 | ?445 | 2-fluoro-N-{4-[3-(1-naphthalene-2-base-ethyl)-thioureido]-phenyl }-benzamide |
800 | ?412 | 3-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
801 | ?412 | 4-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
802 | ?384 | 2-fluoro-N-{4-[3-(1-furans-2-base-ethyl)-thioureido]-phenyl }-benzamide |
803 | ?395 | 2-fluoro-N-{4-[3-(1-pyridin-4-yl-ethyl)-thioureido]-phenyl }-benzamide |
804 | ?397 | 2-fluoro-N-(4-{3-[1-(1-methyl isophthalic acid H-pyrroles-2-yl)-ethyl]-thioureido }-phenyl)-benzamide |
805 | ?401 | 2-fluoro-N-{4-[3-(1-thiene-3-yl--ethyl)-thioureido]-phenyl }-benzamide |
806 | ?445 | N-{4-[3-(3-chloro-4-oxyethyl group-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
807 | ?459 | N-{4-[3-(3-chloro-4-propoxy--phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
808 | ?459 | N-{4-[3-(3-chloro-4-isopropoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
809 | ?473 | N-{4-[3-(4-butoxy-3-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
810 | ?522 | 2-fluoro-N-{4-[3-(3-iodo-4-methoxyl group-phenyl)-thioureido]-phenyl }-benzamide |
811 | ?475 | N-{4-[3-(3-bromo-4-methoxyl group-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
812 | ?520 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-iodo-benzamide |
813 | ?346 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-propionic acid amide |
814 | ?286 | N-[4-(3-phenyl-thioureido)-phenyl]-ethanamide |
815 | ?463 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[(1S)-1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
816 | ?463 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[(1R)-1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
818 | ?520 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[1-(3,5-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
820 | ?418 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[(1S)-1-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
821 | ?418 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[(1R)-1-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
822 | ?409 | N-[4-[[[[1-(4-cyano-phenyl) ethyl] amino] sulphomethyl] amino] phenyl]-1,2,3-thiadiazoles-4-carboxylic acid amides |
824 | ?462 | The thiazole-4-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
825 | ?520 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-(1S)-[1-(3,5-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
828 | ?470 | N-(4-{[({1-[4-fluoro-3-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino } phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides |
829 | ?486 | N-(4-{[({1-[4-chloro-3-thiadiazoles-4-carboxylic acid amides |
830 | ?519 | N-(4-{[({ (1S)-1-[3,5-thiazole-4-carboxylic acid amides |
831 | ?469 | N-(4-{[({1-[3-fluoro-5-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino } phenyl)-1,3-thiazoles-4-carboxylic acid amides |
832 | ?469 | N-(4-{[({1-[2-fluoro-4-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino } phenyl)-1,3-thiazoles-4-carboxylic acid amides |
833 | ?469 | N-(4-{[({1-[2-fluoro-5-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino } phenyl)-1,3-thiazoles-4-carboxylic acid amides |
834 | ?519 | N-(4-{[({1-[2,4-two (trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino } phenyl)-1,3-thiazoles-4-carboxylic acid amides |
834 | ?411 | N-{4-[({[1-(2, the 4-3,5-dimethylphenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
836 | ?452 | N-{4-[({[1-(2,4 dichloro benzene base) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
837 | ?397 | N-{4-[({[1-(3-aminomethyl phenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
838 | ?469 | N-(4-{[({1-[4-fluoro-3-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino } phenyl)-1,3-thiazoles-4-carboxylic acid amides |
839 | ?435 | N-{4-[({[1-(2-chloro-4-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
840 | ?419 | N-{4-[({[1-(3, the 4-difluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
841 | ?480 | N-{4-[({[1-(4-bromo-2-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
842 | ?401 | N-{4-[({[1-(3-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
843 | ?462 | N-{4-[({[1-(2-bromophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
844 | ?462 | N-{4-[({[1-(3-bromophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
845 | ?451 | N-(4-{[({1-[2-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino } phenyl)-1,3-thiazoles-4-carboxylic acid amides |
846 | ?419 | N-{4-[({[1-(2,4 difluorobenzene base) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
847 | ?519 | N-(4-{[({ (1R)-1-[3,5-two (trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino } phenyl)-1,3-thiazoles-4-carboxylic acid amides |
848 | ?452 | N-{4-[({[1-(3, the 4-dichlorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
849 | ?469 | N-(4-{[({1-[3-fluoro-4-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino } phenyl)-1,3-thiazoles-4-carboxylic acid amides |
850 | ?485 | N-(4-{[({1-[4-chloro-3-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino } phenyl)-1,3-thiazoles-4-carboxylic acid amides |
851 | ?435 | N-{4-[({[1-(4-chloro-2-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
852 | ?469 | N-(4-{[({1-[4-fluoro-2-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino } phenyl)-1,3-thiazoles-4-carboxylic acid amides |
853 | ?435 | N-{4-[({[1-(4-chloro-3-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
854 | ?480 | N-{4-[({[1-(2-bromo-4-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
855 | ?541 | N-{4-[({[1-(3, the 4-dibromo phenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
856 | ?435 | N-{4-[({[1-(3-chloro-4-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides |
857 | ?366 | N-(4-{[({1-[3,5-two (trifluoromethyl) phenyl] propyl group } amino) thiocarbonyl] amino } phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides |
858 | ?392 | N-(4-{[({1-[3,5-two (trifluoromethyl) phenyl] butyl } amino) thiocarbonyl] amino } phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides |
859 | ?330 | N-(4-{[({1-[4-fluoro-2-(trifluoromethyl) phenyl] amyl group } amino) thiocarbonyl] amino } phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides |
860 | ?521 | N-{4-[({[[3,5-two (trifluoromethyl) phenyl] (phenyl) methyl] amino } thiocarbonyl) amino] phenyl }-1,2,3-thiadiazoles-4-carboxylic acid amides |
861 | ?450 | N-(4-{[({1-[3,5-two (trifluoromethyl) phenyl]-the 1-methylethyl } amino) thiocarbonyl] amino } phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides |
862 | ?433 | N-{4-[({[3,5-two (trifluoromethyl) benzyl] amino } thiocarbonyl) amino] phenyl }-1H-imidazoles-4-carboxylic acid amides |
863 | ?440 | N-{4-[({[1-(4-methyl fluoride) ethyl] amino } thiocarbonyl) amino] phenyl }-1H-imidazoles-4-carboxylic acid amides |
864 | ?506 | N-{4-[({[3,5-two (trifluoromethyl) benzyl] amino } thiocarbonyl) amino] phenyl }-1-methyl isophthalic acid H-imidazoles-4-carboxylic acid amides |
865 | ?462 | N-(4-{[({1-[3,5-two (trifluoromethyl) phenyl] propyl group } amino) thiocarbonyl] amino } phenyl)-1,3-thiazoles-4-carboxylic acid amides |
Embodiment 866 (method 32)
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides
2, add in tetrahydrofuran (THF) (20 milliliters) solution of 5-dichlorphenamide bulk powder (0.16 gram) 1,1 of prepared fresh '-thio-carbonyldiimidazole (0.20 gram), about 30 minutes of stirring at room mixture.In reaction flask, add [1,2,3]-thiadiazoles-4-carboxylic acid (4-amino-phenyl) acid amides (0.22 gram), stirred the mixture about 6 hours.Solvent removed by evaporation at reduced pressure adds warm acetonitrile (3 milliliters) then.After 15 hours, filtering mixt is used acetonitrile, and the precipitation of collecting with the ether washing is air-dry then, obtains desired white powder product.Use said procedure and suitable parent material to prepare following compounds:
Embodiment | M+H | The compound title |
Number | ||
867 | ?321 | N-{4-[3-(3-chloro-phenyl)-thioureido]-phenyl }-ethanamide |
868 | ?413 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-benzamide |
869 | ?443 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-2-methoxyl group-benzamide |
870 | ?443 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-3-methoxyl group-benzamide |
871 | ?443 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-4-methoxyl group-benzamide |
872 | ?431 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-4-methoxyl group-benzamide |
873 | ?431 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-3-fluoro-benzamide |
874 | ?431 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-4-fluoro-benzamide |
875 | ?437 | Furans-2-carboxylic acid 4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-acid amides |
876 | ?511 | 4-[3-(5-bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-the own ester of carboxylamine |
877 | ?481 | Caproic acid 4-[3-(5-bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
878 | ?505 | N-{4-[3-(5-bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
879 | ?477 | Furans-2-carboxylic acid 4-[3-(5-bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
880 | ?501 | N-{4-[3-(5-bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2 methyl-benzamide |
881 | ?517 | N-{4-[3-(5-bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl]-4-methoxyl group-benzamide |
882 | ?395 | N-{4-[3-(5-chloro-2-oxyethyl group-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
883 | ?395 | N-{4-[3-(5-chloro-4-oxyethyl group-2-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
884 | ?423 | N-{4-[3-(2-butoxy-5-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
885 | ?423 | N-{4-[3-(2-butoxy-5-chloro-2-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
886 | ?457 | N-{4-[3-(2-benzyloxy-5-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
887 | ?457 | N-{4-[3-(4-benzyloxy-5-chloro-2-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
888 | ?421 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-acid amides |
889 | ?424 | 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-5-methoxyl group-phenoxy group }-ethanamide |
890 | ?367 | N-{4-[3-(5-chloro-2-hydroxyl-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
891 | ?367 | N-{4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-phenyl }-ethanamide |
892 | ?447 | N-[4-(3-{3-chloro-4-[methyl-(1-methyl-piperidin-4-yl)-amino]-phenyl }-thioureido)-phenyl]-ethanamide |
893 | ?426 | N-(4-{3-[3-chloro-4-(methyl-phenyl-amino)-phenyl]-thioureido }-phenyl)-ethanamide |
894 | ?509 | N-[4-(3-{4-[(1-benzyl-tetramethyleneimine-3-yl)-methyl-amino]-3-chloro-phenyl }-thioureido)-phenyl]-ethanamide |
895 | ?418 | N-(4-{3-[3-chloro-4-(cyclopentyl-methyl-amino)-phenyl]-thioureido }-phenyl)-ethanamide |
896 | ?433 | N-[4-(3-{3-chloro-4-[methyl-(1-methyl-tetramethyleneimine-3-yl)-amino]-phenyl }-thioureido)-phenyl]-ethanamide |
897 | ?419 | Furans-2-carboxylic acid 4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-phenyl }-acid amides |
898 | ?447 | N-{4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
899 | ?465 | N-{4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
900 | ?445 | N-{4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
901 | ?441 | N-{4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-2-methyl-benzamide |
902 | ?434 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
903 | ?444 | N-{4-[3-(3-chloro-4-dimethylamino-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
904 | ?517 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-{3-chloro-4-[methyl-(1-methyl-piperidin-4-yl)-amino]-phenyl }-thioureido)-phenyl]-acid amides |
905 | ?579 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-{4[(1-benzyl-tetramethyleneimine-3-yl)-methyl-amino]-3-chloro-phenyl }-thioureido)-phenyl]-acid amides |
906 | ?527 | N-[4-(3-{3-chloro-4-[methyl-(1-methyl-piperidin-4-yl)-amino]-phenyl }-thioureido)-phenyl]-2-fluoro-benzamide |
907 | ?435 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-acid amides |
908 | ?589 | N-[4-(3-{4-[(1-benzyl-tetramethyleneimine-3-yl)-methyl-amino]-3-chloro-phenyl }-thioureido)-phenyl]-2-fluoro-benzamide |
909 | ?501 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-trifluoromethyl-phenyl }-acid amides |
910 | ?366 | 2-fluoro-N-[4-(3-phenyl-thioureido)-phenyl]-benzamide |
911 | ?338 | Furans-2-carboxylic acid [4-(3-phenyl-thioureido)-phenyl]-acid amides |
912 | ?356 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-phenyl-thioureido)-phenyl]-acid amides |
913 | ?365 | N-(4-{3-[3-chloro-4-(1-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-ethanamide |
914 | ?435 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-chloro-4-(1-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-acid amides |
915 | ?365 | N-(4-{3-[3-chloro-4-(2-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-ethanamide |
916 | ?445 | N-(4-{3-[3-chloro-4-(1-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
917 | ?417 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(1-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-acid amides |
918 | ?371 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-amino-phenyl)-thioureido]-phenyl }-acid amides |
919 | ?501 | Furans-2-carboxylic acid 4-[3-(3-bromo-4-trifluoromethoxy-phenyl)-thioureido]-phenyl }-acid amides |
920 | ?423 | N-{4-[3-(the 3-tertiary butyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
1025 | ?440 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
1026 | ?485 | N-{4-[3-(1-cumarone-2-base-ethyl)-thioureido]-phenyl }-2-trifluoromethyl-benzamide |
??1027 | ??412 | N-(4-fluoro-phenyl)-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-benzamide |
??1028 | ??446 | Isoquinoline 99.9-1-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1029 | ??468 | Isoquinoline 99.9-1-carboxylic acid 4-[3-(1-cumarone-2-base-ethyl)-thioureido]-phenyl }-acid amides |
??1030 | ??506 | Isoquinoline 99.9-1-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1031 | ??453 | Isoquinoline 99.9-1-carboxylic acid (4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1032 | ??435 | Cumarone-2-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1033 | ??457 | Cumarone-2-carboxylic acid 4-[3-(1-cumarone-2-base-ethyl)-thioureido]-phenyl }-acid amides |
??1034 | ??495 | Cumarone-2-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1035 | ??442 | Cumarone-2-carboxylic acid (4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1036 | ??446 | Isoquinoline 99.9-3-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1037 | ??468 | Isoquinoline 99.9-3-carboxylic acid 4-[3-(1-cumarone-2-base-ethyl)-thioureido]-phenyl }-acid amides |
??1038 | ??453 | Isoquinoline 99.9-3-carboxylic acid (4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1039 | ??506 | Isoquinoline 99.9-3-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1040 | ??446 | Quinoline-3-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1041 | ??446 | The Cinchonic Acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1042 | ??446 | QUINOLINE-6-CARBOXYLIC ACID (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1043 | ??446 | Quinoline-8-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1044 | ??462 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-methyl fluoride-benzamide |
??1045 | ??419 | 2-cyano group-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
??1046 | ??473 | N-{4-[3-(3-chloro-4-isobutoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
??1047 | ??414 | 2-fluoro-N-{4-[3-(3-fluoro-4-methoxyl group-phenyl)-thioureido]-phenyl }-benzamide |
??1048 | ??475 | N-(4-{3-[3-chloro-4-(2-methoxyl group-oxyethyl group)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
??1049 | ??398 | 2-fluoro-N-{4-[3-(3-fluoro-4-methyl-phenyl)-thioureido]-phenyl }-benzamide |
??1050 | ??464 | 2-fluoro-N-{4-[3-(4-methyl-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-benzamide |
??1051 | ??449 | N-{4-[3-(2-amino-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
??1052 | ??459 | N-(4-{3-[1-(3-chloro-4-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
??1053 | ??417 | N-{4-[3-(5-chloro-2-hydroxyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
??1054 | ??435 | N-{4-[3-(1-cumarone-2-base-ethyl)-thioureido]-phenyl }-2-fluoro-benzamide |
??1055 | ??448 | 2-fluoro-N-{4-[3-(4-methyl-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-benzamide |
1056 | ?473 | (S)-N-(4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1057 | ?473 | N-(4-{3-[(1R)-1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1058 | ?494 | 2-fluoro-N-(4-{3-[2-methoxyl group-4-(2,2,2-three fluoro-oxyethyl groups)-phenyl]-thioureido }-phenyl)-benzamide |
1059 | ?399 | N-{4-[3-(2-amino-5-fluoro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
1060 | ?502 | N-(4-{3-[1-(4-dimethylamino alkylsulfonyl phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1061 | ?542 | 2-fluoro-N-[4-(3-{1-[4-(piperidines-1-alkylsulfonyl)-phenyl]-ethyl }-thioureido)-phenyl]-benzamide |
1062 | ?562 | N-(4-{3-[2,4-two (2,2,2-three fluoro-oxyethyl groups)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1063 | ?409 | 2-fluoro-N-{4-[3-((1S)-1-p-methylphenyl-ethyl)-thioureido]-phenyl }-benzamide |
1064 | ?409 | 2-fluoro-N-{4-[3-((1R)-1-p-methylphenyl-ethyl)-thioureido]-phenyl }-benzamide |
1065 | ?394 | 2-fluoro-N-{4-[3-((1S)-1-phenyl-ethyl)-thioureido]-phenyl }-benzamide |
1066 | ?429 | N-(4-{3-[(1R)-1-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1067 | ?429 | N-(4-{3-[(1S)-1-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1068 | ?394 | 2-fluoro-N-{4-[3-((1R)-1-phenyl-ethyl)-thioureido]-phenyl }-benzamide |
1069 | ?432 | N-(4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-2-methoxyl group-benzamide |
1070 | ?447 | N-{4-[3-(1-cumarone-2-base-ethyl)-thioureido]-phenyl }-2-methoxyl group-benzamide |
1071 | ?485 | N-(4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-2-methoxyl group-benzamide |
1072 | ?419 | 3-cyano group-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
1073 | ?462 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-4-trifluoromethyl-benzamide |
1074 | ?419 | 4-cyano group-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
1075 | ?469 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2,3,5,6-tetramethyl--phenyl)-benzamide |
1076 | ?480 | N-(4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-2,5-dimethoxy-phenyl)-2-fluoro-benzamide |
1077 | ?473 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2,5-dimethoxy-phenyl)-benzamide |
1078 | ?530 | N-{3,5-two chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
1079 | ?447 | N-(3-chloro-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2,5-dimethoxy-phenyl)-2-fluoro-benzamide |
1080 | ?480 | 2,3,4,5-tetrafluoro-N-(3-chloro-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-3-methyl-phenyl)-benzamide |
1081 | ?462 | 2,4,5-three fluoro-N-(3-chloro-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-3-methyl-phenyl)-benzamide |
1082 | ?427 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-3-methyl-phenyl)-benzamide |
1083 | ?457 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-methoxyl group-5-methyl-phenyl)-benzamide |
1084 | ?443 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-3-methoxyl group-phenyl)-benzamide |
1085 | ?570 | N-(2,6-two bromo-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-3-methyl-phenyl)-2-fluoro-benzamide |
1086 | ?480 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-trifluoromethyl-phenyl)-benzamide |
1087 | ?541 | N-(4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-2-trifluoromethyl-phenyl)-2-fluoro-benzamide |
1088 | ?487 | N-(4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-2-trifluoromethyl-phenyl)-2-fluoro-benzamide |
1089 | ?503 | N-{4-[3-(1-cumarone-2-base-ethyl)-thioureido]-2-trifluoromethyl-phenyl }-2-fluoro-benzamide |
1090 | ?447 | N-(2-chloro-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1091 | ?454 | N-(2-chloro-4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1092 | ?437 | N-(2-cyano group-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1093 | ?498 | N-(4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-the 2-cyano-phenyl)-2-fluoro-benzamide |
1094 | ?445 | N-(2-cyano group-4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1095 | ?460 | N-{4-[3-(1-cumarone-2-base-ethyl)-thioureido]-2-cyano group-phenyl }-2-fluoro-benzamide |
1096 | ?517 | N-(2-benzoyl-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1097 | ?427 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-methyl-phenyl)-benzamide |
1098 | ?487 | N-(4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-2-methyl-phenyl)-2-fluoro-benzamide |
1099 | ?434 | N-(4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-2-methyl-phenyl)-2-fluoro-benzamide |
1100 | ?449 | N-{4-[3-(1-cumarone-2-base-ethyl)-thioureido]-2-methyl-phenyl }-2-fluoro-benzamide |
1101 | ?456 | N-(2-dimethylamino-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1102 | ?526 | N-(2-benzyloxy-4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1103 | ?519 | N-(2-benzyloxy-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1104 | ?603 | N-[4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-2-(2-morpholine-4-base-oxyethyl group)-phenyl]-2-fluoro-benzamide |
1105 | ?603 | N-[4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-2-(2-morpholine-4-base-oxyethyl group)-phenyl]-2-fluoro-benzamide |
1106 | ?542 | 2-fluoro-N-[4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-(2-morpholine-4-base-oxyethyl group)-phenyl]-benzamide |
1107 | ?485 | N-(2-butoxy-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1108 | ?492 | N-(2-butoxy-4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1109 | ?589 | N-[4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-2-(2-diethylamino-oxyethyl group)-phenyl]-2-fluoro-benzamide |
1110 | ?528 | N-(2-(2-diethylamino-oxyethyl group)-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1111 | ?589 | N-[4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-2-(2-diethylamino-oxyethyl group)-phenyl]-2-fluoro-benzamide |
1112 | ?457 | N-(2-oxyethyl group-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1113 | ?464 | N-(4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-2-oxyethyl group-phenyl)-2-fluoro-benzamide |
1114 | ?468 | 2-fluoro-N-[4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-2-(2-nitrilo-oxyethyl group)-phenyl]-benzamide |
1115 | ?475 | N-[4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-2-(2-nitrilo-oxyethyl group)-phenyl]-2-fluoro-benzamide |
1116 | ?443 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-methoxyl group-phenyl)-benzamide |
1117 | ?489 | 2-fluoro-N-(5-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-biphenyl-2-yl)-benzamide |
1118 | ?514 | Isoquinoline 99.9-1-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-trifluoromethyl-phenyl)-acid amides |
1119 | ?503 | Cumarone-2-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-trifluoromethyl-phenyl)-acid amides |
1120 | ?514 | Isoquinoline 99.9-3-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-trifluoromethyl-phenyl)-acid amides |
1121 | ?471 | Isoquinoline 99.9-1-carboxylic acid (2-cyano group-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido]-phenyl)-acid amides |
1122 | ?460 | Cumarone-2-carboxylic acid (2-cyano group-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
1123 | ?471 | Isoquinoline 99.9-3-carboxylic acid (2-cyano group-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
1124 | ?460 | Isoquinoline 99.9-1-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-methyl-phenyl)-acid amides |
1125 | ?449 | Cumarone-2-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-methyl-phenyl)-acid amides |
1126 | ?460 | Isoquinoline 99.9-3-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-methyl-phenyl)-acid amides |
1127 | ?396 | Pyrazine-2-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
1128 | ?401 | Thiophene-2-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
1129 | ?401 | Thiophene-3-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
1130 | ?500 | 2-sec.-propyl-thiazole-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
1131 | ?466 | 2-sec.-propyl-thiazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
1132 | ?466 | 2-sec.-propyl-thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
1133 | ?534 | 2-sec.-propyl-thiazole-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
1134 | ?480 | 2-butyl-thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
1135 | ?514 | 2-butyl-thiazole-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
1136 | ?480 | 2-butyl-thiazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
1137 | ?548 | 2-butyl-thiazole-4-carboxylic acid 4-[3-(3,4-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
1138 | ?438 | 2-methyl-thiazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
1139 | ?438 | 2-methyl-thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
1140 | ?505 | 2-methyl-thiazole-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
1141 | ?534 | 2-phenyl-thiazole-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
1142 | ?500 | 2-phenyl-thiazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
1143 | ?500 | 2-phenyl-thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
1144 | ?568 | 2-phenyl-thiazole-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
1145 | ?401 | 2-fluoro-N-{4-[3-(1-thiazol-2-yl-ethyl)-thioureido]-phenyl }-benzamide |
1146 | ?588 | 2-fluoro-N-[4-(3-{1-[1-(toluene-4-alkylsulfonyl)-1H-indoles-2-yl]-ethyl }-thioureido)-phenyl]-benzamide |
1147 | ?446 | 2-fluoro-N-{4-[3-(1-quinoline-2-base-ethyl)-thioureido]-phenyl }-benzamide |
1148 | ?446 | 2-fluoro-N-{4-[3-(1-quinolyl-4-ethyl)-thioureido]-phenyl }-benzamide |
1149 | ?446 | 2-fluoro-N-{4-[3-(1-isoquinoline 99.9-3-base-ethyl)-thioureido]-phenyl }-benzamide |
1150 | ?446 | 2-fluoro-N-{4-[3-(1-isoquinolyl-1-ethyl)-thioureido]-phenyl }-benzamide |
1151 | ?446 | 2-fluoro-N-{4-[3-(1-quinoline-6-base-ethyl)-thioureido]-phenyl }-benzamide |
1152 | ?446 | 2-fluoro-N-{4-[3-(1-quinoline-3-base-ethyl)-thioureido]-phenyl }-benzamide |
1153 | ?413 | 2-methoxyl group-N-{4-[3-(1-thiene-3-yl--ethyl)-thioureido]-phenyl }-benzamide |
Embodiment 921 (method 33)
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides
3, add in tetrahydrofuran (THF) (20 milliliters) solution of 5-dichlorphenamide bulk powder (0.16 gram) 1,1 of prepared fresh '-thiocarbonyl-two-(1,2,4)-triazole (0.20 gram), about 30 minutes of stirring at room mixture.In reaction beaker, add [1,2,3]-thiadiazoles-4-carboxylic acid (4-amino-phenyl) acid amides (0.22 gram), stirred the mixture about 6 hours.Solvent removed by evaporation at reduced pressure adds hot acetonitrile (3 milliliters) then.15 hours after-filtration mixtures are used acetonitrile, wash the precipitation of collecting with ether then, and dry air obtains desired white powder product [M+H] 424.
Use said procedure and suitable parent material to prepare following compounds:
Embodiment number | ??M+H | The compound title |
922 | ?465 | N-{4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-3-fluoro-benzamide |
923 | ?477 | N-{4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-2-methoxyl group-benzamide |
924 | ?465 | N-{4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
925 | ?477 | N-{4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-3-methoxyl group-benzamide |
926 | ?399 | N-{4-[3-(3,5-two chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
927 | ?365 | N-{4-[3-(3-chloro-4-methoxyl group-5-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
928 | ?331 | N-{4-[3-(2-nitro-phenyl)-thioureido]-phenyl }-ethanamide |
929 | ?331 | N-{4-[3-(4-nitro-phenyl)-thioureido]-phenyl }-ethanamide |
930 | ?477 | N-{4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-4-methoxyl group-benzamide |
931 | ?351 | N-{4-[3-(2-chloro-5-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
932 | ?428 | 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2,6-two chloro-phenoxy groups }-ethanamide |
933 | ?443 | 4-[3-(4-acetylamino-phenyl)-thioureido] and-2,6-two chloro-phenoxy groups }-methyl acetate |
934 | ?457 | 4-[3-(4-acetylamino-phenyl)-thioureido] and-2,6-two chloro-phenoxy groups }-ethyl acetate |
935 | ?447 | N-{4-[3-(3,5-two chloro-4-phenoxy group-phenyl)-thioureido]-2,6-two chloro-phenoxy groups }-ethanamide |
936 | ?410 | N-(4-{3-[3,5-two chloro-4-(2-nitrilo-oxyethyl group)-phenyl]-thioureido }-phenyl-ethanamide |
937 | ?485 | 4-[3-(4-acetylamino-phenyl)-thioureido] and-2,6-two chloro-phenoxy groups }-tert.-butyl acetate |
938 | ?469 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-acid amides |
939 | ?335 | N-{4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
940 | ?335 | N-{4-[3-(5-chloro-2-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
941 | ?703 | N-{4-[3-(4-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-diphenyl disulfide base }-3-chloro-phenyl)-thioureido]-phenyl }-ethanamide |
942 | ?369 | N-{4-[3-(3,5-two chloro-4-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
943 | ?598 | N-{4-[3-(3,5-two iodo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
944 | ?504 | N-{4-[3-(3,5-two bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
945 | ?317 | N-{4-[3-(6-methoxyl group-pyridin-3-yl)-thioureido]-phenyl }-ethanamide |
946 | ?347 | N-{4-[3-(2,6-dimethoxy-pyridin-3-yl)-thioureido]-phenyl }-ethanamide |
947 | ?457 | Acetate 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2,6-two chloro-phenoxy groups }-ethyl ester |
948 | ?365 | 4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenylformic acid |
949 | ?346 | N-{4-[3-(3-chloro-4-cyano group-phenyl)-thioureido]-phenyl }-ethanamide |
950 | ?512 | N-(4-{3-[5-chloro-2-(4-chloro-phenoxy group)-4-pyrroles-1-base-phenyl]-thioureido }-phenyl)-ethanamide |
951 | ?355 | N-{4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-ethanamide |
952 | ?339 | N-{4-[3-(3-chloro-4-fluoro-phenyl)-thioureido]-phenyl }-ethanamide |
953 | ?447 | N-{4-[3-(3-chloro-4-iodo-phenyl)-thioureido]-phenyl }-ethanamide |
954 | ?400 | N-{4-[3-(4-bromo-3-chloro-phenyl)-thioureido]-phenyl }-ethanamide |
955 | ?424 | N-[4-(3-{4-[two-(2-hydroxyl-ethyl)-amino]-3-chloro-phenyl }-thioureido)-phenyl]-ethanamide |
956 | ?434 | N-(4-{3-[3-chloro-4-(hexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-ethanamide |
957 | ?406 | N-(4-{3-[3-chloro-4-(isobutyl--methyl-amino)-phenyl]-thioureido }-phenyl)-ethanamide |
958 | ?389 | N-{4-[3-(3-chloro-4-trifluoromethyl-phenyl)-thioureido]-phenyl }-ethanamide |
959 | ?441 | Furans-2-carboxylic acid 4-[3-(3-bromo-4-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
960 | ?459 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
961 | ?469 | N-{4-[3-(3-chloro-4-trifluoromethyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
962 | ?435 | N-{4-[3-(3,4-dichlor-4-trifluoromethyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
963 | ?407 | Furans-2-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
964 | ?425 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
965 | ?480 | N-{4-[3-(4-bromo-3-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
966 | ?527 | N-{4-[3-(3-chloro-4-iodo-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
967 | ?452 | Furans-2-carboxylic acid 4-[3-(4-bromo-3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
968 | ?499 | Furans-2-carboxylic acid 4-[3-(3-chloro-4-iodo-phenyl)-thioureido]-phenyl }-acid amides |
969 | ?391 | Furans-2-carboxylic acid 4-[3-(3-chloro-4-fluoro-phenyl)-thioureido]-phenyl }-acid amides |
970 | ?470 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-bromo-3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
971 | ?517 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-iodo-phenyl)-thioureido]-phenyl }-acid amides |
972 | ?419 | N-{4-[3-(3-chloro-4-f fluoro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
973 | ?409 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-fluoro-phenyl)-thioureido]-phenyl }-acid amides |
974 | ?388 | N-{4-[3-(3-chloro-4-isoxazole-5-base-phenyl)-thioureido]-phenyl }-ethanamide |
975 | ?387 | N-(4-{3-[3-chloro-4-(1H-pyrazole-3-yl)-phenyl]-thioureido }-phenyl)-ethanamide |
976 | ?355 | N-{4-[3-(2,3-two chloro-phenyl)-thioureido]-phenyl }-ethanamide |
977 | ?435 | N-{4-[3-(2,3-two chloro-phenyl)-thioureido]-phenyl }-2-fluoro-ethanamide |
978 | ?407 | Furans-2-carboxylic acid 4-[3-(2,3-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
979 | ?425 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2,3-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
980 | ?355 | N-{4-[3-(2,5-two chloro-phenyl)-thioureido]-phenyl }-ethanamide |
981 | ?435 | N-{4-[3-(2,5-two chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
982 | ?407 | Furans-2-carboxylic acid 4-[3-(2,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
983 | ?355 | N-{4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-ethanamide |
984 | ?435 | N-{4-[3-(2,5-two chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
985 | ?407 | Furans-2-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
986 | ?390 | N-{4-[3-(3,4,5-three chloro-phenyl)-thioureido]-phenyl }-ethanamide |
987 | ?470 | 2-fluoro-N-{4-[3-(3,4,5-three chloro-phenyl)-thioureido]-phenyl }-benzamide |
988 | ?442 | Furans-2-carboxylic acid 4-[3-(3,4,5-three chloro-phenyl)-thioureido]-phenyl }-acid amides |
989 | ?460 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4,5-three chloro-phenyl)-thioureido]-phenyl }-acid amides |
990 | ?458 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-isoxazole-5-base-phenyl)-thioureido]-phenyl }-acid amides |
991 | ?457 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-chloro-4-(1H-pyrazole-3-yl)-phenyl]-thioureido }-phenyl)-acid amides |
992 | ?391 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
993 | ?373 | Furans-2-carboxylic acid 4-[3-(3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
994 | ?401 | N-{4-[3-(3-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
995 | ?373 | Furans-2-carboxylic acid 4-[3-(4-chloro-phenyl)-thioureido]-phenyl }-acid amides |
996 | ?401 | N-{4-[3-(4-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
997 | ?391 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-phenyl)-thioureido]-phenyl }-acid amides |
998 | ?401 | N-{4-[3-(2-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
999 | ?396 | 3-(3-{4-[(4-furans-2-carbonyl)-amino]-phenyl }-thioureido)-methyl benzoate |
1000 | ?424 | 3-{3-[4-(2-fluoro-benzoyl-amido)-phenyl]-thioureido }-methyl benzoate |
1001 | ?414 | 3-(3-{4-[([1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-thioureido)-methyl benzoate |
1002 | ?409 | N-[4-[[[[3-(aminocarboxyl)-phenyl] amino] sulphomethyl] amino] phenyl]-2-fluoro-benzamide |
1003 | ?373 | Furans-2-carboxylic acid 4-[3-(2-chloro-phenyl)-thioureido]-phenyl }-acid amides |
1004 | ?381 | Furans-2-carboxylic acid 4-[3-(3-formamyl-phenyl)-thioureido]-phenyl }-acid amides |
1005 | ?399 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-formamyl-phenyl)-thioureido]-phenyl }-acid amides |
1006 | ?391 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-chloro-phenyl)-thioureido]-phenyl }-acid amides |
1007 | ?356 | Furans-2-carboxylic acid 4-[3-(3-fluoro-phenyl)-thioureido]-phenyl }-acid amides |
1008 | ?383 | Furans-2-carboxylic acid 4-[3-(3-nitro-phenyl)-thioureido]-phenyl)-acid amides |
1009 | ?411 | 2-fluoro-N-{4-[3-(3-nitro-phenyl)-thioureido]-phenyl }-benzamide |
1010 | ?422 | Furans-2-carboxylic acid 4-[3-(3-trifluoromethoxy-phenyl)-thioureido]-phenyl }-acid amides |
1011 | ?450 | 2-fluoro-N-{4-[3-(3-trifluoromethoxy-phenyl)-thioureido]-phenyl }-benzamide |
1012 | ?384 | 2-fluoro-N-{4-[3-(3-fluoro-phenyl)-thioureido]-phenyl }-benzamide |
1013 | ?410 | 3-{3-[4-(2-fluoro-benzoyl-amido)-thioureido]-phenyl }-phenylformic acid |
1014 | ?382 | 3-(3-{4-[(furans-2-carbonyl)-amino]-phenyl }-thioureido)-phenylformic acid |
??1015 | ??408 | N-{4-[3-(3-ethanoyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
??1016 | ??502 | N-{4-[3-(3-butyl amino-sulfonyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
??1017 | ??380 | Furans-2-carboxylic acid 4-[3-(3-ethanoyl-phenyl)-thioureido]-phenyl }-acid amides |
??1018 | ??447 | Furans-2-carboxylic acid (4-{3-[3-(2-hydroxyl-ethylsulfonyl)-phenyl]-thioureido }-phenyl)-acid amides |
??1019 | ??475 | 2-fluoro-N-(4-{3-[3-(2-hydroxyl-ethylsulfonyl)-phenyl]-thioureido }-phenyl)-benzamide |
??1020 | ??474 | Furans-2-carboxylic acid 4-[3-(3-butyl amino-sulfonyl-phenyl)-thioureido]-phenyl }-acid amides |
Embodiment 1021 (method 57)
1-(4-fluoro-phenyl)-2-methyl-third-1-alcohol
In ether (40 milliliters) solution of 0 ℃ 4-fluorobenzaldehyde (2.0 gram), drip while stirring the bromination isopropyl-magnesium (2.0M, 9.6ml).1.5 after hour,, use extracted with diethyl ether with aqueous ammonium chloride solution cancellation reaction.Wash ethereal extract with saturated sodium-chloride, use anhydrous magnesium sulfate drying, filtration and evaporation obtain oil.With silica gel column chromatography purifying oil,, obtain yellow oil product (1.76 gram) with 10% methylene dichloride-hexane wash-out.
Embodiment 1022 (method 58)
1-(4-fluoro-phenyl)-2-methyl-third-1-ketone
In acetone (10 milliliters) solution of 0 ℃ 1-(4-fluoro-phenyl)-2-methyl-third-1-alcohol (1.6 gram), drip Jones reagent (20ml) while stirring.After 10 minutes, add Virahol and destroy excessive Jones reagent.Add ether, add anhydrous magnesium then, filtering mixt, evaporation obtains yellow oil product (1.2 gram).
Embodiment 1023 (method 59)
3-dimethylamino-5-trifluoromethyl-benzonitrile
At the N of 3-dimethylamino-5-methyl bromobenzene trifluoride (7.3 gram), add cuprous cyanide (2.7 gram) in dinethylformamide (20 milliliters) solution, reflux mixture 12 hours.Water (40 milliliters) diluting reaction thing adds methylene dichloride.Use dense ammonium hydroxide, wash the methylene dichloride component then with water.Use anhydrous magnesium sulfate drying solution, concentrate, obtain yellow solid,, obtain yellow solid (4.7 gram) its recrystallization in hexane.
Tested the activity of above-claimed cpd as the simplexvirus inhibitor.
Human cytomegalic inclusion disease virus
Volume analysis.With HCMV wild-type (usually to be equivalent to 0.2 infection multiplicity) infection human foreskin fibroblast monolayer culture thing under inhibitor compound (different concns).Infected back 3 days, and, be determined at the viral total amount that produces in these cultures in the 12-well culture plate by the human foreskin fibroblast virus (in the presence of the unrestraint agent, carrying out) of collecting and titration is cultivated.Infect the quantitative plaque in 2 week backs.By existing under the situation of compound and not having the minimizing that the titre in the presence of the compound compares the viral yield titre, identify the inhibitor of HCMV.In this test, a kind of HCMV-of antagonism mutually of inhibitor is active usually by calculating IC
50Or IC
90Value (that is, respectively viral yield being reduced by 50% or 90% required compound amount) is determined.Table I has been described the IC of the compound of measuring at HCMV
50Data.
The microtiter plate test.In the presence of inhibitor compound, (its genome contains protokaryon beta-Glucuronidase gene (Jefferson with a kind of HCMV recombination mutation virus, R.A., S.M.Burgess, and D.Hirsh, 1986, from intestinal bacteria, as the beta-Glucuronidase of gene fusion mark, Proc.Natl.Acad.Sci.USA83:8447-8451), its expression is controlled by viral promotors), the fibroblastic 96-orifice plate of infected person foreskin culture.An example of this virus be RV145 virus (Jones, T.R., V.P.Muzithras and Y.Gluzman1991, the displacement mutagenesis of human cytomegalovirus gene group: US10 and US11 gene product are nonessential, J.Virol.65:5860-5872).Because it is in the control of viral promotors, it is the indirect index that HCMV grows and duplicates that beta-Glucuronidase is expressed in this test.In infection back 96 hours, the cell lysate that preparation is infected is (with 50mM sodium phosphate [pH7.0], contain 0.1%Triton X-100 and 0.1% sodium lauryl sulphate), measure the beta-Glucuronidase activity with enzyme substrates (when cutting, obtaining under spectrophotometer, to measure or under microfluorimeter, using the product of fluoroscopic examination) with development process.The example of these substrates is respectively p-nitrophenyl-β-D-glucuronide and methyl Umbrella shape base glucuronide.The existence of the minimizing indication antiviral compound of comparing when residing the beta-Glucuronidase expression of gene with the unrestraint agent with the HCMV genome.Like this, the corresponding minimizing of generation of chromophoric group or fluorophore product in this test.The data that this test uses the inhibitor compound of different amounts to produce also are used for estimating the IC of inhibitor compound
50
HSV antiviral (ELISA) test
In the tissue culturing plate of 96-hole, replenished the tissue culture medium (TCM) DMEM (the improvement Eale substratum of Dulbecco) of 2% foetal calf serum (FBS) with every hole 100 microlitres, wherein contain 3.5x10
4Vero cell (ATCC#CCL-81).37 ℃ of overnight incubation are (at 5%CO
2In) after, infected preceding 30 minutes with HSV-1 (infection multiplicity is equivalent to 0.006), do not handle, or with the standard drug control treatment cell of test compounds (different concns) or reference.Infect the back at 37 ℃ (at 5%CO
2In) incubation is after about 24 hours, fixed cell is used for the ELISA test.First antibody is mouse anti-HSV glycoprotein D mono-clonal first antibody, and two anti-be that the goat that is connected with beta-galactosidase enzymes resists-mouse IgG.Therefore, after adding methyl Umbrella shape base β-D-galactoside (Sigma#M1633) substrate, go up quantitative 4-methylumbelliferone fluorescence cleaved products, measure the virus replication degree at microfluorimeter (excite 365 nanometers, launch 450 nanometers).Fluorescence that obtains when relatively not having compound and the fluorescence that obtains when compound is arranged are determined the antiviral activity (IC of test compounds
50).Table I has shown data.
VZV antiviral (ELISA) test
In order to produce the original seed VZV that uses in test, infect human foreskin fibroblast (HFF) cell with VZV strain Ellen (ATCC#VR-1367) with low infection multiplicity (less than 0.1), and at 37 ℃ of (5%CO
2) in be incubated overnight.Spend the night behind the incubation, collect the mixture of the HFF cells infected that has not infected and infected VZV, and be added in each hole of 96-well culture plate and go that (100 microlitres are supplemented with among the DMEM of 2%FBS and contain 3.5 * 10
4Individual cell), the standard drug contrast (100 microlitres in every hole have replenished among the DMEM of 2%FBS) of test compounds or reference is contained in each hole.At 37 ℃ of (5%CO
2) cultivated these cells 3, be fixed for the ELISA test then.First antibody be mouse anti-VZV glycoprotein I I monoclonal antibody (Applied Biosystems, Inc.#13-145-100), two anti-be that the goat that is connected with beta-galactosidase enzymes resists-mouse IgG.Therefore, after adding methyl Umbrella shape base β-D-galactoside (Sigma#M1633) substrate, go up quantitative 4-methylumbelliferone fluorescence cleaved products, measure the virus replication degree at microfluorimeter (excite 365 nanometers, launch 450 nanometers).Fluorescence that obtains when relatively not having compound and the fluorescence that obtains when compound is arranged are determined the antiviral activity (IC of test compounds
50).Table I has shown data.Example I C50 IC50 suppresses % IC50
μg/ml?????(μg/ml)?????10μg/ml???????(μg/ml)
HCMV HSV VZV VZV 86>10 32>10 0.04 88>10 .03 0.013 90>10 0.07 91>10 6>10 0.018 144 7 10 145 2 51>15>10 146>10 14>10>10 147 10 42>10>50 153 2 8>10>10 154 4 23>10 10 155 5 22>10 5 158 4 52>15>10 159>10 62>10>10 160 2.5 27>10>10 161 3 113 5>10 163 3 30>10 7 166 9 30>10>10 167 10 70 3.8 9 168 3>10 2.5 169 3 26>10 4 170>10 32>10 0.2 172>10 25>10>10 173>10 31>10 0.08 IC50 IC50 % IC50。
μg/ml???????(μg/ml)??????10μg/ml???(μg/ml)
HCMV HSV VZV VZV 174 50 8>10 6 175 2 24>10>10 200>10 55>15 0.02 201>10 78 8 0.023 224 3.5 30>10 0.8 225 1 30>10>10 230>10>10 0.015 233>10 30>10 0.09 236>10 40>10 0.7 237>10 17>10 0.02 246>10 37 4 0.05 249>10 59>10 0.4 264>10 28>10>10 279>10>10>10 280>10>10>10 281>10 31>10>10 288>10 30>10 4 323 3 45>10 0.03 330>10 29>10 0.15 331 1.8 98 5 2 341 2 50>10 0.15 344 4 72 7 0.25 350>10 50>10 1 351 3 90 3.5 0.3 352 3 51>10 0.6 353 0.6 86 7 0.04 354 0.8 75 7 2 361 8 26>10 0.25 365 10 75 5 0.035 368>10 20>10 0.35 371>10 45>10>10 376 3 83 7 0.8 378>10 31>10 0.033 379>10 27>10>10 391 8 97 6 0.019 396>10 26>10 0.7 398>10 5>10 0.13 403 6 108>15 0.09 406>10 28>10 0.12 409>10 5>10 2 411 8 99 2 0.024 413 5 103 5 0.081 416>10 87>15 0.25 421 8>10 0.75 422 5 69>10 0.058 424 3 103 0.7 0.09 IC50 IC50 % IC50
μg/ml??????(μg/ml)?????10μg/l??????(μg/ml)
HCMV HSV VZV VZV 430>10>10 0.4 431>10>10 0.06 435 10 94 0.9 0.08 436 10>10 0.15 438 5 73 1.5 3 439 9 46>10 0.5 440 1 9 0.3 441>10>10 0.17 445 10>10 0.15 446 10>10 0.7 447>10>10>10 449>10>10 1.6 450>10>10 0.05 451 8>10 0.15 453>10 3 0.07 455>10 30>10 0.3 456>10 12>10 0.07 457>10 26>10 0.019 462>10 6>10 1 464>10 25>10 0.15 466>10 93>10 0.011 467>10 93>15 0.12 468>10 50>10 0.06 469>10 54>10 0.1 470 0.6 17>10 0.7 472>10 31>10 0.8 473>10 40>10 0.3 474>10 22>10 1 478>10 31>10 0.4 479>10 30>10 0.1 481>10 32>10 0.5 482 9 33>10 0.3 485>10 11>10 0.03 486>10 22>10 0.045 488>10 13>10 1.2 489 5 99 3.5 0.17 494>10 6>10 3.5 495>10 27>10 3 500>10 48>10 0.021 501>10 10>10 0.032 503 8 64>10 0.053 505 10 79 8 0.2 508>10 7>10 0.013 509>10 31>10 0.03 510 8 19>10 0.04 IC50 IC50 % IC50
μg/ml?????(μg/ml)??????10μg/ml?????????(μg/ml)
HCMV HSV VZV VZV 513>10 10>10 0.011 516>10 7>10 0.04 521 10 97 3 0.04 522>10 32>10 0.025 524 4 95 2 0.055 526>10 22 2.5 3 528 3.2 107 5 0.25 530 5 96 6 0.15 532>10 6 0.009 534 7>10 0.05 535>10>10 0.016 537 9 10 0.003 539>10>10 0.036 541 7>10 0.017 542>10>10 0.0011 544>10>10 0.02 545 3 7 0.012 546 1.7 7 0.007 547>10 10 0.006 548>10>10 0.008 550>10>10 0.013 551>10>10 0.043 554>10 1.5 0.01 555>10 4 0.008 556>10>7.5 0.006 557>10>10 0.006 558 7>10 0.05 559>10>10 0.012 560>10>10 0.008 561>10 8 0.05 562>10 8 0.004 564>10 5 0.027 565>10 0.22 0.01 571>10 0.013 572>10 0.0078 573>10 0.05 574>10 0.089 575 2 0.017 579 6 0.05 581>10 0.01 582 8 0.01 584>10 0.0026 585>10 0.015 587>10 0.005 588>10 0.36 0.03 590>10 1 0.12 IC50 IC50 % IC50
μg/ml?????(μg/ml)????10μg/ml????(μg/ml)
HCMV HSV VZV VZV 592>10 2 0.049 594>10>10 0.011 595>10 3 0.022 597>10>10 0.008 599>10>10 0.005 600>10>10 0.012 601>10>10 0.0011 602>10>10 0.0015 603>10>10>0.5 604>10 10 0.025 605>10 10 0.062 606>10>10 0.0023 607 8>10 0.09 611>10 0.5 612 1 0.049 613>10 0.011 614 7 0.024 615>10 0.005 617>10 0.013 618>10 0.0016 624>10 0.002 626 10>10 0.07 627 10>10 0.014 630>10 4 0.4 631 6 6 0.15 635 10 4 0.15 637>10>10 0.014 638>10>10 0.01 639>10>10 0.07 644>10 8 0.03 645>10 10 0.003 646>10 2.5 0.03 647>10 0.1 0.007 648>10 0.01 650>10 0.05 651>10 0.03 652>10 0.03 654>10 0.07 655>10 0.01 657 6 0.04 662>10 0.03 663>10 0.01 665 5 0.02 667 8 0.03 668>10 0.009 670>10 0.02 IC50 IC50 % IC50
μg/ml??????????(μg/ml)??????????10μg/ml???????????(μg/ml)
HCMV HSV VZV VZV 671>10 0.005 674>10 0.006 675>10 0.05 676>10 0.013 678>10 0.005 679 10 0.01 681>10 0.002 682>10 0.006 683 10 0.02 684 10 0.005 685 10 0.006 686>10 0.007 688>10 0.006 689 7 0.007 690 7 0.004 691>10 0.008 692 6 0.04 693>10 0.03 694 10 0.04 697 7 0.04 698 6 0.04 699>10 0.016 700>10 0.004 701>10 0.008 702 4 0.01 703>10 0.007 704>10 0.006 705>10 0.006 706>10 0.04 707>10 0.005 708>10 0.005 709>10 0.05 710>10 0.006 711>10 0.004 713>10 0.009 714>10 0.02 715>10 0.03 716>10 0.01 717>10 0.003 718 6 0.02 720>10 0.01 722>10 0.015 723>10 0.03 726>10 728 9 729 0.02 IC50 IC50 % IC50
μg/ml???????????(μg/ml)????????????10μg/ml???????????(μg/ml)
HCMV HSV VZV VZV 730 0.033 731>10 0.007 732 0.022 733 0.018 734>10 0.009 735 0.022 736 0.012 737>10 0.005 738>10 0.11 739>10 0.02 740 0.1 741>10 0.02 742>10 0.009 743>10 0.09 745 9 0.0025 746>10 0.005 747>10 0.002 748>10 0.28 749>10 0.06 750>10 0.01 759>10 2>10 762>10 1.5 0.002 763 5 5 0.004 764>10 0.004 766>10 0.006 767>10 1 0.006 768>10 0.005 769>10 0.04 770>10 0.006 796>10>7.5 4 815 0.27 0.0095 816>7.5 0.0053 818>7.5 0.0016 820>7.5 0.006 821>7.5 0.005 822>7.5 0.018 824 0.17 0.014 825>7.5 0.0013 828>7.5 0.002 829>7.5 0.002 IC50 IC50 % IC50。
μg/ml???????????(μg/ml)????????????????10μg/ml????????????(μg/ml)
HCMV HSV VZV VZV 830>7.5 0.0003 831>7.5 0.0011 832>7.5 0.0001 833>7.5 0.0019 834>7.5 0.002 835>7.5 0.005 836>7.5 0.004 837 3.60 0.03 838>7.5 0.0007 839>7.5 0.004 840 0.14 0.0015 841 0.77 0.0011 842 1.55 0.02 843>7.5 0.0031 844 1.03 0.0008 845>7.5 0.0060 846 1.04 0.0130 847>7.5 0.0008 848 0.19 0.002 849 1.82 0.002 850 2.33 0.0008 851 1.43 0.017 852>7.5 0.005 853 0.62 0.004 854 0.02 855 0.02 856 0.02 857>7.5 0.0006 858>7.5 0.0007 859 0.5 0.00001 860>7.5 0.001 861>7.5 0.002 862>7.5 0.1 863>7.5 2.0 864>7.5 0.5 865>7.5 0.0001 866>10 50>10 0.035 875>50 18>10>2.2 879 4 65 10 0.3 888 6 31>10 0.06 897>10 62>10 0.037 902>10 10>10 0.12 904 12 58>10 0.4 905 4 82 2 0.3 907>10 36>10 0.009 911>10 25>10 0.3 IC50 IC50 % IC50
μg/ml????????????(μg/ml)???????????????10μg/ml?????????????(μg/ml)
HCMV???????????????HSV????????????????????VZV???????????????????VZV?912?????????????????>10????????????????0?????????????????????>10?????????????????0.16?913?????????????????>10????????????????15????????????????????>10?????????????????0.056?917?????????????????10????????????????????????????????????????>10?????????????????0.2?918?????????????????>10??????????????????????????????????????>10?????????????????0.03?919?????????????????>10??????????????????????????????????????>10?????????????????0.05?921?????????????????8???????????????????85????????????????????7????????????????????0.05?922?????????????????>10????????????????84????????????????????7????????????????????0.01?939?????????????????>10????????????????53????????????????????15???????????????????0.018?960?????????????????>10????????????????58????????????????????>10?????????????????0.03?961?????????????????>10????????????????20????????????????????>10?????????????????0.006?964?????????????????>10????????????????9?????????????????????>10?????????????????0.03?965?????????????????>10????????????????36????????????????????>10?????????????????0.008?966?????????????????>10????????????????42????????????????????>10?????????????????0.02?969?????????????????>10????????????????40????????????????????>10?????????????????0.03?970?????????????????>10????????????????16????????????????????>10?????????????????0.06?971?????????????????>10????????????????9?????????????????????>10?????????????????0.013?972?????????????????>10????????????????95????????????????????>15?????????????????0.006?974?????????????????>10????????????????14????????????????????>10?????????????????0.011?979?????????????????8???????????????????88????????????????????12???????????????????0.19?980?????????????????>10????????????????56????????????????????>10?????????????????0.05?983?????????????????>10????????????????52????????????????????>10?????????????????0.12?986?????????????????>10????????????????5?????????????????????>10?????????????????0.031?989?????????????????>10????????????????21????????????????????>10?????????????????0.016?990?????????????????8???????????????????99????????????????????4.5??????????????????0.011?991?????????????????>10????????????????3?????????????????????>10?????????????????0.022?992?????????????????>10????????????????29????????????????????>10?????????????????0.018?993?????????????????>10??????????????????????????????????????>10?????????????????0.013?994?????????????????>10??????????????????????????????????????>10?????????????????0.07?996?????????????????10????????????????????????????????????????>10?????????????????0.15?998?????????????????>10??????????????????????????????????????>10?????????????????0.016?1000????????????????>10??????????????????????????????????????>10?????????????????0.39?1002????????????????>10??????????????????????????????????????>10?????????????????0.07?1004????????????????>10????????????????36????????????????????>10?????????????????0.5?1005????????????????>10????????????????16????????????????????>10?????????????????2?1006????????????????>10????????????????13????????????????????>10?????????????????0.2?1007????????????????>10????????????????18????????????????????>10?????????????????0.11?1008????????????????>10????????????????15????????????????????>10?????????????????0.12?1009????????????????10??????????????????22????????????????????>10?????????????????0.2?1011????????????????>10????????????????20????????????????????>10?????????????????0.039?1018????????????????>10????????????????2?????????????????????>10?????????????????0.4?1019????????????????>10????????????????2?????????????????????>10?????????????????1.5?1021????????????????8???????????????????68????????????????????>10?????????????????0.094?1126????????????????>10??????????????????????????????????????0.7??????????????????5.8?1127????????????????9.5???????????????????????????????????????3.7??????????????????1?1128????????????????>10??????????????????????????????????????>10?????????????????1.3
Example I C50 IC50 suppresses % IC50
μg/ml????????????(μg/ml)?????????????10μg/ml?????????(μg/ml)
HCMV????????????????HSV?????????????????VZV???????????????VZV
1129?????????????????1.9????????????????????????????????????>10??????????????1
1130?????????????????2??????????????????????????????????????5.5???????????????2
1131?????????????????2.2????????????????????????????????????9?????????????????1.5
1132?????????????????2.6????????????????????????????????????3.9???????????????1.2
1133?????????????????6??????????????????????????????????????>10??????????????1.5
1134?????????????????2.4????????????????????????????????????1.6???????????????1
1135?????????????????3.6????????????????????????????????????7.5???????????????1.3
1136?????????????????2.9????????????????????????????????????5?????????????????1.6
1137?????????????????>10???????????????????????????????????3.5???????????????0.6
1138?????????????????>10???????????????????????????????????>10??????????????0.65
1139?????????????????3.7????????????????????????????????????6?????????????????1.2
1140?????????????????3.5????????????????????????????????????4?????????????????1.6
1141?????????????????>10???????????????????????????????????>10??????????????1.9
1142?????????????????>10???????????????????????????????????>10??????????????1.8
1143?????????????????>10???????????????????????????????????>10??????????????7.5
Therefore, compound of the present invention is the potent inhibitor that simplexvirus (comprising HCMV, VZV and HSV) grows and duplicates, and effectively suppresses viral yield.
According to the present invention, compound of the present invention can be applied to the patient who infects simplexvirus (comprising HCMV, VZV and HSV) with significant quantity, suppress virus.Therefore, compound of the present invention can be used for improving or eliminating the herpesvirus infection symptom of Mammals (including but not limited to the people).
Compound of the present invention can be pure or and conventional medicine learn carrier and be applied to patient together.
Spendable solid carrier comprises one or more materials, and they are also as perfume compound, lubricant, solubilizing agent, suspension agent, filler, glidant, compression auxiliary material, tackiness agent or tablet-disintegrating agent or encapsulated materials.With powder type, carrier can be superfine solid, and it mixes with superfine activeconstituents.With tablet form, the carrier with required compression performance of activeconstituents and proper ratio mixes, and is pressed into desired shape and size.Powder and tablet preferably contain and reach 99% activeconstituents.Suitable solid-state carrier for example comprises: calcium phosphate, Magnesium Stearate, talcum, sugar, lactose, dextrin, starch, gelatin, Mierocrystalline cellulose/methylcellulose gum, carboxylic acid methyl sodium cellulosate, polyvinylpyrrolidone/, low melt wax and ion exchange resin.
Liquid phase carrier can be used for preparing solution, suspension, emulsion, syrup and elixir.Activeconstituents of the present invention dissolves in or is suspended in acceptable carrier on the pharmacology, as water, organic solvent, both mixture or pharmacology in acceptable oil or the fat.Liquid phase carrier can contain other suitable pharmacology additive, as solubilizing agent, emulsifying agent, buffer reagent, sanitas, sweeting agent, reodorant, suspension agent, thickening material, pigment, viscosity modifier, stablizer or Osmolyte regulator.Liquid phase carrier oral or that the parenteral dispenser is suitable comprises that water (particularly contains above-mentioned additive, as derivatived cellulose, the preferably carboxymethyl cellulose sodium solution), alcohol (comprising monohydroxy-alcohol and polyvalent alcohol) and derivative thereof as glycol, and oil (as fractionated Oleum Cocois and peanut oil).For the parenteral dispenser, carrier can also be a grease, as ethyl oleate and Isopropyl myristate.Aseptic liquid phase carrier is used for the sterile liquid form composition that parenteral is used.
But the liquid medicine composition of sterile liquid or suspensions is used in intramuscular, intraperitoneal or subcutaneous injection.Also but intravenously is used sterile solution.Oral dispenser can be liquid state or solid-state composition form.
Preferred pharmaceutical compositions is single agent form, as tablet or capsule.The composition of this form is divided into the unitary dose that contains an amount of activeconstituents again; Unit dosage form can be a packaged composition, as powder, tubule, ampoule, prepackage syringe of packing or the pouch that contains liquid.Unit dosage for example can be: capsule or tablet itself maybe can be these compositions of an amount of any packaged form.
Must in the treatment of herpesvirus infection, determine the used effective dosage of treatment according to the personal considerations by the doctor who participates in.Relevant factor comprises patient's situation, age and body weight.The novel method that the present invention treats herpesvirus infection comprises the compound of using (comprising the mankind) at least a formula I of significant quantity to individual, or it is nontoxic, acceptable salt on the pharmacology.But these compounds are used in oral cavity, rectum, parenteral or external application (to skin or mucous membrane).General consumption every day is determined by particular compound, methods of treatment and patient.General every day consumption for oral be 0.01-1000 milligram/kilogram, preferred 0.5-500 milligram/kilogram, using for parenteral is 0.1-100 milligram/kilogram, preferably 0.5-50 milligram/kilogram.
Claims (28)
R
1-R
5Be selected from respectively cycloalkyl, a 3-10 carbon atom of perhaloalkyl radical, a 3-10 carbon atom of alkynyl, a 1-6 carbon atom of alkenyl, a 2-6 carbon atom of alkyl, a 2-6 carbon atom of hydrogen, a 1-6 carbon atom Heterocyclylalkyl, aryl, heteroaryl, halogen ,-CN ,-NO
2,-CO
2R
6,-COR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6,-CONR
7R
8,-NR
6N (R
7R
8) ,-N (R
7R
8) or W-Y-(CH
2)
n-Z, condition is R
1-R
5At least one is not a hydrogen; Or R
2And R
3, or R
3And R
4Form 3-7 unit's Heterocyclylalkyl or 3-7 unit heteroaryl altogether;
R
6And R
7Be respectively the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, or aryl;
R
8Be the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, cycloalkyl, 3-10 unit Heterocyclylalkyl, aryl or the heteroaryl of a 3-10 carbon atom, or
R
7And R
8Can form 3-7 unit Heterocyclylalkyl altogether;
W is O, NR
6, or do not exist;
Y is-(CO)-or-(CO
2)-, or do not exist;
Z be 1-4 carbon atom alkyl ,-CN ,-CO
2R
6, COR
6,-CONR
7R
8,-OCOR
6,-NR
6COR
7,-OCONR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6, SR
6N (R
7R
8) ,-N (R
7R
8) or phenyl;
G is a bicyclic heteroaryl;
X be a key ,-alkylamino of the alkoxyl group of the alkyl of NH, a 1-6 carbon atom, the alkenyl of a 1-6 carbon atom, a 1-6 carbon atom, the alkylthio of a 1-6 carbon atom, a 1-6 carbon atom or (CH) J;
J is the alkyl of 1-6 carbon atom, cycloalkyl, phenyl or the benzyl of a 3-7 carbon atom; With
N is the integer of 1-6.
2. compound as claimed in claim 1 is characterized in that R
1-R
5Be respectively alkyl, the halogen of hydrogen, a 1-6 carbon atom, perhaloalkyl radical, the OR of a 1-6 carbon atom
6Or N (R
7R
8).
3. compound as claimed in claim 1 is characterized in that R
1, R
2And R
3Be hydrogen, and R
4And R
5Be respectively halogen or CF
3
4. compound as claimed in claim 1 is characterized in that R
1, R
2And R
4Be hydrogen, and R
3And R
5Be respectively halogen or CF
3
5. compound as claimed in claim 1 is characterized in that, G is thiazolyl, thiadiazolyl group, oxazolyl, furyl or isoquinoline 99.9.
6. compound as claimed in claim 1 is characterized in that G is a thiazolyl.
7. compound as claimed in claim 1 is characterized in that G is 1,2,3 thiadiazolyl groups.
8. compound as claimed in claim 1 is characterized in that X is a key.
9. compound as claimed in claim 1 is characterized in that X is a straight chained alkyl.
10. compound as claimed in claim 1 is characterized in that, X is the alkyl of 1-4 carbon atom.
11. compound as claimed in claim 1 is characterized in that, X is CH (J), and J is the alkyl of 1-6 carbon atom.
12. compound as claimed in claim 1 is characterized in that, J is a methyl.
13. compound as claimed in claim 1 is characterized in that, X is CH (J), and G is a thiazolyl.
14. compound as claimed in claim 1 is characterized in that, this compound is selected from:
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-piperidines-1-base-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-dimethylamino-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-dimethylamino-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-fluoro-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
The thiazole-4-carboxylic acid 4-[3-(the 4-tertiary butyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-fluoro-5-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
The thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-benzyls)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(the 4-tertiary butyl-benzyl)-thioureido]-phenyl }-acid amides
The thiazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-5-trifluoromethyl-thiophenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2,4-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-fluoro-3-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,5-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-iodo-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-thiophenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2,4-two chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-5-trifluoromethyl-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides
The thiazole-4-carboxylic acid 4-[3-(2-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-iodo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
Furans-2-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(2-methyl-butyl)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-isobutyl--5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-dimethylamino-5-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(5-bromo-2-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,5-two chloro-phenoxy groups)-ethyl]-thioureido }-phenyl)-acid amides
The thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides
The thiazole-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two chloro-thiophenyls)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-3-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-5-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-iodo-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid [4-(3-benzo [1,3] dioxole-5-ylmethyl-thioureido)-phenyl]-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,3-phenylbenzene-propyl group)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-fluoro-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two chloro-phenoxy groups)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-bromo-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-tetramethyleneimine-1-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(butyl-methyl-amino)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-dimethyl-phenmethyl)-thioureido]-phenyl }-acid amides
The thiazole-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-bromo-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-chloro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-ethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-benzyls)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(3,5-two chloro-benzyls)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-p-methylphenyl-ethyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-phenyl-butyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-thiophenyl-ethyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-iodo-benzyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid (4-{3-[2-(3-bromo-thiophenyl)-ethyl]-thioureido }-phenyl)-acid amides
Oxazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,5-two fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-iodo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-amino-5-chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-bromo-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(isobutyl--methyl-amino)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-phenyl-propyl group)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-fluoro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4,5-three chloro-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-morpholine-4-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-fluoro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-fluoro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-iodo-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-bromo-4-trifluoromethoxy-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-dimethylamino-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[4-(4-methyl-piperazine-1-yl)-3-trifluoromethyl-benzyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-bromo-3-chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-phenoxy group-ethyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-methoxyl group-phenyl)-ethyl]-thioureido }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(3-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-nitro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-piperidines-1-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
Oxazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(3,4,5-three chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid [4-(3-benzo [1,3] dioxole-5-base-methyl-thioureido)-phenyl]-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid [4-(3-styroyl-thioureido)-phenyl]-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-chloro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-chloro-4-(1H-pyrazole-3-yl)-phenyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-chloro-4-(2-piperidines-1-base-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-acid amides
Furans-2-carboxylic acid [4-(3-benzyl-thioureido)-phenyl]-acid amides
Furans-2-carboxylic acid (4-{3-[2-(3,5-two chloro-phenoxy groups)-ethyl]-thioureido }-phenyl)-acid amides
Furans-2-carboxylic acid 4-[3-(2-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-4-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
Oxazole-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid (4-{3-[2-(3,4-two chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-chloro-benzyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-bromo-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-fluoro-benzyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(4-bromo-3-chloro-phenyl)-thioureido]-phenyl }-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[(1S)-1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[(1R)-1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[1-(3,5-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[(1S)-1-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[(1R)-1-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
N-[4-[[[[1-(4-cyano-phenyl) ethyl] amino] sulphomethyl] amino] phenyl]-1,2,3-thiadiazoles-4-carboxylic acid amides
The thiazole-4-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[(1S)-1-(3,5-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides
N-(4-{[({1-[4-fluoro-3-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl]-amino }-phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides
N-(4-{[({1-[4-chloro-3-thiadiazoles-4-carboxylic acid amides
N-(4-{[({ (1S)-1-[3,5-thiazole-4-carboxylic acid amides
N-(4-{[({1-[3-fluoro-5-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[2-fluoro-4-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl]-amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[2-fluoro-5-trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl]-amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[2,4-two (trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl]-amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(2, the 4-3,5-dimethylphenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(2,4 dichloro benzene base) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(3-aminomethyl phenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[4-fluoro-3-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl]-amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(2-chloro-4-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(3, the 4-difluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(4-bromo-2-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(3-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(2-bromophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(3-bromophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[2-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(2,4 difluorobenzene base) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({ (1R)-1-[3,5-two (trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(3, the 4-dichlorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[3-fluoro-4-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[4-chloro-3-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(4-chloro-2-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[4-fluoro-2-(trifluoromethyl) phenyl] ethyl } amino) thiocarbonyl] amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(4-chloro-3-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(2-bromo-4-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(3, the 4-dibromo phenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-{4-[({[1-(3-chloro-4-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1,3-thiazoles-4-carboxylic acid amides
N-(4-{[({1-[3,5-two (trifluoromethyl) phenyl] propyl group } amino) thiocarbonyl] amino }-phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides
N-(4-{[({1-[3,5-two (trifluoromethyl) phenyl] butyl } amino) thiocarbonyl] amino }-phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides
N-(4-{[({1-[3,5-two (trifluoromethyl) phenyl] amyl group } amino) thiocarbonyl] amino }-phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides
N-{4-[({[[3,5-two (trifluoromethyl) phenyl] (phenyl) methyl] amino } thiocarbonyl) amino] phenyl }-1,2,3-thiadiazoles-4-carboxylic acid amides
N-(4-{[({1-[3,5-two (trifluoromethyl) phenyl]-the 1-methylethyl } amino) thiocarbonyl] amino }-phenyl)-1,2,3-thiadiazoles-4-carboxylic acid amides
N-{4-[({[3,5-two (trifluoromethyl) benzyl] amino } thiocarbonyl) amino] phenyl }-1H-imidazoles-4-carboxylic acid amides
N-{4-[({[1-(4-fluorophenyl) ethyl] amino } thiocarbonyl) amino] phenyl }-1H-imidazoles-4-carboxylic acid amides
N-{4-[({[3,5-two (trifluoromethyl) benzyl] amino } thiocarbonyl) amino] phenyl }-1-methyl isophthalic acid H-imidazoles-4-carboxylic acid amides
N-(4-{[({1-[3,5-two (trifluoromethyl) phenyl] propyl group } amino) thiocarbonyl] amino }-phenyl)-1,3-thiazoles-4-carboxylic acid amides; Or the salt on its pharmacology.
15. a compound is characterized in that, this compound is [1,2,3]-thiadiazoles-4-carboxylic acid { 4-[3 (3,5-di-trifluoromethyl phenyl)-thioureido]-phenyl } acid amides; Or the salt on its pharmacology.
16. a compound is characterized in that, this compound is [1,2,3]-thiadiazoles-4-carboxylic acid { 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl } acid amides; Or the salt on its pharmacology.
17. a compound is characterized in that, this compound is thiazole-4-carboxylic acid { 4-[3 (3,5-di-trifluoromethyl phenyl)-thioureido]-phenyl } acid amides; Or the salt on its pharmacology.
18. a pharmaceutical composition is characterized in that, this pharmaceutical composition contains the compound of following formula:
Wherein
R
1-R
5Be selected from respectively cycloalkyl, a 3-10 carbon atom of perhaloalkyl radical, a 3-10 carbon atom of alkynyl, a 1-6 carbon atom of alkenyl, a 2-6 carbon atom of alkyl, a 2-6 carbon atom of hydrogen, a 1-6 carbon atom Heterocyclylalkyl, aryl, heteroaryl, halogen ,-CN ,-NO
2,-CO
2R
6,-COR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6,-CONR
7R
8,-NR
6N (R
7R
8) ,-N (R
7R
8) or W-Y-(CH
2)
n-Z, condition is R
1-R
5At least one is not a hydrogen; Or R
2And R
3, or R
3And R
4Form 3-7 unit's Heterocyclylalkyl or 3-7 unit heteroaryl altogether;
R
6And R
7Be respectively the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, or aryl;
R
8Be the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, cycloalkyl, 3-10 unit Heterocyclylalkyl, aryl or the heteroaryl of a 3-10 carbon atom, or
R
7And R
8Can form 3-7 unit Heterocyclylalkyl altogether;
W is O, NR
6, or do not exist;
Y is-(CO)-or-(CO
2)-, or do not exist;
Z be 1-4 carbon atom alkyl ,-CN ,-CO
2R
6, COR
6,-CONR
7R
8,-OCOR
6,-NR
6COR
7,-OCONR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6, SR
6N (R
7R
8) ,-N (R
7R
8) or phenyl;
G is a bicyclic heteroaryl;
X be a key ,-alkylamino of the alkoxyl group of the alkyl of NH, a 1-6 carbon atom, the alkenyl of a 1-6 carbon atom, a 1-6 carbon atom, the alkylthio of a 1-6 carbon atom, a 1-6 carbon atom or (CH) J;
J is the alkyl of 1-6 carbon atom, cycloalkyl, phenyl or the benzyl of a 3-7 carbon atom; With
N is the integer of 1-6;
Or acceptable carrier or thinner on acceptable salt and the pharmacology on its pharmacology.
19. a method that suppresses herpes virus replication is characterized in that, this method comprises the compound that makes following formula:
Wherein
R
1-R
5Be selected from respectively cycloalkyl, a 3-10 carbon atom of perhaloalkyl radical, a 3-10 carbon atom of alkynyl, a 1-6 carbon atom of alkenyl, a 2-6 carbon atom of alkyl, a 2-6 carbon atom of hydrogen, a 1-6 carbon atom Heterocyclylalkyl, aryl, heteroaryl, halogen ,-CN ,-NO
2,-CO
2R
6,-COR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6,-CONR
7R
8,-NR
6N (R
7R
8) ,-N (R
7R
8) or W-Y-(CH
2)
n-Z, condition is R
1-R
5At least one is not a hydrogen; Or R
2And R
3, or R
3And R
6Form 3-7 unit's Heterocyclylalkyl or 3-7 unit heteroaryl altogether;
R
6And R
7Be respectively the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, or aryl;
R
8Be the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, cycloalkyl, 3-10 unit Heterocyclylalkyl, aryl or the heteroaryl of a 3-10 carbon atom, or
R
7And R
8Can form 3-7 unit Heterocyclylalkyl altogether;
W is O, NR
6, or do not exist;
Y is-(CO)-or-(CO
2)-, or do not exist;
Z be 1-4 carbon atom alkyl ,-CN ,-CO
2R
6, COR
6,-CONR
7R
8,-OCOR
6,-NR
6COR
7,-OCONR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6, SR
6N (R
7R
8) ,-N (R
7R
8) or phenyl;
G is a bicyclic heteroaryl;
X be a key ,-alkylamino of the alkoxyl group of the alkyl of NH, a 1-6 carbon atom, the alkenyl of a 1-6 carbon atom, a 1-6 carbon atom, the alkylthio of a 1-6 carbon atom, a 1-6 carbon atom or (CH) J;
J is the alkyl of 1-6 carbon atom, cycloalkyl, phenyl or the benzyl of a 3-7 carbon atom; With
N is the integer of 1-6;
Or the salt on its pharmacology contacts with simplexvirus.
20. method as claimed in claim 19 is characterized in that, described simplexvirus is a human cytomegalic inclusion disease virus.
21. method as claimed in claim 19 is characterized in that, described simplexvirus is a varicella zoster virus.
22. method as claimed in claim 21 is characterized in that, described compound is pure (S) optical isomer on substantially.
23. method as claimed in claim 19 is characterized in that, described simplexvirus is a hsv.
24. a method for the treatment of the patient who suffers from herpesvirus infection is characterized in that this method comprises the compound with following formula that is applied to the patient significant quantity:
Wherein
R
1-R
5Be selected from respectively cycloalkyl, a 3-10 carbon atom of perhaloalkyl radical, a 3-10 carbon atom of alkynyl, a 1-6 carbon atom of alkenyl, a 2-6 carbon atom of alkyl, a 2-6 carbon atom of hydrogen, a 1-6 carbon atom Heterocyclylalkyl, aryl, heteroaryl, halogen ,-CN ,-NO
2,-CO
2R
6,-COR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6,-CONR
7R
8,-NR
6N (R
7R
8) ,-N (R
7R
8) or W-Y-(CH
2)
n-Z, condition is R
1-R
5At least one is not a hydrogen; Or R
2And R
3, or R
3And R
4Form 3-7 unit's Heterocyclylalkyl or 3-7 unit heteroaryl altogether;
R
6And R
7Be respectively the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, or aryl;
R
8Be the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, cycloalkyl, 3-10 unit Heterocyclylalkyl, aryl or the heteroaryl of a 3-10 carbon atom, or
R
7And R
8Can form 3-7 unit Heterocyclylalkyl altogether;
W is O, NR
6, or do not exist;
Y is-(CO)-or-(CO
2)-, or do not exist;
Z be 1-4 carbon atom alkyl ,-CN ,-CO
2R
6, COR
6,-CONR
7R
8,-OCOR
6,-NR
6COR
7,-OCONR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6, SR
6N (R
7R
8) ,-N (R
7R
8) or phenyl;
G is a bicyclic heteroaryl;
X be a key ,-alkylamino of the alkoxyl group of the alkyl of NH, a 1-6 carbon atom, the alkenyl of a 1-6 carbon atom, a 1-6 carbon atom, the alkylthio of a 1-6 carbon atom, a 1-6 carbon atom or (CH) J;
J is the alkyl of 1-6 carbon atom, cycloalkyl, phenyl or the benzyl of a 3-7 carbon atom; With
N is the integer of 1-6;
Or the salt on its pharmacology.
25. method as claimed in claim 24 is characterized in that, described simplexvirus is a human cytomegalic inclusion disease virus.
26. method as claimed in claim 24 is characterized in that, described simplexvirus is a varicella zoster virus.
27. method as claimed in claim 26 is characterized in that, described compound is pure basically (S) optical isomer.
28. method as claimed in claim 24 is characterized in that, described simplexvirus is a hsv.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20855998A | 1998-12-09 | 1998-12-09 | |
US09/208,559 | 1998-12-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1348446A true CN1348446A (en) | 2002-05-08 |
Family
ID=22775044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN99815997A Pending CN1348446A (en) | 1998-12-09 | 1999-12-06 | Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1144397A3 (en) |
JP (1) | JP2002531554A (en) |
CN (1) | CN1348446A (en) |
AU (1) | AU1934700A (en) |
BG (1) | BG105581A (en) |
BR (1) | BR9916046A (en) |
CA (1) | CA2350767A1 (en) |
CZ (1) | CZ20011956A3 (en) |
EA (1) | EA200100631A1 (en) |
HU (1) | HUP0200232A2 (en) |
ID (1) | ID30158A (en) |
IL (1) | IL143182A0 (en) |
NO (1) | NO20012832L (en) |
PL (1) | PL349217A1 (en) |
SK (1) | SK7682001A3 (en) |
TR (1) | TR200101664T2 (en) |
WO (1) | WO2000034258A2 (en) |
ZA (1) | ZA200104377B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6166028A (en) * | 1998-12-09 | 2000-12-26 | American Home Products Corporation | Diaminopuridine-containing thiourea inhibitors of herpes viruses |
US6844367B1 (en) | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
ES2254385T3 (en) | 2000-02-29 | 2006-06-16 | Millennium Pharmaceuticals, Inc. | RELATED BENZAMIDS AND INHIBITORS OF FACTOR XA. |
US7220768B2 (en) * | 2003-02-11 | 2007-05-22 | Wyeth Holdings Corp. | Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus |
ATE544749T1 (en) | 2006-11-02 | 2012-02-15 | Millennium Pharm Inc | METHOD FOR SYNTHESIZING PHARMACEUTICAL SALTS FROM A FACTOR XA INHIBITOR |
JP6372666B2 (en) * | 2012-11-03 | 2018-08-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Inhibitor of cytomegalovirus |
WO2014070978A1 (en) * | 2012-11-03 | 2014-05-08 | Boehringer Ingelheim International Gmbh | Inhibitors of cytomegalovirus |
CN110565100B (en) * | 2019-07-12 | 2021-05-07 | 西北工业大学 | Cobaltocene cation-based corrosion inhibitor and preparation method and use method thereof |
CN117769548A (en) | 2021-08-05 | 2024-03-26 | 浙江海正药业股份有限公司 | Aromatic acetylene derivative and preparation method and application thereof |
WO2023088718A1 (en) | 2021-11-19 | 2023-05-25 | Basf Se | Bicyclic compounds for the control of invertebrate pests |
CN115433093A (en) * | 2022-09-26 | 2022-12-06 | 无锡双启科技有限公司 | Preparation method of 3-chloro-4-trifluoromethylaniline |
CN115710190A (en) * | 2022-11-16 | 2023-02-24 | 常州佳德医药科技有限公司 | 4-methoxy-2-amino-N, N-dimethylaniline, preparation method and application |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998045259A2 (en) * | 1997-04-10 | 1998-10-15 | Pharmacia & Upjohn Company | Polyaromatic antiviral compositions |
-
1999
- 1999-12-06 EP EP99963023A patent/EP1144397A3/en not_active Withdrawn
- 1999-12-06 SK SK768-2001A patent/SK7682001A3/en unknown
- 1999-12-06 CZ CZ20011956A patent/CZ20011956A3/en unknown
- 1999-12-06 TR TR2001/01664T patent/TR200101664T2/en unknown
- 1999-12-06 JP JP2000586705A patent/JP2002531554A/en active Pending
- 1999-12-06 ID IDW00200101231A patent/ID30158A/en unknown
- 1999-12-06 BR BR9916046-3A patent/BR9916046A/en not_active Application Discontinuation
- 1999-12-06 WO PCT/US1999/028842 patent/WO2000034258A2/en not_active Application Discontinuation
- 1999-12-06 CA CA002350767A patent/CA2350767A1/en not_active Abandoned
- 1999-12-06 CN CN99815997A patent/CN1348446A/en active Pending
- 1999-12-06 EA EA200100631A patent/EA200100631A1/en unknown
- 1999-12-06 IL IL14318299A patent/IL143182A0/en unknown
- 1999-12-06 AU AU19347/00A patent/AU1934700A/en not_active Abandoned
- 1999-12-06 HU HU0200232A patent/HUP0200232A2/en unknown
- 1999-12-06 PL PL99349217A patent/PL349217A1/en not_active Application Discontinuation
-
2001
- 2001-05-28 ZA ZA200104377A patent/ZA200104377B/en unknown
- 2001-06-08 NO NO20012832A patent/NO20012832L/en not_active Application Discontinuation
- 2001-06-08 BG BG105581A patent/BG105581A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000034258A2 (en) | 2000-06-15 |
EP1144397A3 (en) | 2002-09-11 |
SK7682001A3 (en) | 2002-07-02 |
CA2350767A1 (en) | 2000-06-15 |
NO20012832D0 (en) | 2001-06-08 |
ZA200104377B (en) | 2002-12-20 |
NO20012832L (en) | 2001-08-07 |
BG105581A (en) | 2001-12-31 |
IL143182A0 (en) | 2002-04-21 |
WO2000034258A3 (en) | 2001-11-29 |
CZ20011956A3 (en) | 2001-10-17 |
PL349217A1 (en) | 2002-07-01 |
HUP0200232A2 (en) | 2002-05-29 |
ID30158A (en) | 2001-11-08 |
AU1934700A (en) | 2000-06-26 |
JP2002531554A (en) | 2002-09-24 |
EA200100631A1 (en) | 2002-02-28 |
EP1144397A2 (en) | 2001-10-17 |
TR200101664T2 (en) | 2002-03-21 |
BR9916046A (en) | 2001-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1169795C (en) | Nitrogenous heterocyclic compounds | |
CN1211382C (en) | Quinazoline ditosylate salt compounds | |
CN1219768C (en) | Quinoline derivatives as inhibitors of MEK enzymes | |
CN1252054C (en) | Qinoline derivatives inhibiting effect of growth factors such as VEGF | |
CN1171872C (en) | Compounds for modulation of PPAP gamma activity | |
CN1267431C (en) | Substituted quinazoline derivatives and their use as inhibitors | |
CN1151140C (en) | Glucokinase activators | |
CN1114402C (en) | Isothiazolones | |
CN1333750A (en) | Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses | |
CN1926103A (en) | Sulphonylpyrroles as HDAC inhibitors | |
CN1118457C (en) | Cyclic diamine compounds and medicine contg. same | |
CN1151157A (en) | Metalloproteinase inhibitors | |
CN1351590A (en) | Compounds | |
CN1906155A (en) | Novel hydroxamic acid esters and pharmaceutical use thereof | |
CN1413210A (en) | Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases | |
CN1214041A (en) | Sulfonated amino acid derivatives and metalloproteinase inhibitors contg. same | |
CN1331688A (en) | Aminopyrazole derivatives | |
CN1348446A (en) | Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group | |
CN1678586A (en) | Substituted quinoline CCR5 receptor antagonists | |
CN1157617A (en) | Heterobicyclic derivatives | |
CN1942445A (en) | Novel quinoline-carbaxamides as JACK3 kinase modulators | |
CN1659156A (en) | Novel guanidinobenzamides | |
CN1168667A (en) | Pyridopyrimidones, quinolines and fused N-heretocycles as bradykinin antagonists | |
CN1070173C (en) | Benzoylaguanidine derivatives as medicaments | |
CN101068797A (en) | Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |